Patent Grant
12082581
The present application is a 35 U.S.C. § 371 national stage patent application of International patent application PCT/JP2020/025341, filed on Jun. 26, 2020, which is based on and claims the benefits of priority to Japanese Application No. 2019-120901, filed on Jun. 28, 2019, and Japanese Application No. 2020-015184, filed on Jan. 31, 2020. The entire contents of all of the above applications are incorporated herein by reference.
This application claims priority to and the benefit of Japanese Patent Application Nos. 2019-120901 filed Jun. 28, 2019 and 2020-015184 filed Jan. 31, 2020, the entire contents of which are incorporated herein by reference.
The present invention is related to an acrylate derivative, a use and a production intermediate compound of the same.
Patent document 1 describes an acrylate derivative.
An object of the present invention is to provide a compound having an excellent efficacy for controlling pests.
The present inventors have intensively studied to find compounds having an excellent efficacy for controlling pests, and as a result, found that a compound represented by the following formula (I) has an excellent efficacy for controlling pests.
That is, the present invention includes the followings.
[1] A compound represented by formula (I):
[wherein,
[wherein
[wherein
[wherein
[wherein
The present invention can control pests.
The substituents as used herein are explained as follows.
The term “halogen atom” represents a fluorine atom, a chlorine atom, a bromine atom, or an iodine atom.
When a substituent has two or more halogen atoms, the halogen atoms are identical to or different from each other.
The expression “CX-CY” as used herein represents that the number of carbon atoms is from X to Y. For example, the expression “C1-C6” represents that the number of carbon atoms is from 1 to 6.
The term “chain hydrocarbon group” represents an alkyl group, an alkenyl group, or an alkynyl group.
Examples of the “alkyl group” include methyl group, ethyl group, propyl group, isopropyl group, 1,1-dimethylpropyl group, 1,2-dimethylpropyl group, butyl group, sec-butyl group, tert-butyl group, pentyl group, hexyl group, and decyl group.
Examples of the “alkenyl group” include vinyl group, 1-propenyl group, 2-propenyl group, 1-methyl-1-propenyl group, 1-methyl-2-propenyl group, 1,2-dimethyl-1-propenyl group, 3-butenyl group, 4-pentenyl group, 5-hexenyl group, and 9-decenyl group.
Examples of the “alkynyl group” include ethynyl group, 1-propynyl group, 2-propynyl group, 1-methyl-2-propynyl group, 1,1-dimethyl-2-propynyl group, 2-butynyl group, 4-pentynyl group, 5-hexynyl group, and 9-decynyl group.
Examples of the “alkoxy group” include methoxy group, ethoxy group, propoxy group, isopropoxy group, butoxy group, tert-butoxy group, pentyloxy group, and hexyloxy group.
Examples of the “alkylthio group” includes methylthio group, ethylthio group, propylthio group, isopropylthio group, butylthio group, tert-butylthio group, pentylthio group, and hexylthio group.
Examples of the “cycloalkyl group” include cyclopropyl group, cyclobutyl group, cyclopentyl group, and cyclohexyl group.
Examples of the “aryl group” include phenyl group, indenyl group, indanyl group, naphthyl group, and tetrahydronaphthyl group.
Examples of the “aromatic heterocyclic group” include pyrrolyl group, furyl group, thienyl group, pyrazolyl group, imidazolyl group, triazolyl group, tetrazolyl group, oxazolyl group, isoxazolyl group, thiazolyl group, isothiazolyl group, oxadiazolyl group, thiadiazolyl group, pyridyl group, pyridazinyl group, pyrimidinyl group, pyrazinyl group, triazinyl group, tetrazinyl group, indolyl group, indazolyl group, benzimidazolyl group, imidazopyridyl group, benzothiophenyl group, benzofuranyl group, quinolyl group, isoquinolyl group, quinazolinyl group, and quinoxalinyl group.
Examples of the “Non-aromatic heterocyclic group” include aziridinyl group, oxiranyl group, thiranyl group, azetidinyl group, oxetanyl group, thietanyl group, pyrrolidinyl group, tetrahydrofuranyl group, tetrahydrothienyl group, piperidyl group, pyranyl group, tetrahydropyranyl group, tetrahydrothiopyranyl group, azepanyl group, oxepanyl group, thiepanyl group, pyrazolynyl group, pyrazolidinyl group, imidazolinyl group, imidazolidinyl group, oxazolinyl group, thiazolinyl group, oxazolidinyl group, thiazolidinyl group, isoxazolinyl group, isoxazolidinyl group, isothiazolynyl group, isothiazolidinyl group, morpholinyl group, thiomorpholinyl group, and piperazinyl group.
The term(s) as described herein is/are explained.
The term of “soybean rust fungus having an amino acid substitution of F129L on mitochondrial cytochrome b protein” represents soybean rust fungus (scientific name: Phakopsora pachyrhizi) which shows a resistance against QoI fungicide by having a mutation in the mitochondrial cytochrome b gene encoding mitochondrial cytochrome protein and as a result of the mutation, causing amino acid substitution of F129L.
The present compound, the intermediate compound A, the intermediate compound B, the intermediate compound C, and the intermediate compound D may be existed as one or more stereoisomers. Examples of the stereoisomer include enantiomer, diastereoisomer, atropisomer, and geometric isomer. Each stereoisomer, and stereoisomer mixture(s) in an arbitrary ratio thereof are included in the present invention.
The present compound N or its N oxide may form an acid additional salts thereof such as hydrochloride salt, sulfate, nitrate, phosphate, acetate, and benzoate by mixing it with an acid such as hydrochloric acid, sulfuric acid, nitric acid, phosphoric acid, acetic acid, and benzoic acid.
Embodiments of the compound N of the present invention include the following compounds.
[Embodiment 1] The compound N of the present invention wherein n is 0.
[Embodiment 2] The compound according to the Embodiment 1 wherein R1 represents a methyl group or a chlorine atom.
[Embodiment 3] The compound according to the Embodiment 1 wherein R1 represents a methyl group.
[Embodiment 4] The compound according to the Embodiment 1 wherein L represents an oxygen atom.
[Embodiment 5] The compound according to the Embodiment 2 wherein L represents an oxygen atom.
[Embodiment 6] The compound according to the Embodiment 3 wherein L represents an oxygen atom.
[Embodiment 7] The compound according to the Embodiment 1 wherein R1 represents a chlorine atom.
[Embodiment 8] The compound according to the Embodiment 1 wherein L represents CH2.
[Embodiment 9] The compound according to the Embodiment 2 wherein L represents CH2.
[Embodiment 10] The compound according to the Embodiment 3 wherein L represents CH2.
[Embodiment 11] The compound according to any one of the Embodiment 1 to Embodiment 10 or the compound N of the present invention wherein
Embodiments of the intermediate compound A include the following compounds.
[Embodiment A1] The intermediate compound A wherein n is 0.
[Embodiment A2] The compound according to Embodiment A1 wherein R1 represents a methyl group or a chlorine atom.
[Embodiment A3] The compound according to Embodiment A1 wherein R1 represents a methyl group.
[Embodiment A4] The compound according to Embodiment A1 wherein L represents an oxygen atom.
[Embodiment A5] The compound according to Embodiment A2 wherein L represents an oxygen atom.
[Embodiment A6] The compound according to Embodiment A3 wherein L represents an oxygen atom.
[Embodiment A7] The compound according to Embodiment A1 wherein R1 represents a chlorine atom.
[Embodiment A8] The compound according to Embodiment A7 wherein L represents an oxygen atom.
[Embodiment A9] The compound according to Embodiment A1 wherein L represents CH2.
[Embodiment A10] The compound according to Embodiment A2 wherein L represents CH2.
[Embodiment A11] The compound according to Embodiment A3 wherein L represents CH2.
[Embodiment A12] The compound according to Embodiment A7 wherein L represents CH2.
Embodiments of the intermediate compound B include the following compounds.
[Embodiment B1] The intermediate compound B wherein n is 0.
[Embodiment B2] The compound according to Embodiment B1 wherein R1 represents a methyl group or a chlorine atom.
[Embodiment B3] The compound according to Embodiment B1 wherein R1 represents a methyl group.
[Embodiment B4] The compound according to Embodiment B1 wherein L represents an oxygen atom.
[Embodiment B5] The compound according to Embodiment B2 wherein L represents an oxygen atom.
[Embodiment B6] The compound according to Embodiment B3 wherein L represents an oxygen atom.
[Embodiment B7] The compound according to any one of Embodiment B1 to Embodiment B6 or the intermediate compound B, wherein E represents a methyl group which is substituted with one or more substituents selected from Group A, or a C2-C10 chain hydrocarbon group which may be optionally substituted with one or more substituents selected from Group A.
[Embodiment B8] The compound according to any one of Embodiment B1 to Embodiment B6 or the intermediate compound B, wherein E represents a methyl group which is substituted with one or more substituents selected from Group A.
[Embodiment B9] The compound according to any one of Embodiment B1 to Embodiment B6 or the intermediate compound B, wherein E represents a C2-C10 chain hydrocarbon group which may be optionally substituted with one or more substituents selected from Group A.
[Embodiment B10] The compound according to any one of Embodiment B1 to Embodiment B6 or the intermediate compound B, wherein E represents R6C(O)—, R4OC(O)—, R3R5NC(O)—, R3R5NC(S)—, R4S(O)2—, or R3R5NS(O)2—.
[Embodiment B11] The compound according to any one of Embodiment B1 to Embodiment B6 or the intermediate compound B, wherein E represents R3R5NC(O)—.
[Embodiment B12] The compound according to any one of Embodiment B1 to Embodiment B6 or the intermediate compound B, wherein E represents a benzyl group or a (C3-C6 cycloalkyl)methyl group.
Embodiments of the intermediate compound C include the following compounds.
[Embodiment C1] The intermediate compound C wherein n is 0.
[Embodiment C2] The compound according Embodiment C1 or the intermediate compound C, wherein E represents a methyl group which is substituted with one or more substituents selected from Group A, or a C2-C10 chain hydrocarbon group which may be optionally substituted with one or more substituents selected from Group A.
[Embodiment C3] The compound according to Embodiment C1 or the intermediate compound C, wherein E represents a methyl group which is substituted with one or more substituents selected from Group A.
[Embodiment C4] The compound according to Embodiment C1 or the intermediate compound C, wherein E represents a C2-C10 chain hydrocarbon group which may be optionally substituted with one or more substituents selected from Group A.
[Embodiment C5] The compound according to Embodiment C1 or the intermediate compound C, wherein E represents R6C(O)—, R4OC(O)—, R3R5NC(O)—, R3R5NC(S)—, R4S(O)2—, or R3R5NS(O)2—.
[Embodiment C6] The compound according to Embodiment C1 or the intermediate compound C, wherein E represents R3R5NC(O)—.
[Embodiment C7] The compound according to Embodiment C1 or the intermediate compound C, wherein E represents a benzyl group or a (C3-C6 cycloalkyl)methyl group.
Embodiments of the intermediate compound D include the following compounds.
[Embodiment D1] The intermediate compound D wherein n is 0.
[Embodiment D2] The compound according to Embodiment D1 wherein R1 represents a methyl group or a chlorine atom.
[Embodiment D3] The compound according to Embodiment D1 wherein R1 represents a methyl group.
[Embodiment D4] The compound according to Embodiment D1 wherein L represents an oxygen atom.
[Embodiment D5] The compound according to Embodiment D2 wherein L represents an oxygen atom.
[Embodiment D6] The compound according to Embodiment D3 wherein L represents an oxygen atom.
[Embodiment D7] The compound according to Embodiment D1 wherein R1 represents a chlorine atom.
[Embodiment D8] The compound according to Embodiment D7 wherein L represents an oxygen atom.
[Embodiment D9] The compound according to Embodiment D1 wherein L represents CH2.
[Embodiment D10] The compound according to Embodiment D2 wherein L represents CH2.
[Embodiment D11] The compound according to Embodiment D3 wherein L represents CH2.
[Embodiment D12] The compound according to Embodiment D7 wherein L represents CH2.
Next, a process for preparing a compound of the present invention is explained.
Process A
A compound represented by formula (I-E1) (hereinafter, referred to as Compound (I-E1)) can be prepared by reacting the intermediate compound A represented by formula (II) with a compound represented by formula (R1) (hereinafter, referred to as Compound (R1)) in the presence of phosphines and azodiesters.
[wherein E1 represents a methyl group which is substituted with one or more substituents selected from Group A, or a C2-C10 chain hydrocarbon group which may be optionally substituted with one or more substituents selected from Group A, and other symbols are the same as defined above.]
The reaction is usually carried out in a solvent. Examples of the solvent to be used in the reaction include hydrocarbons such as hexane, toluene, and xylene (hereinafter, collectively referred to as hydrocarbons); ethers such as methyl tert-butyl ether (hereinafter, referred to as MTBE), tetrahydrofuran (hereinafter, referred to as THF), dimethoxyethane (hereinafter, collectively referred to as ethers); halogenated hydrocarbons such as chloroform and chlorobenzene) (hereinafter, collectively referred to as halogenated hydrocarbons); amides such as dimethylformamide (hereinafter, referred to as DMF) and N-methyl pyrrolidone (hereinafter, collectively referred to as amides); esters such as methyl acetate and ethyl acetate (hereinafter, collectively referred to as esters); nitriles such as acetonitrile and propionitrile (hereinafter, referred to as nitriles); and mixed solvents of two or more kinds of the solvents.
Examples of phosphines include triphenylphosphine and trimethylphosphine.
Examples of azodiesters include diethyl azodicarboxylate, diisopropyl azodicarboxylate, and bis(2-methoxyethyl) azodicarboxylate.
In the reaction, the compound (R1) is usually used within a range of 1 to 10 molar ratio(s), the phosphines is usually used within a range of 1 to 10 molar ratio(s), and the azodiesters is usually used within a range of 1 to 10 molar ratio(s), as opposed to 1 mole of the intermediate compound A.
The reaction temperature for the reaction is usually with a range of 0 to 150° C. The reaction period in the reaction is usually within a range of 0.1 to 48 hours.
When the reaction is completed, water is added to reaction mixture, and the reaction mixture is extracted with organic solvent(s), and the organic layer is worked up (for example, drying and concentration) to isolate the compound (I-E1).
The compound (R1) is commercially available, or can be prepared according to a publicly known method.
Process B
The compound (I-E1) can be prepared by the intermediate compound represented by formula (II) with a compound represented by formula (R2) (hereinafter, referred to as Compound (R2)) in the presence of a base.
[wherein X1 represents a leaving group such as a chlorine atom, a bromine atom, an iodine atom, a methansulfonyl group, a p-toluenesulfonyl group, and the other symbols are the same as defined above.]
The reaction is usually carried out in a solvent. Examples of the solvent to be used in the reaction include hydrocarbons, ethers, halogenated hydrocarbons, amides, esters, nitriles, and mixed solvents of two or more of these solvents.
Examples of the bases include organic bases such as triethylamine and pyridine (hereinafter, referred to as organic bases); alkali metal carbonates such as sodium carbonate and potassium carbonate (hereinafter, referred to as alkali metal carbonates); alkali metal hydrocarbonates (such as sodium hydrocarbonates and potassium hydrocarbonates) (hereinafter, referred to as alkali metal hydrocarbonates); sodium hydride and tripotassium phosphate.
In the reaction, the compound (R2) is usually used within a range of 1 to 10 molar ratio(s), and the base is usually used within a range of 1 to 10 molar ratio(s), as opposed to 1 mole of the intermediate compound A.
The reaction mixture is usually within a range of −20 to 150° C. The reaction period in the reaction is usually within a range of 0.1 to 48 hours.
When the reaction is completed, the reaction mixtures are worked up (such as concentration and drying) to isolate the compound (I-E1).
The compound (R2) is publicly known or can be prepared according to a publicly known method.
Process C
A compound represented by formula (I-E2) (hereinafter, referred to as Compound (I-E2)) can be prepared by reacting an intermediate compound A represented by formula (II) and a compound represented by formula (R3) (hereinafter, referred to as Compound (R3)) in the presence of a base.
[wherein E2 represents R6C(O)—, R4OC(O)—, R3R5NC(O)—, R3R5NC(S)—, R4S(O)2—, or R3R5NS(O)2—, and the other symbols are the same as defined above.]
The reaction is usually carried out in a solvent. Examples of the solvents to be used in the reaction include hydrocarbons, ethers, halogenated hydrocarbons, amides, esters, nitriles and mixed solvents of two or more these solvents.
Examples of the base include organic bases, alkali metal carbonates, alkali metal hydrocarbonates, sodium hydride, and tripotassium phosphate.
In the reaction, the compound (R3) is usually used within a range of 1 to 10 molar ratio(s), and the base is usually used within a range of 1 to 10 molar ratio(s), as opposed to 1 mole of the intermediate compound A.
The reaction temperature of the reaction is usually within a range of −78 to 100° C. The reaction period in the reaction is usually within a range of 0.1 to 48 hours.
When the reaction is completed, water is added to the reaction mixtures, and the resulting mixtures are extracted with organic solvent, and the organic layers are worked up (such as drying and concentration) to isolate the compound (I-E2).
The compound (R3) is publicly known, or can be prepared according to a publicly known method.
Process D
A compound represented by formula (I-E3) (hereinafter, referred to Compound (I-E3)) can be prepared by reacting the intermediate compound A represented by formula (II) and triphosgene in the presence of a base, followed by reacting with a compound represented by formula (R4) (hereinafter, referred to as Compound (R4)). Also the reaction can be conducted in one pot.
[wherein E3 represents R4O—, or R3R5N—, and the other symbols are the same as defined.]
The reaction is usually carried out in a solvent. Examples of the solvents to be used in the reaction include hydrocarbons, ethers, halogenated hydrocarbons, amides, esters, nitriles, and mixed solvents of two or more of these solvents.
Examples of the base include organic bases.
In the reaction, triphosgene is usually used within a range of 0.3 to 3 molar ratios, the base is usually used within a range of 1 to 10 molar ration(s), and the compound (R4) is usually used within a range of 1 to 10 molar ratio(s), as opposed to 1 mole of the intermediate compound A.
The reaction temperature of the reaction of the intermediate compound A and triphosgene is usually within a range of −78 to 100° C., and the reaction period in the reaction is usually within a range of 0.1 to 48 hours. The reaction temperature of the subsequent reaction with the compound (R4) is within a range of −78 to 100° C., and the reaction period in the reaction is usually within a range of 0.1 to 48 hours.
When the reaction is completed, water is added to the reaction mixtures, and the reaction mixtures are extracted with organic solvent(s), and the organic layers are worked up (such as drying and concentration) to isolate the compound (I-E3).
The compound (R4) is publicly known, or can be prepared according to a publicly known method.
Process E
The compound N of the present invention can be prepared by reacting the intermediate compound B represented by formula (III) and iodomethane in the presence of a base.
[wherein the symbols are the same as defined above.]
The reaction is usually carried out in a solvent. Examples of the solvents to be used in the reaction include hydrocarbons, ethers, halogenated hydrocarbons, amides, esters, nitriles, and mixed solvents of two or more of these solvents.
Examples of the base to be used in the reaction include organic bases, alkali metal carbonates, alkali metal hydrocarbonates, sodium hydride, and mixtures thereof.
In the reaction, iodomethane is usually used within a range of 1 to 10 molar ratio(s), and the base is usually used within a range of 1 to 20 molar ratio(s).
The reaction temperature for the reaction is usually within a range of −20 to 100° C. The reaction period in the reaction is usually within a range of 0.1 to 48 hours.
When the reaction is completed, water is added to the reaction mixtures, and the reaction mixtures are extracted with organic solvent(s), and the organic layers are worked up (such as drying and concentration) to isolate the compound N of the present invention.
Process F
The compound (I-E1) can be prepared by reacting the intermediate compound D represented by formula (VI) and the compound (R1) in the presence of a palladium catalyst.
[wherein the symbols are the same as defined above.]
The reaction is usually carried out in a solvent. Examples of the solvents to be used in the reaction include hydrocarbons, ethers, halogenated hydrocarbons, amides, esters, nitriles, water, and mixed solvents of two or more of these solvents.
Examples of the palladium catalyst to be used in the reaction include palladium (II) acetate, {1,1′-bis (diphenylphosphino) ferrocene} dichloropalladium (II), Xphos Pd G3, BrettPhos Pd G3, tBuBrettPhos Pd G3, XantPhos Pd G3, and RockPhos Pd G3.
A ligand, a base or an additive may be added to the reaction as needed.
Examples of the ligand to be used in the reaction include 2-(di-t-butylphosphino)-1,1′-binaphthyl, BrettPhos, tBuBrettPhos, RockPhos, AdBrettPhos, tBuXPhos, and 5-(di-t-butylphosphino)-1,3′,5′-triphenyl-1′H-[1,4′]-bipyrazol.
When a ligand is used in the reaction, the ligand is usually used within a range of 0.01 to 1 molar ratio(s) as opposed to 1 mole of the intermediate compound D.
Examples of the base to be used in the reaction include organic bases; alkali metal carbonates: alkali metal alkoxides such as potassium t-butoxide, and sodium t-butoxide; and tripotassium phosphate.
When the base is used in the reaction, the base is usually used within a range of 1 to 10 molar ratio(s), as opposed to 1 mole of the intermediate compound D.
Examples of the additive to be used in the reaction include sodium iodide, and potassium iodide.
When the additive is used in the reaction, the additive is usually used within a range of 0.1 to 10 molar ratios as opposed to 1 mole of the intermediate compound D.
In the reaction, the compound (R1) is usually used within a range of 1 to 10 molar ratio(s), and palladium catalyst is used within a range of 0.01 to 1 molar ratio(s), as opposed to 1 mole of the intermediate compound D.
The reaction temperature for the reaction is usually within a range of 0 to 150° C. The reaction period in the reaction is usually within a range of 0.1 to 120 hours.
When the reaction is completed, water is added to reaction mixtures, and the reaction mixtures are extracted with organic solvent(s), and the organic layers are worked up (for example, drying and concentration) to isolate the compound (I-E1).
The compound (R1) is publicly known, or can be prepared according to a publicly known method.
Process G
The N oxide of the compound N of the present invention can be prepared by reacting the compound N of the present invention and an oxidizing agent. The reaction can be conducted according the method described in U.S. patent publication No. 2018/0009778 or WO 2016/121970 A1.
Reference Process A
The intermediate compound A represented by formula (II) can be prepared by reacting a compound represented by formula (II-A) (hereinafter, referred to as Compound (II-A)) and bis(pinacolato)diboron in the presence of a base and a palladium catalyst to obtain a compound represented by formula (II-B) (hereinafter, referred to as compound (II-B)), followed by oxidizing the compound (II-B).
[wherein X2 represents a bromine atom, an iodine atom, or a trifluoromethansulfonyl group, and the other symbols are the same as defined above.]
First, a process for preparing the compound (II-B) from the compound (II-A) is described.
The reaction is usually carried out in a solvent. Examples of the solvents to be used in the reaction include hydrocarbons, ethers, halogenated hydrocarbons, amides, esters, sulfoxides such as dimethyl sulfoxide (hereinafter, which is referred to as “DMSO”) (hereinafter, which is collectively referred to as “sulfoxides”), nitriles, and mixed solvents of two or more of these solvents.
Examples of the bases to be used in the reaction include organic bases, alkali metal carbonates, alkali metal hydrocarbonates, and tripotassium phosphate.
Examples of the palladium include [1,1′-bis(diphenylphosphino) ferrocene] palladium (II) dichloride.
In the reaction, bis(pinacolato)diboron is usually used within a range of 1 to 5 molar ratio(s), the base is usually used within a range of 1 to 5 molar ratios, and the palladium catalyst is usually used within a range of 0.01 to 0.5 molar ratios, as opposed to 1 mole of the compound (II-A).
The reaction temperature for the reaction is usually within a range of 0 to 150° C., and the reaction period in the reaction is usually within a range of 0.1 to 48 hours.
When the reaction is completed, water is added to reaction mixtures, and the reaction mixtures are extracted with organic solvent(s), and the organic layers are worked up (for example, drying and concentration) to isolate the compound (II-B).
Next, a process for preparing the intermediate compound A from the compound (II-B) is described.
The reaction is usually carried out in a solvent. Examples of the solvents to be used in the reaction include hydrocarbons; ethers; halogenated hydrocarbons; amides; esters; nitriles; alcohols such as methanol, ethanol, propanol and butanol (hereinafter, collectively referred to as alcohols), water; and mixed solvents of two or more of these solvents.
Examples of the oxidizing agent to be used in the reaction include meta-chloroperoxybenzoic and hydrogen peroxide water.
When hydrogen peroxide is used as an oxidizing agent, a base may be added as needed.
Examples of the base include sodium hydroxide and potassium hydroxide.
In the reaction, the oxidizing agent is usually used within a range of 1 to 5 molar ratio(s) as opposed to 1 mole of the compound (II-B).
When a base is usually used, the base is usually used within a range of 0.1 to 5 molar ratios as opposed to 1 mole of the compound (II-B).
The reaction temperature of the reaction is usually within a range of −20 to 120° C., and the reaction period in the reaction is usually within a range of 0.1 to 48 hours.
When the reaction is completed, water and a reducing agent such as sodium thiosulfate are added to reaction mixtures, and the reaction mixtures are extracted with organic solvent(s), and the organic layers are worked up (for example, drying and concentration) to isolate the intermediate compound A.
The compound (II-A) is publicly known, or can be prepared according to a publicly known method.
Reference Process B
The intermediate compound B represented by formula (III) can be prepared by reacting a compound represented by formula (V) (hereinafter, referred to as compound (V)) and methyl formate in the presence of a base.
[wherein the symbols are the same defined above.]
The reaction is usually carried out in a solvent. Examples of the solvents to be used in the reaction include hydrocarbons, ethers, halogenated hydrocarbons, amides, nitriles, and mixed solvents of two or more of these solvents.
Examples of the base include alkali metal hydrides such as sodium hydride and potassium hydride; alkali metal alkoxides such as sodium methoxide, sodium ethoxide and potassium tert-butoxide; alkali metal amides such as sodium amide, lithium amide, lithium diisopropylamide, sodium hexamethyldisilazide, and lithium hexamethyldisilazide; and mixtures thereof.
In the reaction, methyl formate is usually used within a range of 1 to 100 molar ratio(s), and the base is usually used within a range of 1 to 10 molar ratio(s), as opposed to 1 mole of the compound (V).
The reaction temperature for the reaction is usually within a range of −20 to 80° C. The reaction period in the reaction is usually within a range of 0.1 to 48 hours.
When the reaction is completed, acidic aqueous solution such as dilute hydrochloric acid is added to reaction mixtures, and the reaction mixtures are extracted with organic solvent(s), and the organic layers are worked up (for example, drying and concentration) to isolate the intermediate compound B.
Reference Process C
A compound represented by formula (V-E1) (hereinafter, referred to as Compound (V-E1)) can be prepared by reacting a compound represented by formula (V-A) (hereinafter referred to as Compound (V-A)) and the compound (R1) in the presence of phosphines and azo diesters.
[wherein the symbols are the same as defined above.]
The reaction can be conducted by using the compound (V-A) in the place of the intermediate compound A according to the process A.
The compound (V-A) is publicly known, or can be prepared according to a publicly known method.
Reference Process D
A compound represented by formula (V-E2) (hereinafter, referred to as “Compound (V-E2)”) can be prepared by reacting the compound (V-A) and the compound (R3) in the presence of a base.
[wherein the symbols are the same as defined above.]
The reaction can be conducted by using the compound (V-A) in the place of the intermediate compound A according to the process C.
Reference Process E
The intermediate compound D can be prepared by reacting a compound represented by formula (VI-A) (hereinafter, referred to as “Compound (VI-A)” and iodomethane in the presence of a base.
[wherein the symbols are the same as defined above.]
The reaction can be conducted by using the compound (VI-A) in the place of the intermediate compound B according to the process E.
Reference Process F
The compound (VI-A) can be prepared by reacting a compound represented by formula (VI-B) (hereinafter, referred to as “Compound (VI-B)” and methyl formate in the presence of a base.
[wherein the symbols are the same as defined above.]
The reaction can be conducted by using the compound (VI-B) in the place of the compound (V) according to the Reference process B.
The compound (VI-B) is publicly known, or can be prepared according to a publicly known method.
The present compound can be mixed or combined with one or more ingredients selected from the group consisting of the following Group (a), Group (b), Group (c), and Group (d) (hereinafter, referred to as “present ingredient”).
The mixing or combining represents that the present compound and the present ingredient are used concurrently, separately, or at an interval.
When the present compound and the present ingredient are concurrently used, the present compound and the present ingredient may be incorporated as a separate formulation or one formulation.
One aspect of the present invention relates to a composition comprising one or more ingredients selected from the group consisting of the Group (a), the Group (b), the Group (c), and the Group (d), and the present compound (hereinafter, the composition is referred to as “Composition A”).
The Group (a) represents insecticidal ingredients, miticidal ingredients and nematicidal ingredients that are a group consisting of acetylcholinesterase inhibitors (for example, carbamate insecticides and organophosphate insecticides), GABA-gated chloride ion channel antagonists (for example, phenylpyrazole insecticides), sodium channel modulators (for example, pyrethroid insecticides), nicotinic acetylcholine receptor antagonist modulators (for example, neonicotinoid insecticides), nicotinic acetylcholine receptor allosteric modulators, glutamate-gated chloride ion channel allosteric modulators (for example, macrolide insecticides), juvenile hormone mimics, multisite inhibitors, chordotonal organ TRPV channel modulators, mites growth regulators, mitochondrial ATP synthase inhibitors, uncouplers of oxidative phosphorylation, nicotinic acetylcholine receptor channel blockers (for example, nereistoxin insecticides), inhibitors of chitin biosynthesis, moulting disruptors, ecdysone receptor agonists, octopamine receptor agonists, Inhibitors of mitochondrial electron transport chain complex I, II, III, and IV, voltage-dependent sodium channel blockers, Inhibitors of acetyl CoA carboxylase, ryanodine receptor modulators (for example, diamide insecticides), chordotonal organ modulators, each active ingredient of microbial fungicides, and other insecticidal ingredients, miticidal ingredients and nematicidal ingredients. These agents are described in the classification based on the IRAC mode of action.
The Group (b) represents fungicidal ingredients that are a group consisting of nucleic acid synthesis inhibitors (for example, phenylamide fungicides and acylamino acid fungicides), cytostatic and cytoskeletal inhibitors (for example, MBC fungicides), respiration inhibitors (for example, QoI fungicides and QiI fungicides), amino-acid synthesis and protein synthesis inhibitors (for example, anilinopyridine fungicides), signal-transduction inhibitors, lipid synthesis and membrane synthesis inhibitors, sterol biosynthesis inhibitors (for example, DMI fungicides such as triazoles), cell wall synthesis inhibitors, melanin synthesis inhibitors, plant defense inducer, multisite fungicides, microbial fungicides, and other fungicidal ingredients. These agents are described in the classification based on the FRAC mode of action.
The Group (c) represents a group of plant growth modulating ingredients including mycorrhizal fungus and rhizobia.
The Group (d) represents a group of repellent ingredients.
Examples of combinations of the present ingredient and the present compound are recited as follows. For example, the “alanycarb+SX” indicates a combination of alanycarb and SX.
The abbreviation “SX” means to any one of the present compounds X selected from the compound classes SX1 to SX80 described in Examples. Further, any of the present ingredients as described below are a known ingredient, and can be obtained as a commercially available drug or prepared according to a known method. When the present ingredient represents a microorganism, the present ingredient can be obtained from a microorganism depositary authority. The number in parentheses represents CAS RN (registered trademark).
A combination of the present ingredient in the above-mentioned Group (a) and the present compound:
abamectin+SX, acephate+SX, acequinocyl+SX, acetamiprid+SX, acetoprole+SX, acrinathrin+SX, acynonapyr+SX, afidopyropen+SX, afoxolaner+SX, alanycarb+SX, aldicarb+SX, allethrin+SX, alpha-cypermethrin+SX, alpha-endosulfan+SX, aluminium phosphide+SX, amitraz+SX, azadirachtin+SX, azamethiphos+SX, azinphos-ethyl+SX, azinphos-methyl+SX, azocyclotin+SX, bark of Celastrus angulatus+SX, bendiocarb+SX, benfluthrin+SX, benfuracarb+SX, bensultap+SX, benzoximate+SX, benzpyrimoxan+SX, beta-cyfluthrin+SX, beta-cypermethrin+SX, bifenazate+SX, bifenthrin+SX, bioallethrin+SX, bioresmethrin+SX, bistrifluron+SX, borax+SX, boric acid+SX, broflanilide+SX, bromopropylate+SX, buprofezin+SX, butocarboxim+SX, butoxycarboxim+SX, cadusafos+SX, calcium phosphide+SX, carbaryl+SX, carbofuran+SX, carbosulfan+SX, cartap hydrochloride+SX, cartap+SX, chinomethionat+SX, chlorantraniliprole+SX, chlordane+SX, chlorethoxyfos+SX, chlorfenapyr+SX, chlorfenvinphos+SX, chlorfluazuron+SX, chlormephos+SX, chloropicrin+SX, chlorpyrifos+SX, chlorpyrifos-methyl+SX, chromafenozide+SX, clofentezine+SX, clothianidin+SX, concanamycin A+SX, coumaphos+SX, cryolite+SX, cyanophos+SX, cyantraniliprole+SX, cycloniliprole+SX, cycloprothrin+SX, cycloxaprid+SX, cyenopyrafen+SX, cyflumetofen+SX, cyfluthrin+SX, cyhalodiamide+SX, cyhalothrin+SX, cyhexatin+SX, cypermethrin+SX, cyphenothrin+SX, cyromazine+SX, dazomet+SX, deltamethrin+SX, demeton-S-methyl+SX, diafenthiuron+SX, diazinon+SX, dichlorvos+SX, dicloromezotiaz+SX, dicofol+SX, dicrotophos+SX, diflovidazin+SX, diflubenzuron+SX, dimefluthrin+SX, dimethoate+SX, dimethylvinphos+SX, dimpropyridaz+SX, dinotefuran+SX, disodium octaborate+SX, disulfoton+SX, DNOC (2-methyl-4,6-dinitrophenol)+SX, doramectin+SX, dried leaves of Dryopteris filix-mas+SX, emamectin-benzoate+SX, empenthrin+SX, endosulfan+SX, EPN (O-ethyl 0-(4-nitrophenyl) phenylphosphonothioate+SX, epsilon-metofluthrin+SX, epsilon-momfluorothrin+SX, esfenvalerate+SX, ethiofencarb+SX, ethion+SX, ethiprole+SX, ethoprophos+SX, etofenprox+SX, etoxazole+SX, extract of Artemisia absinthium+SX, extract of Cassia nigricans+SX, extract of clitoria ternatea+SX, extract of Symphytum officinale+SX, extracts or simulated blend of Chenopodium ambrosioides+SX, extract of Tanacetum vulgare+SX, extract of Urtica dioica+SX, extract of Viscum album+SX, famphur+SX, fenamiphos+SX, fenazaquin+SX, fenbutatin oxide+SX, fenitrothion+SX, fenobucarb+SX, fenoxycarb+SX, fenpropathrin+SX, fenpyroximate+SX, fenthion+SX, fenvalerate+SX, fipronil+SX, flometoquin+SX, flonicamid+SX, fluacrypyrim+SX, fluazaindolizine+SX, fluazuron+SX, flubendiamide+SX, flucycloxuron+SX, flucythrinate+SX, fluensulfone+SX, flufenoprox+SX, flufenoxuron+SX, flufiprole+SX, flumethrin+SX, flupyradifurone+SX, flupyrimin+SX, fluralaner+SX, fluvalinate+SX, fluxametamide+SX, formetanate+SX, fosthiazate+SX, furamethrin+SX, furathiocarb+SX, gamma-cyhalothrin+SX, GS-omega/kappa HXTX-Hvla peptide+SX, halfenprox+SX, halofenozide+SX, heptafluthrin+SX, heptenophos+SX, hexaflumuron+SX, hexythiazox+SX, potassium salt of hop beta acid+SX, hydramethylnon+SX, hydroprene+SX, imicyafos+SX, imidacloprid+SX, imidaclothiz+SX, imiprothrin+SX, indoxacarb+SX, isocycloseram+SX, isofenphos+SX, isoprocarb+SX, isopropyl-O-(methoxyaminothiophosphoryl) salicylate+SX, isoxathion+SX, ivermectin+SX, kadethrin+SX, kappa-tefluthrin+SX, kappa-bifenthrin+SX, kinoprene+SX, lambda-cyhalothrin+SX, lenoremycin+SX, lepimectin+SX, lime sulfur+SX, lotilaner+SX, lufenuron+SX, machine oil+SX, malathion+SX, mecarbam+SX, meperfluthrin+SX, metaflumizone+SX, metam+SX, methamidophos+SX, methidathion+SX, methiocarb+SX, methomyl+SX, methoprene+SX, methoxychlor+SX, methoxyfenozide+SX, methyl bromide+SX, metofluthrin+SX, metolcarb+SX, metoxadiazone+SX, mevinphos+SX, milbemectin+SX, milbemycin oxime+SX, momfluorothrin+SX, monocrotophos+SX, moxidectin+SX, naled+SX, neem oil+SX, nicotine+SX, nicotine-sulfate+SX, nitenpyram+SX, novaluron+SX, noviflumuron+SX, oil of the seeds of Chenopodium anthelminticum+SX, omethoate+SX, oxamyl+SX, oxazosulfyl+SX, oxydemeton-methyl+SX, parathion+SX, parathion-methyl+SX, permethrin+SX, phenothrin+SX, phenthoate+SX, phorate+SX, phosalone+SX, phosmet+SX, phosphamidon+SX, phosphine+SX, phoxim+SX, pirimicarb+SX, pirimiphos-methyl+SX, prallethrin+SX, profenofos+SX, profluthrin+SX, propargite+SX, propetamphos+SX, propoxur+SX, propylene glycol alginate+SX, prothiofos+SX, pyflubumide+SX, pymetrozine+SX, pyraclofos+SX, pyrethrins+SX, pyridaben+SX, pyridalyl+SX, pyridaphenthion+SX, pyrifluquinazone+SX, pyrimidifen+SX, pyriminostrobin+SX, pyriprole+SX, pyriproxyfen+SX, quinalphos+SX, resmethrin+SX, rotenone+SX, ryanodine+SX, sarolaner+SX, selamectin+SX, sigma-cypermethrin+SX, silafluofen+SX, sodium borate+SX, sodium metaborate+SX, spinetoram+SX, spinosad+SX, spirodiclofen+SX, spiromesifen+SX, spiropidion+SX, spirotetramat+SX, sulfluramid+SX, sulfotep+SX, sulfoxaflor+SX, sulfur+SX, sulfuryl fluoride+SX, tartar emetic+SX, tau-fluvalinate+SX, tebufenozide+SX, tebufenpyrad+SX, tebupirimfos+SX, teflubenzuron+SX, tefluthrin+SX, temephos+SX, terbufos+SX, terpene constituents of the extract of Chenopodium ambrosioides near ambrosioides+SX, tetrachlorantraniliprole+SX, tetrachlorvinphos+SX, tetradifon+SX, tetramethrin+SX, tetramethylfluthrin+SX, tetraniliprole+SX, theta-cypermethrin+SX, thiacloprid+SX, thiamethoxam+SX, thiocyclam+SX, thiodicarb+SX, thiofanox+SX, thiometon+SX, thiosultap-disodium+SX, thiosultap-monosodium+SX, tioxazafen+SX, tolfenpyrad+SX, tralomethrin+SX, transfluthrin+SX, triazamate+SX, triazophos+SX, trichlorfon+SX, triflumezopyrim+SX, triflumuron+SX, trimethacarb+SX, tyclopyrazoflor+SX, vamidothion+SX, wood extract of Quassia amara+SX, XMC (3,5-dimethylphenyl N-methylcarbamate)+SX, xylylcarb+SX, zeta-cypermethrin+SX, zinc phosphide+SX, N-[3-chloro-1-(pyridin-3-yl)-1H-pyrazol-4-yl]-N-ethyl-3-(3,3,3-trifluoropropanesulfinyl)propanamide (1477923-37-7)+SX, 4-[5-(3,5-dichlorophenyl)-5-(trifluoromethyl)-4,5-dihydro-1,2-oxazol-3-yl]-2-methyl-N-(1-oxothietan-3-yl)benzamide (1241050-20-3)+SX, 3-methoxy-N-(5-{5-(trifluoromethyl)-5-[3-(trifluoromethyl)phenyl]-4,5-dihydro-1,2-oxazol-3-yl}indan-1-yl)propanamide (1118626-57-5)+SX, N-[2-bromo-6-chloro-4-(1,1,1,2,3,3,3-heptafluoropropan-2-yl) phenyl]-3-{ethyl[(pyridin-4-yl)carbonyl]amino}-2-methoxybenzamide (1429513-53-0)+SX, N-[2-bromo-6-chloro-4-(1,1,1,2,3,3,3-heptafluoropropan-2-yl)phenyl]-3-[ethyl(4-cyanobenzoyl)amino]-2-methoxybenzamide (1609007-65-9)+SX, N-[2-bromo-6-(difluoromethoxy)-4-(1,1,1,2,3,3,3-heptafluoropropan-2-yl)phenyl]-3-{methyl[(pyridin-4-yl)carbonyl]amino}-2-methoxybenzamide (1630969-78-6)+SX, 1-{2-fluoro-4-methyl-5-[(2,2,2-trifluoroethyl)sulfanyl]phenyl}-3-(trifluoromethyl)-1H-1,2,4-triazol-5-amine (885026-50-6)+SX, (1Z)-2-(4-tert-butylphenyl)-2-cyano-1-(1-ethyl-3-methyl-1H-pyrazol-5-yl)ethenyl 2,2-dimethylpropanoate (1253429-01-4)+SX, N-[(1S,2S)-2-(2,4-dichlorophenyl)cyclobutyl]-2-(trifluoromethyl)pyridine-3-carboxamide+SX, BT crop protein Cry1Ab+SX, BT crop protein Cry1Ac+SX, BT crop protein Cry1Fa)+SX, BT crop protein Cry1A.105+SX, BT crop protein Cry2Ab+SX, BT crop protein Vip3A+SX, BT crop protein Cry3A+SX, BT crop protein Cry3Ab+SX, BT crop protein Cry3Bb+SX, BT crop protein Cry34Ab1/Cry35Ab1+SX, Adoxophyes orana granulosis virus strain BV-0001+SX, Anticarsia gemmatalis mNPV+SX, Autographa californica mNPV+SX, Cydia pomonella GV strain V15+SX, Cydia pomonella GV strain V22+SX, Cryptophlebia leucotreta GV+SX, Dendrolimus punctatus cypovirus+SX, Helicoverpa armigera NPV strain BV-0003+SX, Helicoverpa zea NPV+SX, Lymantria dispar NPV+SX, Mamestra brassicae NPV+SX, Mamestra configurata NPV+SX, Neodiprion abietis NPV+SX, Neodiprion lecontei NPV+SX, Neodiprion sertifer NPV+SX, Nosema locustae+SX, Orgyia pseudotsugata NPV+SX, Pieris rapae GV+SX, Plodia interpunctella GV+SX, Spodoptera exigua mNPV+SX, Spodoptera littoralis mNPV+SX, Spodoptera litura NPV+SX, Arthrobotrys dactyloides+SX, Bacillus firmus strain GB-126+SX, Bacillus firmus strain I-1582+SX, Bacillus megaterium+SX, Bacillus sp. strain AQ175+SX, Bacillus sp. strain AQ177+SX, Bacillus sp. strain AQ178+SX, Bacillus sphaericus strain 2362+SX, Bacillus sphaericus strain ABTS1743+SX, Bacillus sphaericus Serotype strain H5a5b+SX, Bacillus thuringiensis strain AQ52+SX, Bacillus thuringiensis strain BD #32+SX, Bacillus thuringiensis strain CR-371+SX, Bacillus thuringiensis subsp. aizawai strain ABTS-1857+SX, Bacillus thuringiensis subsp. aizawai strain AM65-52+SX, Bacillus thuringiensis subsp. aizawai strain GC-91+SX, Bacillus thuringiensis subsp. aizawai Serotype strain H-7+SX, Bacillus thuringiensis subsp. kurstaki strain ABTS351+SX, Bacillus thuringiensis subsp. kurstaki strain BMP123+SX, Bacillus thuringiensis subsp. kurstaki strain EG234+SX, Bacillus thuringiensis subsp. kurstaki strain EG7841+SX, Bacillus thuringiensis subsp. kurstaki strain EVB113-19+SX, Bacillus thuringiensis subsp. kurstaki strain F810+SX, Bacillus thuringiensis subsp. kurstaki strain HD-1+SX, Bacillus thuringiensis subsp. kurstaki strain PB54+SX, Bacillus thuringiensis subsp. kurstaki strain SA-11+SX, Bacillus thuringiensis subsp. kurstaki strain SA-12+SX, Bacillus thuringiensis subsp. tenebriosis strain NB176+SX, Bacillus thuringiensis subsp. thuringiensis strain MPPL002+SX, Bacillus thuringiensis subsp. morrisoni+SX, Bacillus thuringiensis var. colmeri+SX, Bacillus thuringiensis var. darmstadiensis strain 24-91+SX, Bacillus thuringiensis var. dendrolimus+SX, Bacillus thuringiensis var. galleriae+SX, Bacillus thuringiensis var. israelensis strain BMP144+SX, Bacillus thuringiensis var. israelensis serotype strain H-14+SX, Bacillus thuringiensis var. japonensis strain buibui+SX, Bacillus thuringiensis var. san diego strain M-7+SX, Bacillus thuringiensis var.7216+SX, Bacillus thuringiensis var.aegypti+SX, Bacillus thuringiensis var. T36+SX, Beauveria bassiana strain ANT-03+SX, Beauveria bassiana strain ATCC74040+SX, Beauveria bassiana strain GHA+SX, Beauveria brongniartii+SX, Burkholderia rinojensis strain A396+SX, Chromobacterium subtsugae strain PRAA4-1T+SX, Dactyllela ellipsospora+SX, Dectylaria thaumasia+SX, Hirsutella minnesotensis+SX, Hirsutella rhossiliensis+SX, Hirsutella thompsonii+SX, Lagenidium giganteum+SX, Lecanicillium lecanii strain KV01+SX, Lecanicillium lecanii conidia of strain DAOM198499+SX, Lecanicillium lecanii conidia of strain DAOM216596+SX, Lecanicillium muscarium strain Ve6+SX, Metarhizium anisopliae strain F52+SX, Metarhizium anisopliae var. acridum+SX, Metarhizium anisopliae var. anisopliae BIPESCO 5/F52+SX, Metarhizium flavoviride+SX, Monacrosporium phymatopagum+SX, Paecilomyces fumosoroseus Apopka strain 97+SX, Paecilomyces lilacinus strain 251+SX, Paecilomyces tenuipes strain T1+SX, Paenibacillus popilliae+SX, Pasteuria nishizawae strain Pn1+SX, Pasteuria penetrans+SX, Pasteuria usgae+SX, Pasteuria thoynei+SX, Serratia entomophila+SX, Verticillium chlamydosporium+SX, Verticillium lecani strain NCIM1312+SX, 2-chloro-4-fluoro-5-{[5-(trifluoromethylthio)pentyl]oxy} phenyl 2,2,2-trifluoroethyl sulfoxide (1472050-04-6)+SX, 4-chloro-5-[2,2-difluoro-2-(3,4,5-trifluorophenyl)ethoxy]-2-methylphenyl 2,2,2-trifluoroethyl sulfoxide (1632218-00-8)+SX, 4-fluoro-5-[2,2-difluoro-2-(3,4,5-trifluorophenyl)ethoxy]-2-methylphenyl 2,2,2-trifluoroethyl sulfoxide (1632217-98-1)+SX, 2-({2-fluoro-4-methyl-5-[(2,2,2-trifluoroethyl)sulfinyl]phenyl} imino)-3-(2,2,2-trifluoroethyl)-1,3-thiazolidin-4-one (1445683-71-5)+SX, (3R)-3-(2-chlorothiazol-5-yl)-8-methyl-7-oxo-6-phenyl-2,3-dihydrothiazolo[3,2-a]pyrimidin-4-ium-5-olate (2249718-27-0)+SX, N-{4-chloro-3-[(1-cyanocyclopropyl)carbamoyl]phenyl}-1-methyl-4-(methanesulfonyl)-3-(1,1,2,2,2-pentafluoroethyl)-1H-pyrazole-3-carboxamide (1400768-21-9)+SX, 11-(4-chloro-2,6-dimethylphenyl)-12-hydroxy-1,4-dioxa-9-azadispiro[4.2.4.2]tetradec-11-en-10-one (907187-07-9)+SX, 3-(4′-fluoro-2,4-dimethyl[1,1′-biphenyl]-3-yl)-4-hydroxy-8-oxa-1-azaspiro[4.5]dec-3-en-2-one (1031385-91-7)+SX, N-[3-chloro-1-(pyridin-3-yl)-1H-pyrazol-4-yl]-2-(methanesulfonyl)propanamide (2396747-83-2)+SX, 2-isopropyl-5-[(3,4,4-trifluoro-3-buten-1-yl)sulfonyl]-1,3,4-thiadiazole (2058052-95-0)+SX, nicofluprole+SX, 1,4-dimethyl-2-[2-(3-pyridinyl)-2H-indazol-5-yl]-1,2,4-triazolidine-3,5-dione (2171099-09-3)+SX.
A combination of the present ingredient in the above-mentioned Group (b) and the present compound:
acibenzolar-S-methyl+SX, aldimorph+SX, ametoctradin+SX, aminopyrifen+SX, amisulbrom+SX, anilazine+SX, azaconazole+SX, azoxystrobin+SX, basic copper sulfate+SX, benalaxyl+SX, benalaxyl-M+SX, benodanil+SX, benomyl+SX, benthiavalicarb+SX, benthivalicarb-isopropyl+SX, benzovindiflupyr+SX, binapacryl+SX, biphenyl+SX, bitertanol+SX, bixafen+SX, blasticidin-S+SX, Bordeaux mixture+SX, boscalid+SX, bromothalonil+SX, bromuconazole+SX, bupirimate+SX, captafol+SX, captan+SX, carbendazim+SX, carboxin+SX, carpropamid+SX, chinomethionat+SX, chitin+SX, chloroneb+SX, chlorothalonil+SX, chlozolinate+SX, colletochlorin B+SX, copper(II) acetate+SX, copper(II) hydroxide+SX, copper oxychloride+SX, copper(II) sulfate+SX, coumoxystrobin+SX, cyazofamid+SX, cyflufenamid+SX, cymoxanil+SX, cyproconazole+SX, cyprodinil+SX, dichlobentiazox+SX, dichlofluanid+SX, diclocymet+SX, diclomezine+SX, dicloran+SX, diethofencarb+SX, difenoconazole+SX, diflumetorim+SX, dimethachlone+SX, dimethirimol+SX, dimethomorph+SX, dimoxystrobin+SX, diniconazole+SX, diniconazole-M+SX, dinocap+SX, dipotassium hydrogenphosphite+SX, dipymetitrone+SX, dithianon+SX, dodecylbenzenesulphonic acid bisethylenediamine copper(II) salt+SX, dodemorph+SX, dodine+SX, edifenphos+SX, enoxastrobin+SX, epoxiconazole+SX, etaconazole+SX, ethaboxam+SX, ethirimol+SX, etridiazole+SX, extract from Melaleuca alternifolia+SX, extract from Reynoutria sachalinensis+SX, extract from the cotyledons of lupine plantlets (“BLAD”)+SX, extract of Allium sativum+SX, extract of Equisetum arvense+SX, extract of Tropaeolum majus+SX, famoxadone+SX, fenamidone+SX, fenaminstrobin+SX, fenarimol+SX, fenbuconazole+SX, fenfuram+SX, fenhexamid+SX, fenoxanil+SX, fenpiclonil+SX, fenpicoxamid+SX, fenpropidin+SX, fenpropimorph+SX, fenpyrazamine+SX, fentin acetate+SX, fentin chloride+SX, fentin hydroxide+SX, ferbam+SX, ferimzone+SX, florylpicoxamid+SX, fluazinam+SX, fludioxonil+SX, flufenoxystrobin+SX, fluindapyr+SX, flumorph+SX, fluopicolide+SX, fluopyram+SX, fluopimomide+SX, fluoroimide+SX, fluoxapiprolin+SX, fluoxastrobin+SX, fluquinconazole+SX, flusilazole+SX, flusulfamide+SX, flutianil+SX, flutolanil+SX, flutriafol+SX, fluxapyroxad+SX, folpet+SX, fosetyl+SX, fosetyl-aluminium+SX, fuberidazole+SX, furalaxyl+SX, furametpyr+SX, guazatine+SX, hexaconazole+SX, hymexazole+SX, imazalil+SX, imibenconazole+SX, iminoctadine+SX, iminoctadine triacetate+SX, inpyrfluxam+SX, iodocarb+SX, ipconazole+SX, ipfentrifluconazole+SX, ipflufenoquin+SX, iprobenfos+SX, iprodione+SX, iprovalicarb+SX, isofetamid+SX, isoflucypram+SX, isoprothiolane+SX, isopyrazam+SX, isotianil+SX, kasugamycin+SX, kresoxim-methyl+SX, laminarin+SX, leaves and bark of Quercus+SX, mancozeb+SX, mandestrobin+SX, mandipropamid+SX, maneb+SX, mefentrifluconazole+SX, mepanipyrim+SX, mepronil+SX, meptyldinocap+SX, metalaxyl+SX, metalaxyl-M+SX, metconazole+SX, methasulfocarb+SX, metiram+SX, metominostrobin+SX, metrafenone+SX, metyltetraprole+SX, mineral oils+SX, myclobutanil+SX, naftifine+SX, nuarimol+SX, octhilinone+SX, ofurace+SX, orysastrobin+SX, oxadixyl+SX, oxathiapiprolin+SX, oxine-copper+SX, oxolinic acid+SX, oxpoconazole+SX, oxpoconazole fumarate+SX, oxycarboxin+SX, oxytetracycline+SX, pefurazoate+SX, penconazole+SX, pencycuron+SX, penflufen+SX, penthiopyrad+SX, phenamacril+SX, phosphorous acid+SX, phthalide+SX, picarbutrazox+SX, picoxystrobin+SX, piperalin+SX, polyoxins+SX, potassium hydrogencarbonate+SX, potassium dihydrogenphosphite+SX, probenazole+SX, prochloraz+SX, procymidone+SX, propamidine+SX, propamocarb+SX, propiconazole+SX, propineb+SX, proquinazid+SX, prothiocarb+SX, prothioconazole+SX, pydiflumetofen+SX, pyraclostrobin+SX, pyrametostrobin+SX, pyraoxystrobin+SX, pyrapropoyne+SX, pyraziflumid+SX, pyrazophos+SX, pyribencarb+SX, pyributicarb+SX, pyridachlometyl+SX, pyrifenox+SX, pyrimethanil+SX, pyrimorph+SX, pyriofenone+SX, pyrisoxazole+SX, pyroquilon+SX, Quillaja extract+SX, quinconazole+SX, quinofumelin+SX, quinoxyfen+SX, quintozene+SX, Saponins of Chenopodium quinoa+SX, sedaxane+SX, silthiofam+SX, simeconazole+SX, sodium hydrogencarbonate+SX, spiroxamine+SX, streptomycin+SX, sulfur+SX, tebuconazole+SX, tebufloquin+SX, teclofthalam+SX, tecnazene+SX, terbinafine+SX, tetraconazole+SX, thiabendazole+SX, thifluzamide+SX, thiophanate+SX, thiophanate-methyl+SX, thiram+SX, thymol+SX, tiadinil+SX, tolclofos-methyl+SX, tolfenpyrad+SX, tolprocarb+SX, tolylfluanid+SX, triadimefon+SX, triadimenol+SX, triazoxide+SX, triclopyricarb+SX, tricyclazole+SX, tridemorph+SX, trifloxystrobin+SX, triflumizole+SX, triforine+SX, triticonazole+SX, validamycin+SX, valifenalate+SX, vinclozolin+SX, yellow mustard powder+SX, zinc thiazole+SX, zineb+SX, ziram+SX, zoxamide+SX, N′-[4-({3-[(4-chlorophenyl)methyl]-1,2,4-thiadiazol-5-yl}oxy)-2,5-dimethylphenyl]-N-ethyl-N-methylmethanimidamide (1202781-91-6)+SX, N′-{4-[(4,5-dichlorothiazol-2-yl)oxy]-2,5-dimethylphenyl}-N-ethyl-N-methylmethanimidamide (929908-57-6)+SX, N′-(2,5-dimethyl-4-phenoxyphenyl)-N-ethyl-N-methylmethanimidamide (1052688-31-9)+SX, N′-[5-choro-4-(2-fluorophenoxy)-2-methylphenyl)-N-ethyl-N-methylmethanimidamide (2055589-28-9)+SX, N′-[2-choro-4-(2-fluorophenoxy)-5-methylphenyl)-N-ethyl-N-methylmethanimidamide (2055756-21-1)+SX, N′-[4-(1-hydroxy-1-phenyl-2,2,2-trifluoroethyl)-2-methyl-5-methoxyphenyl)-N-isopropyl-N-methylmethanimidamide (2101814-55-3)+SX, N′-[5-bromo-6-(1-methyl-2-propoxyethoxy)-2-methylpyridin-3-yl)-N-ethyl-N-methylmethanimidamide (1817828-69-5)+SX, 4-(2-bromo-4-fluorophenyl)-N-(2-chloro-6-fluorophenyl)-1,3-dimethyl-1H-pyrazol-5-amine (1362477-26-6)+SX, 2-[6-(3-fluoro-4-methoxyphenyl)-5-methylpyridin-2-yl]quinazoline (1257056-97-5)+SX, 5-fluoro-4-imino-3-methyl-1-tosyl-3,4-dihydropyrimidin-2(1H)-one (1616664-98-2)+SX, ethyl (2Z)-3-amino-2-cyano-3-phenylacrylate (39491-78-6)+SX, N-[(2-chlorothiazol-5-yl)methyl]-N-ethyl-6-methoxy-3-nitropyridin-2-amine (1446247-98-8)+SX, 5-(4-chlorobenzyl)-2-(chloromethyl)-2-methyl-1-(1H-1,2,4-triazol-1-ylmethyl)cyclopentan-1-ol (1394057-11-4)+SX, (1R, 2S, 5S)-5-(4-chlorobenzyl)-2-(chloromethyl)-2-methyl-1-(1H-1,2,4-triazol-1-ylmethyl)cyclopentan-1-ol (1801930-06-2)+SX, (is, 2R, 5R)-5-(4-chlorobenzyl)-2-(chloromethyl)-2-methyl-1-(1H-1,2,4-triazol-1-ylmethyl)cyclopentan-1-ol (1801930-07-3)+SX, 2-(chloromethyl)-5-(4-fluorobenzyl)-2-methyl-1-(1H-1,2,4-triazol-1-ylmethyl)cyclopentan-1-ol (1394057-13-6)+SX, (1R, 2S, 5S)-2-(chloromethyl)-5-(4-fluorobenzyl)-2-methyl-1-(1H-1,2,4-triazol-1-ylmethyl)cyclopentan-1-ol (1801930-08-4)+SX, (is, 2R, 5R)-2-(chloromethyl)-5-(4-fluorobenzyl)-2-methyl-1-(1H-1,2,4-triazol-1-ylmethyl)cyclopentan-1-ol (1801930-09-5)+SX, methyl 3-[(4-chlorophenyl)methyl]-2-hydroxy-1-methyl-2-(1H-1,2,4-triazol-1-ylmethyl)cyclopentan-1-carboxylate (1791398-02-1)+SX, 1-(2,4-difluorophenyl)-2-(1H-1,2,4-triazol-1-yl)-1-[1-(4-bromo-2,6-difluorophenoxy)cyclopropyl]ethanol (2019215-86-0)+SX, 1-(2,4-difluorophenyl)-2-(1H-1,2,4-triazol-1-yl)-1-[1-(4-chloro-2,6-difluorophenoxy)cyclopropyl]ethanol (2019215-84-8)+SX, 1-[2-(1-chlorocyclopropyl)-3-(2-fluorophenyl)-2-hydroxypropyl]-1H-imidazole-5-carbonitrile (2018316-13-5)+SX, 1-[2-(1-chlorocyclopropyl)-3-(2,3-difluorophenyl)-2-hydroxypropyl]-1H-imidazole-5-carbonitrile (2018317-25-2)+SX, 4-({6-[2-(2,4-difluorophenyl)-1,1-difluoro-2-hydroxy-3-(1H-1,2,4-triazol-1-yl)propyl]pyridin-3-yl}oxy)benzonitrile (2046300-61-0)+SX, 2-[6-(4-bromophenoxy)-2-(trifluoromethyl)pyridin-3-yl]-1-(1H-1,2,4-triazol-1-yl)propan-2-ol (2082661-43-4)+SX, 2-[6-(4-chlorophenoxy)-2-(trifluoromethyl)pyridin-3-yl]-1-(1H-1,2,4-triazol-1-yl)propan-2-ol (2082660-27-1)+SX, methyl ({2-methyl-5-[1-(4-methoxy-2-methylphenyl)-1H-pyrazol-3-yl]phenyl}methyl)carbamate (1605879-98-8)+SX, 2-(difluoromethyl)-N-[1,1,3-trimethyl-2,3-dihydro-1H-inden-4-yl]pyridine-3-carboxamide (1616239-21-4)+SX, 2-(difluoromethyl)-N-[3-ethyl-1,1-dimethyl-2,3-dihydro-1H-inden-4-yl]pyridine-3-carboxamide (1847460-02-9)+SX, 2-(difluoromethyl)-N-[3-propyl-1,1-dimethyl-2,3-dihydro-1H-inden-4-yl]pyridine-3-carboxamide (1847460-05-2)+SX, (2E,3Z)-5-{[1-(4-chlorophenyl)-1H-pyrazol-3-yl]oxy}-2-(methoxyimino)-N,3-dimethylpent-3-enamide (1445331-27-0)+SX, (2E,3Z)-5-{[1-(2,4-dichlorophenyl)-1H-pyrazol-3-yl]oxy}-2-(methoxyimino)-N,3-dimethylpent-3-enamide (1445331-54-3)+SX, 5-chloro-4-({2-[6-(4-chlorophenoxy)pyridin-3-yl]ethyl} amino)-6-methylpyrimidine (1605340-92-8)+SX, N-(1-benzyl-1,3-dimethylbutyl)-8-fluoroquinoline-3-carboxamide (2132414-04-9), N-(1-benzyl-3,3,3-trifluoro-1-methylpropyl)-8-fluoroquinoline-3-carboxamide (2132414-00-5)+SX, 4,4-dimethyl-2-({4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl} methyl)isoxazolidin-3-one (2098918-25-1)+SX, 5,5-dimethyl-2-({4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl} methyl)isoxazolidin-3-one (2098918-26-2)+SX, Agrobacterium radiobactor strain K1026+SX, Agrobacterium radiobactor strain K84+SX, Bacillus amyloliquefaciens (Aveo(registered trademark) EZ Nematicide)+SX, Bacillus amyloliquefaciens strain AT332+SX, Bacillus amyloliquefaciens strain B3+SX, Bacillus amyloliquefaciens strain D747+SX, Bacillus amyloliquefaciens strain DB101+SX, Bacillus amyloliquefaciens strain DB102+SX, Bacillus amyloliquefaciens strain GB03+SX, Bacillus amyloliquefaciens strain FZB24+SX, Bacillus amyloliquefaciens strain FZB42+SX, Bacillus amyloliquefaciens strain IN937a+SX, Bacillus amyloliquefaciens strain MBI600+SX, Bacillus amyloliquefaciens strain QST713+SX, Bacillus amyloliquefaciens isolate strain B246+SX, Bacillus amyloliquefaciens strain F727+SX, Bacillus amyloliquefaciens subsp. plantarum strain D747+SX, Bacillus licheniformis strain HB-2+SX, Bacillus licheniformis strain SB3086+SX, Bacillus pumilus strain AQ717+SX, Bacillus pumilus strain BUF-33+SX, Bacillus pumilus strain GB34+SX, Bacillus pumilus strain QST2808+SX, Bacillus simplex strain CGF2856+SX, Bacillus subtilis strain AQ153+SX, Bacillus subtilis strain AQ743+SX, Bacillus subtilis strain BU1814+SX, Bacillus subtilis strain D747+SX, Bacillus subtilis strain DB101+SX, Bacillus subtilis strain FZB24+SX, Bacillus subtilis strain GB03+SX, Bacillus subtilis strain HAI0404+SX, Bacillus subtilis strain IAB/BS03+SX, Bacillus subtilis strain MBI600+SX, Bacillus subtilis strain QST30002/AQ30002+SX, Bacillus subtilis strain QST30004/AQ30004+SX, Bacillus subtilis strain QST713+SX, Bacillus subtilis strain QST714+SX, Bacillus subtilis var. Amyloliquefaciens strain FZB24+SX, Bacillus subtilis strain Y1336+SX, Burkholderia cepacia+SX, Burkholderia cepacia type Wisconsin strain J82+SX, Burkholderia cepacia type Wisconsin strain M54+SX, Candida oleophila strain 0+SX, Candida saitoana+SX, Chaetomium cupreum+SX, Clonostachys rosea+SX, Coniothyrium minitans strain CGMCC8325+SX, Coniothyrium minitans strain CON/M/91-8+SX, cryptococcus albidus+SX, Erwinia carotovora subsp. carotovora strain CGE234M403+SX, Fusarium oxysporum strain Fo47+SX, Gliocladium catenulatum strain J1446+SX, Paenibacillus polymyxa strain AC-1+SX, Paenibacillus polymyxa strain BS-0105+SX, Pantoea agglomerans strain E325+SX, Phlebiopsis gigantea strain VRA1992+SX, Pseudomonas aureofaciens strain TX-1+SX, Pseudomonas chlororaphis strain 63-28+SX, Pseudomonas chlororaphis strain AFS009+SX, Pseudomonas chlororaphis strain MA342+SX, Pseudomonas fluorescens strain 1629RS+SX, Pseudomonas fluorescens strain A506+SX, Pseudomonas fluorescens strain CL145A+SX, Pseudomonas fluorescens strain G7090+SX, Pseudomonas sp. strain CAB-02+SX, Pseudomonas syringae strain 742RS+SX, Pseudomonas syringae strain MA-4+SX, Pseudozyma flocculosa strain PF-A22UL+SX, Pseudomonas rhodesiae strain HAI-0804+SX, Pythium oligandrum strain DV74+SX, Pythium oligandrum strain M1+SX, Streptomyces griseoviridis strain K61+SX, Streptomyces lydicus strain WYCD108US+SX, Streptomyces lydicus strain WYEC108+SX, Talaromyces flavus strain SAY-Y-94-01+SX, Talaromyces flavus strain V117b+SX, Trichoderma asperellum strain ICC012+SX, Trichoderma asperellum SKT-1+SX, Trichoderma asperellum strain T25+SX, Trichoderma asperellum strain T34+SX, Trichoderma asperellum strain TV1+SX, Trichoderma atroviride strain CNCM 1-1237+SX, Trichoderma atroviride strain LC52+SX, Trichoderma atroviride strain IMI 206040+SX, Trichoderma atroviride strain SC1+SX, Trichoderma atroviride strain SKT-1+SX, Trichoderma atroviride strain T11+SX, Trichoderma gamsii strain ICC080+SX, Trichoderma harzianum strain 21+SX, Trichoderma harzianum strain DB104+SX, Trichoderma harzianum strain DSM 14944+SX, Trichoderma harzianum strain ESALQ-1303+SX, Trichoderma harzianum strain ESALQ-1306+SX, Trichoderma harzianum strain IIHR-Th-2+SX, Trichoderma harzianum strain ITEM908+SX, Trichoderma harzianum strain kd+SX, Trichoderma harzianum strain MO1+SX, Trichoderma harzianum strain SF+SX, Trichoderma harzianum strain T22+SX, Trichoderma harzianum strain T39+SX, Trichoderma harzianum strain T78+SX, Trichoderma harzianum strain TH35+SX, Trichoderma polysporum strain IMI206039+SX, Trichoderma stromaticum+SX, Trichoderma virens strain G-41+SX, Trichoderma virens strain GL-21+SX, Trichoderma viride+SX, Variovorax paradoxus strain CGF4526+SX, Harpin protein+SX, flubeneteram+SX, N-acetyl-2-(ethanesulfonyl)-N-[2-(methoxycarbonyl)-4-(trifluoromethoxy)phenyl]-4-(trifluoromethyl)benzamide (2043675-28-9)+SX, (2S,3S)-3-(2-methylphenyl)butan-2-yl N-[(3-acetoxy-4-methoxypyridin-2-yl)carbonyl]-L-alaninate (2376210-00-1)+SX, (2S,3S)-3-(4-fluoro-2-methylphenyl)butan-2-yl N-[(3-acetoxy-4-methoxypyridin-2-yl)carbonyl]-L-alaninate+SX, (2S,3S)-3-(4-methoxy-2-methylphenyl)butan-2-yl N-[(3-acetoxy-4-methoxypyridin-2-yl)carbonyl]-L-alaninate+SX, (2S,3S)-3-(2,4-dimethylphenyl)butan-2-yl N-[(3-acetoxy-4-methoxypyridin-2-yl)carbonyl]-L-alaninate (2376209-13-9)+SX, (2S,3S)-3-(2-methylphenyl)butan-2-yl N-({3-[(2-methylpropanoyl)oxy]-4-methoxypyridin-2-yl}carbonyl)-L-alaninate (2376210-02-3)+SX, (2S,3S)-3-(4-fluoro-2-methylphenyl)butan-2-yl N-({3-[(2-methylpropanoyl)oxy]-4-methoxypyridin-2-yl}carbonyl)-L-alaninate+SX, (2S,3S)-3-(4-methoxy-2-methylphenyl)butan-2-yl N-({3-[(2-methylpropanoyl)oxy]-4-methoxypyridin-2-yl}carbonyl)-L-alaninate (2376209-40-2)+SX, (2S,3S)-3-(2,4-dimethylphenyl)butan-2-yl N-({3-[(2-methylpropanoyl)oxy]-4-methoxypyridin-2-yl}carbonyl)-L-alaninate (2376209-15-1)+SX.
A combination of the present ingredient in the above-mentioned Group (c) and the present compound:
1-methylcyclopropene+SX, 1,3-diphenylurea+SX, 2,3,5-triiodobenzoic acid+SX, IAA ((1H-indol-3-yl)acetic acid)+SX, IBA (4-(1H-indol-3-yl) butyric acid)+SX, MCPA (2-(4-chloro-2-methylphenoxy)acetic acid)+SX, MCPB (4-(4-chloro-2-methylphenoxy)butyric acid)+SX, 4-CPA (4-chlorophenoxyacetic acid)+SX, 5-aminolevulinic acid hydrochloride+SX, 6-benzylaminopurine+SX, abscisic acid+SX, AVG (aminoethoxyvinylglycine)+SX, ancymidol+SX, butralin+SX, calcium carbonate+SX, calcium chloride+SX, calcium formate+SX, calcium peroxide+SX, calcium polysulfide+SX, calcium sulfate+SX, chlormequat-chloride+SX, chlorpropham+SX, choline chloride+SX, cloprop+SX, cyanamide+SX, cyclanilide+SX, daminozide+SX, decan-1-ol+SX, dichlorprop+SX, dikegulac+SX, dimethipin+SX, diquat+SX, ethephon+SX, ethychlozate+SX, flumetralin+SX, flurprimidol+SX, forchlorfenuron+SX, formononetin+SX, Gibberellin A+SX, Gibberellin A3+SX, inabenfide+SX, Kinetin+SX, lipochitooligosaccharide SP104+SX, maleic hydrazide+SX, mefluidide+SX, mepiquat-chloride+SX, oxidized glutathione+SX, pacrobutrazol+SX, pendimethalin+SX, prohexandione-calcium+SX, prohydrojasmon+SX, pyraflufen-ethyl+SX, sintofen+SX, sodium 1-naphthaleneacetate+SX, sodium cyanate+SX, streptmycin+SX, thidiazuron+SX, triapenthenol+SX, Tribufos+SX, trinexapac-ethyl+SX, uniconazole-P+SX, 2-(naphthalen-1-yl)acetamide+SX, [4-oxo-4-(2-phenylethyl)amino]butylate+SX, methyl 5-(trifluoromethyl)benzo[b]thiophene-2-carboxylate+SX, 3-[(6-chloro-4-phenylquinazolin-2-yl)amino]-1-propanol+SX, Claroideoglomus etunicatum+SX, Claroideoglomus claroideum+SX, Funneliformis mosseae+SX, Gigaspora margarita+SX, Gigaspora rosea+SX, Glomus aggregatum+SX, Glomus deserticola+SX, Glomus monosporum+SX, Paraglomus brasillianum+SX, Rhizophagus clarus+SX, Rhizophagus intraradices RTI-801+SX, Rhizophagus irregularis DAOM 197198+SX, Azorhizobium caulinodans+SX, Azospirillum amazonense+SX, Azospirillum brasilense XOH+SX, Azospirillum brasilense Ab-V5+SX, Azospirillum brasilense Ab-V6+SX, Azospirillum caulinodans+SX, Azospirillum halopraeferens+SX, Azospirillum irakense+SX, Azospirillum lipoferum+SX, Bradyrhizobium elkanii SEMIA 587+SX, Bradyrhizobium elkanii SEMIA 5019+SX, Bradyrhizobium japonicum TA-11+SX, Bradyrhizobium japonicum USDA 110+SX, Bradyrhizobium liaoningense+SX, Bradyrhizobium lupini+SX, Delftia acidovorans RAY209+SX, Mesorhizobium ciceri+SX, Mesorhizobium huakii+SX, Mesorhizobium loti+SX, Rhizobium etli+SX, Rhizobium galegae+SX, Rhizobium leguminosarum bv. Phaseoli+SX, Rhizobium leguminosarum bv. Trifolii+SX, Rhizobium leguminosarum bv. Viciae+SX, Rhizobium trifolii+SX, Rhizobium tropici+SX, Sinorhizobium fredii+SX, Sinorhizobium meliloti+SX, Zucchini Yellow Mosaik Virus weak strain+SX.
A combination of the present ingredient in the above-mentioned Group (d) and the present compound:
anthraquinone+SX,deet+SX,icaridin+SX.
Examples of a ratio of the present compound to the present ingredient include, but are not particularly limited to 1000:1 to 1:1000, 500:1 to 1:500, 100:1 to 1:100, 50:1, 20:1, 10:1, 9:1, 8:1, 7:1, 6:1, 5:1, 4:1, 3:1, 2:1, 1:1, 1:2, 1:3, 1:4, 1:5, 1:6, 1:7, 1:8, 1:9, 1:10, 1:20, and 1:50 in the weight ratio (the present compound: the present ingredient).
The present compound has an efficacy against pests. Examples of the pests include plant phytopathogenic microorganism, harmful arthropods such as harmful insects and harmful mites, harmful nematicides, and harmful mollusks.
The present compound can be controlled plant diseases caused by phytopathogenic microorganism such as fungi, oomycete, phytomyxea, and bacteria. Examples of the fungi include Ascomycota, Basidiomycota, Blasocladiomycota, Chytridiomycota, Mucoromycota and Olpidiomycota. Specific examples thereof include the followings. Here the descriptions in a parenthesis indicates an academic name of phytopathogenic microorganism that causes each of the disease.
Rice Diseases:
Examples of harmful arthropods, harmful nematicides and harmful mollusks include the followings.
Hemiptera:
The harmful arthropods such as harmful insects and harmful mites, harmful mollusks and harmful nematodes may be those having a reduced agent-sensitivity to or a developed agent-resistance to an insecticide, a mitecide, a molluscicide or a nematicide.
The method for controlling pests of the present invention is conducted by applying an effective amount of the present compound or the composition A to a harmful pest directly and/or a habitat where the harmful pest lives (for example, plant, soil, an interior of a house, and animal). Examples of a method for controlling pests of the present invention include foliar application, soil application, root application, shower application, smoking application, water-surface application, and seed application.
The present compound or the composition A is usually prepared by mixing them with an inert carrier such as solid carrier, liquid carrier or gaseous carrier, and if necessary, adding surfactants and the other auxiliary agents for formulation, to formulate into emulsifiable concentrates, oil solutions, dust formulations, granules, wettable powders, flowables, dry flowables, microcapsules, aerosols, smoking agents, poison baits, resin formulations, paste-like formulations, foams, and carbon dioxide formulations, and the others. Such formulations may be processed into mosquito repellent coils, electric mosquito repellent mats, liquid mosquito formulations, smoking agents, fumigants, sheet formulations, and which may be used. These formulations comprises usually 0.01 to 95% by weight of the present compound or the composition A.
Examples of the solid carrier to be used in the formulation include fine powders or granules of clays (for example, kaolin clay, diatomaceous earth, bentonite, Fubasami clay, or acid white clay), dry silica, wet silica, hydrated silica, talcs, ceramics, other inorganic minerals (for example, sericite, quartz, sulfur, active carbon, or calcium carbonate) or chemical fertilizers (for example, ammonium sulfate, ammonium phosphate, ammonium nitrate, urea, or ammonium chloride) and the others; as well as synthetic resins (for example, polyester resins such as polypropylene, polyacrylonitrile, polymethyl methacrylate or polyethylene terephthalate; nylon resins (for example, nylon-6, nylon-11, or nylon-66); polyamide resins; polyvinyl chloride, polyvinylidene chloride, vinyl chloride-propylene copolymers, and the others).
Examples of the liquid carriers include water; alcohols (for example, methanol, ethanol, isopropyl alcohol, butanol, hexanol, benzyl alcohol, ethylene glycol, propylene glycol, or phenoxy ethanol); ketones (for example, acetone, methyl ethyl ketone, or cyclohexanone); aromatic hydrocarbons (for example, toluene, xylene, ethyl benzene, dodecyl benzene, phenyl xylyl ethane, or methylnaphthalene); aliphatic hydrocarbons (for example, hexane, cyclohexane, kerosene, or light oil); esters (for example, ethyl acetate, butyl acetate, isopropyl myristate, ethyl oleate, diisopropyl adipate, diisobutyl adipate, or propylene glycol monomethyl ether acetate); nitriles (for example, acetonitrile, or isobutyronitrile); ethers (for example, diisopropyl etheR14-dioxane, 1,2-dimethoxyethane, diethyleneglycol dimethyl ether, diethylene glycol monomethyl ether, propylene glycol monomethyl ether, dipropylene glycol monomethyl ether, or 3-methoxy-3-methyl-1-butanol); amides (for example, DMF, or N,N-dimethylacetamide); sulfoxides (for example, dimethyl sulfoxide); propylene carbonate; and vegetable oils (for example, soybean oil or cottonseed oil).
Examples of gaseous carrier include fluorocarbon, butane gas, liquefied petroleum gas (LPG), dimethyl ether, and carbon dioxide gas.
Examples of the surfactants include nonionic surfactants such as polyoxyethylenated alkyl ethers, polyoxyethylenated alkyl aryl ethers, and polyethylene glycol fatty acid esters; and anionic surfactants such as alkyl sulfonates, alkylbenzene sulfonates and alkyl sulfates.
Examples of the other auxiliary agents for formulation include a binder, a dispersant, a colorant and a stabilizer. Specific examples include casein, gelatin, polysaccharides (for example, starch, gum arabic, cellulose derivatives and alginic acid), lignin derivatives, bentonite, water-soluble synthetic polymers (for example, polyvinyl alcohol, polyvinyl pyrrolidone and polyacrylic acids), acidic isopropyl phosphate, 2,6-di-tert-butyl-4-methylphenol, and a mixture of 2-tert-butyl-4-methoxyphenol and 3-tert-butyl-4-methoxyphenol. Specific examples thereof include Nimbus (registered trademark), Assist (registered trademark), Aureo (registered trademark), Iharol (registered trademark), Silwet L-77 (registered trademark), BreakThru (registered trademark), SundanceII (registered trademark), Induce (registered trademark), Penetrator (registered trademark), AgriDex (registered trademark), Lutensol A8 (registered trademark), NP-7 (registered trademark), Triton (registered trademark), Nufilm (registered trademark), Emulgator NP7 (registered trademark), Emulad (registered trademark), TRITON X 45 (registered trademark), AGRAL 90 (registered trademark), AGROTIN (registered trademark), ARPON (registered trademark), EnSpray N (registered trademark), and BANOLE (registered trademark) and the others.
Examples of a base material of the resin formulation include polyvinyl chloride polymers, polyurethane, and the others, and a plasticizer such as phthalate esters (for example, dimethyl phthalate, and dioctyl phthalate), adipic acid esters and stearic acid may be added to the base material, if necessary. The resin formulation can be prepared by kneading the present compound in the base material with a conventional kneading machine, and then molding it by injection molding, extrusion molding, or pressure molding and the like. The resultant resin formulation can be subjected to further molding or cutting procedure, if necessary, to be processed into shapes such as a plate, film, tape, net and string shape. The resin formulation can be processed into animal collars, animal ear tags, sheet products, trap strings, gardening supports, and other products.
Examples of a base material for the poison bait include bait ingredients such as grain powder, vegetable oil, saccharide and crystalline cellulose, and if necessary, with an addition of antioxidants such as dibutylhydroxytoluene and nordihydroguaiaretic acid, preservatives such as dehydroacetic acid, accidental ingestion inhibitors for children and pets such as a chili powder, and insect attraction fragrances such as cheese flavor, onion flavor and peanut oil.
As used herein, examples of the plant include whole plant, stem and leaf, flower, ear, fruit, tree stem, branch, crown, seed, vegetative reproductive organ, and seedling.
The vegetative reproductive organ represents a part of plant such as root, stem and leaf, which has a growth capacity if the part is cut off from its plant and then placed in the soil. Examples of the vegetative reproductive organ include tuberous root, creeping root, bulb, corm or solid bulb, tuber, rhizome, stolon, rhizophore, cane cuttings, propagule, and vine cutting. The “stolon” is often referred to as “runner”, and the “propagule” is often referred to as “brood bud”, which is divided into broad bud and bulbil. The vine cutting represents a shoot (which is a generic name of leaf and stem) of sweet potato (Ipomoea batatas) and Japanese yam (Dioscorea japonica), etc. The bulb, corm or solid bulb, tuber, rhizome, cane cuttings, rhizophore, and tuberous root are also collectively referred to as “bulb”. For example, when the cultivation of potato starts with planting tubers in the soil, the used tuber is generally referred to as “seed potato”.
Examples of a method for controlling harmful arthropods by applying an effective amount of the present compound or the composition A to soils include a method of applying an effective amount of the present compound or the composition A to soils before planting plants or after planting plants, a method of applying an effective amount of the present compound or the composition A to a root part of a crop to be protected from damage such as ingestion by harmful arthropods, and a method of controlling harmful arthropods that ingest a plant by permeating and transferring an effective amount of the present compound or the composition A from a root into the interior of the plant body. Specifically, examples of the application method include planting hole treatment (spraying into planting holes, soil mixing after planting hole treatment), plant foot treatment (plant foot spraying, soil mixing after plant foot treatment, irrigation at plant foot, plant foot treatment at a later seeding raising stage), planting furrow treatment (planting furrow spraying, soil mixing after planting furrow treatment), planting row treatment (planting row spraying, soil mixing after planting row treatment, planting row spraying at a growing stage), planting row treatment at the time of sowing (planting row spraying at the time of sowing, soil mixing after planting row treatment at the time of sowing), broadcast treatment (overall soil surface spraying, soil mixing after broadcast treatment), side-article treatment, treatment of water surface (application to water surface, application to water surface after flooding), other soil spraying treatment (spraying of a granular formulation on leaves at a growing stage, spraying under a canopy or around a tree stem, spraying on the soil surface, mixing with surface soil, spraying into seed holes, spraying on the ground surfaces of furrows, spraying between plants), other irrigation treatment (soil irrigation, irrigation at a seedling raising stage, drug solution injection treatment, irrigation of a plant part just above the ground, drug solution drip irrigation, chemigation), seedling raising box treatment (spraying into a seedling raising box, irrigation of a seedling raising box, flooding into a seedling raising box with drug solution), seedling raising tray treatment (spraying on a seedling raising tray, irrigation of a seedling raising tray, flooding into a seedling raising tray with drug solution), seedbed treatment (spraying on a seedbed, irrigation of a seedbed, spraying on a lowland rice nursery, immersion of seedlings), seedbed soil incorporation treatment (mixing with seedbed soil, mixing with seedbed soil before sowing, spraying at sowing before covering with soils, spraying at sowing after covering with soils, mixing with covering with soils), and other treatment (mixing with culture soil, plowing under, mixing with surface soil, mixing with soil at the place where raindrops fall from a canopy, treatment at a planting position, spraying of a granule formulation on flower clusters, mixing with a paste fertilizer).
Examples of the application to seeds (or seed treatments) include an application of the present compound or the composition A to seeds or vegetative reproductive organs, and specific examples thereof include spraying treatment in which a suspension of the present compound or the composition A is sprayed onto seed surface or the vegetative reproductive organ surface in the form of mist; smearing treatment in which the present compound or the composition A is coated a surface of seeds or the vegetative reproductive organ; a soaking treatment in which the seeds are soaked into the solution of the present compound or the composition A for a certain time; and a method for coating the seeds or the vegetative reproductive organ with a carrier containing the present compound or the composition A (film coating treatment, pellet coating treatment). Examples of the above-described vegetative reproductive organ include particularly seed potato.
When the composition A is applied to seeds or vegetative reproductive organs, the composition A may be also applied to seeds or vegetative reproductive organs as a single formulation, or the composition A may be applied to seeds or vegetative reproductive organs as a divided plurality of formulation by a plurality of time. Examples of the method in which the composition A is applied as a divided plurality of formulation by a plurality of time include, for example, a method in which the formulations comprising as an active component the present compound only are applied, and seeds or vegetative reproductive organs are air dried, followed by applying the formulations comprising the present ingredient: and a method in which the formulations comprising as an active component the present compound X and the present ingredients are applied, and seeds or vegetative reproductive organs are air dried, followed by applying the formulations comprising the present ingredients other than the already-applied present ingredients, are included.
As used herein, seeds or vegetative reproductive organs carrying the present compound or the composition A means seeds or vegetative reproductive organs in the state where the present compound or the composition A is adhered to a surface of the seeds or the vegetative reproductive organ. The above-described seeds or vegetative reproductive organs carrying the present compound or the composition A may be adhered by any other materials that are different from the present compound or the composition A before or after being adhered the present compound or the composition A to the seeds or vegetative reproductive organs.
Also, when the composition A is adhered in a form of layer(s) to a surface of seeds or vegetative reproductive organ, the layer(s) is/are composed of one layer or a plurality of layer. Also, when a plurality layer are formed, each of the layer may be composed of a layer comprising one or more active ingredients, or a combination of a layer comprising one or more active ingredients and a layer not comprising an active ingredient.
Seeds or vegetative reproductive organs carrying the present compound or the composition A can be obtained, for example, by applying the formulations comprising the present compound or the composition A by the above-described application method to seeds to seeds or vegetative reproductive organs.
When the present compound or the composition A is applied for harmful arthropods control in agricultural fields, the application dose thereof is usually within a range of 1 to 10,000 g of the present compound per 10,000 m2. In the case of being applied to seeds or vegetative reproductive organs, the dose of application dose thereof is usually within a range of 0.001 to 100 g of the present compound per 1 Kg of seeds. When the present compound or the composition A is formulated into an emulsifiable concentrate, a wettable powder or a flowable etc., they are usually applied by diluting them with water so as to make an effective concentration of the active ingredients 0.01 to 10,000 ppm, and the dust formulation or the granular formulation, etc., is usually applied as itself without diluting them.
Also, the resin preparation which is processed into a sheet or a string may be applied by winding a plant with a sheet or a string of the resin preparation, putting a string of the resin preparation around a crop so that the plant is surrounded by the string, or laying a sheet of the resin preparation on the soil surface near the root of a plant.
When the present compound or the composition A is used to control harmful arthropods that live inside a house, the application dose as an amount of the present compound is usually within a range from 0.01 to 1,000 mg per 1 m2 of an area to be treated, in the case of using it on a planar area. In the case of using it spatially, the application dose as an amount of the present compound is usually within a range from 0.01 to 500 mg per 1 m3 of the space to be treated. When the present compound or the composition A is formulated into emulsifiable concentrates, wettable powders, flowables or the others, such formulations are usually applied after diluting it with water in such a way that a concentration of the active ingredient is within a range from 0.1 to 10,000 ppm. In the case of being formulated into oil solutions, aerosols, smoking agents, poison baits and the others, such formulations are used as itself without diluting it.
Also, the composition of the present compound or the composition A may be used as an agent for controlling harmful arthropods in agricultural lands such as paddy fields, fields, turfs, and orchards. Examples of the plants to be applied include the followings.
The above-mentioned plants include also genetically modified crops.
Hereinafter, the present invention is explained in more detail by using Preparation Examples, Reference Preparation Examples, and Formulation Examples, and Test Examples, however, the present invention should not be limited to these examples.
As used herein, “Me” represents a methyl group, “Et” represents an ethyl group, “Pr” represents a propyl group, “Bu” represents a butyl group, “Pen” represents a pentyl group, “i-Pr” represents an isopropyl group, “i-Bu” represents an isobutyl group, “c-Pr” represents a cyclopropyl group, “c-Bu” represents a cyclobutyl group, “c-Pen” represents a cyclopentyl group, “c-Hex” represents a cyclohexyl group, and “Ph” represents a phenyl group.
Firstly, a preparation example of the compound of the present invention is shown.
When the physical property value of a compound is measured by liquid chromatography/mass spectrometry (hereinafter, referred to as LCMS), the measured molecular ion value ([M+H]+ or [M−H]− and relation time (hereinafter, referred to as RT) is described. Each condition of liquid chromatography (hereinafter, referred to as “LC”) and mass spectrometry (hereinafter, referred to as “MS”) is described below.
[Lc Condition]
[Ms Condition]
A mixture of methyl (Z)-2-(5-bromo-2-methylphenoxy)-3-methoxyacrylate (prepared according to a method described in WO 2001/000562 A1) 20.0 g, bis(pinacolato)diboron 20.2 g, and [1,1′-bis(diphenylphosphino)ferrocene]palladium (II) dichloride 2.43 g, potassium acetate 19.5 g, and DMSO 250 mL was stirred at 80° C. for 10 hours. Water was added to the resulting mixture, and the resulting mixture was extracted with ethyl acetate. The resulting organic layers were washed with water and saturated brine successively, dried over anhydrous magnesium sulfate, and concentrated under reduced pressure. The resulting residues were subjected to silica gel column chromatography (ethyl acetate:hexane=1:4) to obtain an intermediate compound 1 represented by the following formula 11.8 g.
Intermediate compound 1: 1H-NMR (CDCl3) δ: 7.37 (1H, d), 7.32 (1H, s), 7.16 (1H, d), 7.10 (1H, s), 3.87 (3H, s), 3.69 (3H, s), 2.37 (3H, s), 1.31 (12H, s).
An intermediate compound 2 represented by the following formula was prepared by using methyl (Z)-2-(5-bromo-2-methylbenzyl)-3-methoxyacrylate (which was prepared according to the method described in WO 2001/000562 A1) in the place of methyl (Z)-2-(5-bromo-2-methylphenoxy)-3-methoxyacrylate according to the Reference Preparation Example 1.
Intermediate compound 2: 1H-NMR (CDCl3) δ: 7.56-7.51 (2H, m), 7.47 (1H, s), 7.12 (1H, d), 3.85 (3H, s), 3.66 (3H, s), 3.57 (2H, s), 2.36 (3H, s), 1.32 (12H, s).
An intermediate compound 3 represented by the following formula was prepared by using methyl (Z)-2-(5-bromo-2-chlorophenoxy)-3-methoxyacrylate (which was prepared according to the method described in WO 98/03464 A1) in the place of methyl (Z)-2-(5-bromo-2-methylphenoxy)-3-methoxyacrylate according to the Reference Preparation Example 1.
Intermediate compound 3: 1H-NMR (CDCl3) δ: 7.38-7.37 (2H, m), 7.36 (1H, s), 7.19-7.17 (1H, m), 3.88 (3H, s), 3.72 (3H, s), 1.32 (12H, s).
To a mixture of the intermediate compound 1 0.50 g, ethanol 20 mL, acetonitrile 20 mL and water 20 mL was added meta-chloroperoxybenzoic acid (purity 70%, containing 30% water) 0.43 g at room temperature, and the mixture was stirred for 3 hours. To the resulting mixture were added saturated sodium thiosulfate aqueous solution and saturated ammonium chloride aqueous solution successively, and the mixture was stirred for 1 hour. The resulting mixture was concentrated under reduced pressure and extracted with ethyl acetate. The resulting organic layer was washed with water and saturated brine successively, and dried over anhydrous magnesium sulfate, and concentrated under reduced pressure. The resulting residue was subjected to a silica gel column chromatography to obtain an intermediate compound A1 represented by the following formula 0.29 g.
Intermediate compound A1: 1H-NMR (CDCl3) δ: 7.31 (1H, s), 6.98 (1H, d), 6.37 (1H, dd), 6.28 (1H, d), 4.75 (1H, s), 3.86 (3H, s), 3.71 (3H, s), 2.25 (3H, s).
The compound which was prepared according to the Reference Preparation Example 2 and its physical property value are shown below.
Intermediate compound A2: 1H-NMR (CDCl3) δ: 7.48 (1H, s), 6.97 (1H, d), 6.61-6.54 (2H, m), 4.67 (1H, br s), 3.84 (3H, s), 3.68 (3H, s), 3.50 (2H, s), 2.27 (3H, s).
Intermediate compound A3: 1H-NMR (DMSO-D6) δ: 9.69 (1H, br s), 7.61 (1H, s), 7.19 (1H, d), 6.40 (1H, dd), 6.26 (1H, d), 3.88 (3H, s), 3.66 (3H, s).
To a mixture of methyl 2-(5-hydroxy-2-methylphenoxy)acetate 0.50 g, triphenylphosphine 0.82 g, benzyl alcohol 0.39 mL and chloroform 10 mL was added bis(2-methoxyethyl) azodicarboxylate 0.78 g at 0° C., and the mixture was stirred at room temperature for 22 hours. To the resulting mixture was added saturated sodium bicarbonate aqueous solution, and the mixture was extracted with ethyl acetate. The resulting organic layer was washed with water and saturated brine successively, and dried over anhydrous magnesium sulfate, and concentrated under reduced pressure. The resulting residue was subjected to a silica gel column chromatography to obtain an intermediate compound C1 represented by the following formula 0.55 g.
Intermediate compound C1: 1H-NMR (CDCl3) δ: 7.45-7.30 (5H, m), 7.05 (1H, d), 6.52 (1H, dd), 6.38 (1H, d), 5.02 (2H, s), 4.62 (2H, s), 3.79 (3H, s), 2.22 (3H, s).
The compound which was prepared according to the Reference Preparation Example 3 and its physical property value are shown below.
A compound represented by formula (1b1):
wherein E represents the below-mentioned groups.
Intermediate compound C3 (E: Pr):
1H-NMR (CDCl3) δ: 7.03 (1H, d), 6.43 (1H, dd), 6.31 (1H, d), 4.62 (2H, s), 3.87 (2H, t), 3.80 (3H, s), 2.21 (3H, s), 1.84-1.73 (2H, m), 1.02 (3H, t).
Intermediate compound C4 (E: Bu):
1H-NMR (CDCl3) δ: 7.03 (1H, d), 6.43 (1H, dd), 6.30 (1H, d), 4.62 (2H, s), 3.91 (2H, t), 3.80 (3H, s), 2.21 (3H, s), 1.78-1.70 (2H, m), 1.53-1.42 (2H, m), 0.97 (3H, t).
Intermediate compound C5 (E: i-Bu):
1H-NMR (CDCl3) δ: 7.02 (1H, d), 6.43 (1H, dd), 6.31 (1H, d), 4.63 (2H, s), 3.80 (3H, s), 3.66 (2H, d), 2.21 (3H, s), 2.11-1.99 (1H, m), 1.01 (6H, d).
Intermediate compound C6 (E: Pen):
1H-NMR (CDCl3) δ: 7.03 (1H, d), 6.43 (1H, dd), 6.31 (1H, d), 4.62 (2H, s), 3.90 (2H, t), 3.80 (3H, s), 2.21 (3H, s), 1.82-1.70 (2H, m), 1.46-1.31 (4H, m), 0.93 (3H, t).
Intermediate compound C7 (E: CH2c-Pr):
1H-NMR (CDCl3) δ: 7.02 (1H, d), 6.41 (1H, dd), 6.34 (1H, d), 4.62 (2H, s), 3.80 (3H, s), 3.74 (2H, d), 2.21 (3H, s), 1.31-1.18 (1H, m), 0.68-0.60 (2H, m), 0.37-0.29 (2H, m).
Intermediate compound C8 (E: CH2c-Pen):
1H-NMR (CDCl3) δ: 7.02 (1H, d), 6.44 (1H, dd), 6.31 (1H, d), 4.63 (2H, s), 3.80 (3H, s), 3.77 (2H, d), 2.39-2.27 (1H, m), 2.21 (3H, s), 1.88-1.76 (2H, m), 1.67-1.53 (4H, m), 1.40-1.28 (2H, m).
Intermediate compound C9 (E: CH2c-Hex):
1H-NMR (CDCl3) δ: 7.02 (1H, d), 6.43 (1H, dd), 6.30 (1H, d), 4.62 (2H, s), 3.80 (3H, s), 3.70 (2H, d), 2.20 (3H, s), 1.90-1.80 (2H, m), 1.80-1.66 (4H, m), 1.35-1.14 (3H, m), 1.10-0.97 (2H, m).
Intermediate compound C10 (E: CH2CH2Ph):
1H-NMR (CDCl3) δ: 7.36-7.21 (5H, m), 7.03 (1H, d), 6.44 (1H, dd), 6.30 (1H, d), 4.62 (2H, s), 4.13 (2H, t), 3.80 (3H, s), 3.08 (2H, t), 2.21 (3H, s).
Intermediate compound C11 (E: CH2C≡CH)
1H-NMR (CDCl3) δ: 7.06 (1H, d), 6.52 (1H, dd), 6.38 (1H, d), 4.64 (2H, d), 4.62 (2H, s), 3.80 (3H, s), 2.52 (1H, t), 2.22 (3H, s).
To a mixture of methyl 2-(5-hydroxy-2-methylphenoxy)acetate 0.30 g, potassium carbonate 0.28 g and DMF 10 mL was added N-methyl-N-phenyl carbamoyl chloride 0.29 g at room temperature, and the mixture was stirred for 3 hours. To the resulting mixture was added saturated ammonium chloride aqueous solution, and the mixture was extracted with ethyl acetate. The resulting organic layer was washed with water and saturated brine successively, dried over anhydrous magnesium sulfate, and concentrated under reduced pressure. The resulting residue was subjected to a silica gel column chromatography to obtain the intermediate compound C2 represented by the following formula 0.47 g.
Intermediate compound C2: 1H-NMR (CDCl3) δ: 7.44-7.32 (4H, m), 7.30-7.23 (1H, m), 7.10 (1H, d), 6.72-6.45 (2H, m), 4.62 (2H, s), 3.80 (3H, s), 3.42 (3H, s), 2.25 (3H, s).
The compound which was prepared according to the Reference Preparation Example 4 and its physical property value are shown below.
Intermediate compound C12: 1H-NMR (CDCl3) δ: 7.11 (1H, d), 6.66 (1H, dd), 6.50 (1H, d), 4.63 (2H, s), 3.80 (3H, s), 3.08 (3H, s), 3.00 (3H, s), 2.25 (3H, s).
Intermediate compound C13: 1H-NMR (CDCl3) δ: 7.10 (1H, d), 6.66 (1H, dd), 6.51 (1H, d), 4.62 (2H, s), 3.80 (3H, s), 3.47-3.32 (4H, m), 2.25 (3H, s), 1.28-1.16 (6H, m).
To a mixture of the intermediate compound C1 0.24 g, methyl formate 0.15 g, and dimethoxyethane 5 mL was added potassium tert-butoxide 0.21 g under ice-cooling, and the mixture was stirred at room temperature for 1 hour. 1N hydrochloric acid was added to the resulting mixture, and the mixture was extracted with ethyl acetate. The resulting organic layer was dried over anhydrous magnesium sulfate, and concentrated under reduced pressure to obtain the intermediate compound B1 represented by below-mentioned formula 0.19 g.
Intermediate compound B1: LCMS: 315 [M+H]+, RT=1.90 min.
The compound which was prepared according to the Reference Preparation Example 5 and its physical property value are shown below.
A compound represented by formula (1d1):
wherein E represents the following groups.
Intermediate compound B2 (E: Pen): LCMS: 295 [M+H]+, RT=2.05 min.
Intermediate compound B3 (E: CH2c-Pr): LCMS: 279 [M+H]+, RT=1.82 min.
Intermediate compound B4 (E: CH2c-Pen): LCMS: 307 [M+H]+, RT=2.07 min.
Intermediate compound B5 (E: CH2c-Hex): LCMS: 321 [M+H]+, RT=2.16 min.
To a mixture of 5-bromo-2-methylbenzaldehyde 4.58 g THF 185 mL was added sodium hydride (60%, oily) 1.00 g under ice-cooling, and the mixture was stirred under ice-cooling for 20 minutes. Methyl diethylphosphonoacetate 5.00 g was added to the resulting mixture, and the mixture was stirred at room temperature for 4 hours. To the resulting mixture was added saturated sodium bicarbonate aqueous solution, and the mixture was extracted with ethyl acetate. The resulting organic layer was washed with water and saturated brine successively, dried over anhydrous sodium sulfate, and concentrated under reduced pressure. The resulting residue was subjected to a silica gel column chromatography to obtain the intermediate compound 4 represented by the following formula 5.80 g.
Intermediate compound 4: 1H-NMR (CDCl3) δ: 7.87 (1H, d), 7.66 (1H, d), 7.38 (1H, dd), 7.08 (1H, d), 6.35 (1H, d), 3.82 (3H, s), 2.37 (3H, s).
A mixture of the intermediate compound 4 108.43 g, cobalt(II) chloride 5.52 g, and methanol 1084 mL was cooled to −54° C., and thereto was added sodium borohydride 40.35 g, and the mixture was stirred at −24° C. for 6 hours. To the resulting mixture was added 10% aqueous ammonium chloride solution, and the mixture was extracted with ethyl acetate. The resulting organic layer was washed with water, dried over anhydrous sodium sulfate, and concentrated under reduced pressure to obtain the intermediate compound 5 represented by the below-mentioned formula 93.91 g.
Intermediate compound 5: 1H-NMR (CDCl3) δ: 7.27-7.22 (2H, m), 7.01 (1H, d), 3.69 (3H, s), 2.90 (2H, t), 2.58 (2H, t), 2.26 (3H, s).
A mixture of the intermediate compound 5 3.80 g and THF 137 mL was cooled to −72° C., and thereto was added lithium diisopropylamide (1.08 M hexane-THF solution) 27 mL, and the mixture was stirred at −66° C. for 30 minutes. To the resulting mixture was added methyl formate 7.10 g, and the mixture was stirred at −63° C. for 1 hour. To the resulting mixture was added 10% aqueous sodium hydrogen sulfate solution, and the mixture was extracted with ethyl acetate. The resulting organic layer was washed with water, dried over anhydrous sodium sulfate, and concentrated under reduced pressure to obtain the crude methyl 2-(5-bromo-2-methylbenzyl)-3-hydroxyacrylate. To the obtained crude methyl 2-(5-bromo-2-methylbenzyl)-3-hydroxyacrylate was added DMF 137 mL, and thereto were added potassium carbonate 6.13 g and dimethyl sulfate 4.66 g successively, and the mixture was stirred at room temperature for 4 hours. Water was added to the resulting mixture, and the mixture was extracted with MTBE. The resulting organic layer was washed with water, dried over anhydrous sodium sulfate, and concentrated under reduced pressure to obtain the intermediate compound E1 represented by the below-mentioned formula 3.61 g.
Intermediate Compound E1
The compound which was prepared according to the Reference Preparation Example 8 and its physical property value are shown below.
A compound represented by formula (II-A):
wherein n is 0, and a combination of R1, X2 and L represents any combinations indicated in [Table II-A].
Intermediate compound E1: 1H-NMR (CDCl3) δ: 7.49 (1H, s), 7.20 (2H, m), 6.97 (1H, d), 3.86 (3H, s), 2.68 (3H, s), 3.50 (2H, m), 2.28 (3H, s).
To a mixture of 5-chloro-2-methylphenol 2.00 g, potassium carbonate 2.33 g, and DMF 20 mL was added methyl 2-bromoacetate 2.58 g, and the mixture was stirred at room temperature for 3 hours. Water was added to the resulting mixture, and the mixture was extracted with ethyl acetate. The resulting organic layer was washed with water and saturated brine successively, dried over anhydrous magnesium sulfate, and concentrated under reduced pressure. The resulting residue was subjected to a silica gel column chromatography (ethyl acetate:hexane=1:4) to obtain the intermediate compound 6 represented by the following formula 2.94 g.
Intermediate compound 6: 1H-NMR (CDCl3) δ: 7.07 (1H, dd), 6.89 (1H, dd), 6.68 (1H, d), 4.64 (2H, s), 3.81 (3H, s), 2.24 (3H, s).
To a mixture of the intermediate compound 6 3.00 g, methyl formate 2.3 mL and 1,2-dimethoxyethane 20 mL was added potassium tert-butoxide 3.15 g under ice-cooling. The mixture was stirred at room temperature for 2 hours. To the resulting mixture was 1N hydrochloric acid, and the mixture was extracted with ethyl acetate. The resulting organic layer was washed with water, dried over anhydrous sodium sulfate, and concentrated under reduced pressure to obtain the intermediate compound 7 represented by the following formula 2.44 g.
Intermediate compound 7: 1H-NMR (CDCl3) δ: 7.53 (1H, d), 7.11 (1H, dt), 6.94 (1H, dd), 6.73 (1H, d), 5.76 (1H, d), 3.71 (3H, t), 2.32 (3H, s).
To a mixture of the intermediate 7 1.09 g, potassium carbonate 0.70 g, and DMF 10 mL was added iodomethane 0.62 mL under ice-cooling, and the mixture was stirred at room temperature for 2 hours. Water was added to the resulting mixture, and the mixture was extracted with MTBE. The resulting organic layer was washed with water and saturated brine successively, dried over anhydrous magnesium sulfate, and concentrated under reduced pressure. The resulting residue was subjected to a silica gel column chromatography (ethyl acetate; hexane=1:4) to obtain the intermediate compound D2 represented by the following formula 1.00 g.
Intermediate Compound D2
The compound which was prepared according to the Reference Preparation Example 11 and its physical property value are shown below.
A compound represented by formula (VI):
wherein n is 0, and a combination of R1 and L represents any combinations indicated in [Table VI].
Intermediate compound D1: 1H-NMR (CDCl3) δ: 7.49 (1H, s), 7.06-7.01 (3H, m), 3.86 (3H, s), 3.68 (3H, s), 3.50 (2H, s), 2.31 (3H, s).
Intermediate compound D2: 1H-NMR (CDCl3) δ: 7.33 (1H, s), 7.07 (1H, dd), 6.88 (1H, dd), 6.70 (1H, d), 3.89 (3H, s), 3.72 (3H, s), 2.30 (3H, s).
To a mixture of the intermediate compound A1 0.25 g, triphenylphosphine 0.33 g, ethanol 0.06 mL and chloroform 5 mL was added bis(2-methoxyethyl) azodicarboxylate 0.32 g at 0° C., and the mixture was stirred at room temperature for 16 hours. To the resulting mixture was added saturated sodium bicarbonate aqueous solution, and the mixture was extracted with ethyl acetate. The resulting organic layer was washed with water and saturated brine, dried over anhydrous magnesium sulfate, and concentrated under reduced pressure. The resulting residue was subjected to a silica gel column chromatography (ethyl acetate:hexane=1:4) to obtain the present compound 1 represented by the following formula 0.23 g.
Present compound 1: 1H-NMR (CDCl3) δ: 7.30 (1H, s), 7.03 (1H, d), 6.44 (1H, dd), 6.33 (1H, d), 3.95 (2H, q), 3.86 (3H, s), 3.70 (3H, s), 2.27 (3H, s), 1.37 (3H, t).
The compound which was prepared according to the Preparation Example 1 and its physical property value are shown below.
A compound represented by formula (1a1):
wherein a combination of E, R1 and L represents any combinations indicated in [Table 1-1] to [Table 1-6].
Present compound 2: 1H-NMR (CDCl3) δ: 7.30 (1H, s), 7.02 (1H, d), 6.45 (1H, dd), 6.31 (1H, d), 4.50-4.40 (1H, m), 3.86 (3H, s), 3.70 (3H, s), 2.27 (3H, s), 1.29 (6H, d).
Present compound 3: 1H-NMR (CDCl3) δ: 7.31 (1H, s), 7.03 (1H, d), 6.45 (1H, dd), 6.33 (1H, d), 3.86 (3H, s), 3.84 (2H, t), 3.70 (3H, s), 2.27 (3H, s), 1.82-1.71 (2H, m), 1.01 (3H, t).
Present compound 4: 1H-NMR (CDCl3) δ: 7.31 (1H, s), 7.03 (1H, d), 6.44 (1H, dd), 6.32 (1H, d), 3.87 (3H, s), 3.71 (3H, s), 3.63 (2H, d), 2.27 (3H, s), 2.09-1.97 (1H, m), 1.00 (6H, d).
Present compound 5: 1H-NMR (CDCl3) δ: 7.33 (1H, s), 7.02 (1H, d), 6.44 (1H, dd), 6.31 (1H, d), 3.88 (3H, s), 3.71 (3H, s), 3.50 (2H, s), 2.26 (3H, s), 1.00 (9H, s).
Present compound 6: 1H-NMR (CDCl3) δ: 7.30 (1H, s), 7.03 (1H, d), 6.44 (1H, dd), 6.32 (1H, d), 3.88 (2H, t), 3.86 (3H, s), 3.70 (3H, s), 2.27 (3H, s), 1.76-1.67 (2H, m), 1.52-1.40 (2H, m), 0.96 (3H, t).
Present compound 7: 1H-NMR (CDCl3) δ: 7.30 (1H, s), 7.02 (1H, d), 6.44 (1H, dd), 6.31 (1H, d), 4.30-4.22 (1H, m), 3.86 (3H, s), 3.70 (3H, s), 2.26 (3H, s), 1.74-1.62 (1H, m), 1.53-1.33 (3H, m), 1.24 (3H, d), 0.92 (3H, t).
Present compound 8: 1H-NMR (CDCl3) δ: 7.31 (1H, s), 7.02 (1H, d), 6.44 (1H, dd), 6.32 (1H, d), 3.86 (3H, s), 3.76-3.62 (2H, m), 3.70 (3H, s), 2.26 (3H, s), 1.86-1.76 (1H, m), 1.59-1.48 (1H, m), 1.29-1.17 (1H, m), 0.98 (3H, d), 0.93 (3H, t).
Present compound 9: 1H-NMR (CDCl3) δ: 7.31 (1H, s), 7.03 (1H, d), 6.45 (1H, dd), 6.32 (1H, d), 3.90 (2H, t), 3.86 (3H, s), 3.70 (3H, s), 2.27 (3H, s), 1.84-1.75 (1H, m), 1.63 (2H, q), 0.94 (6H, d).
Present compound 10: 1H-NMR (CDCl3) δ: 7.32 (1H, s), 7.03 (1H, d), 6.46 (1H, dd), 6.32 (1H, d), 3.87 (3H, s), 3.77 (2H, d), 3.71 (3H, s), 2.27 (3H, s), 1.66-1.58 (1H, m), 1.52-1.36 (4H, m), 0.91 (6H, t).
Present compound 11: 1H-NMR (CDCl3) δ: 7.30 (1H, s), 7.03 (1H, d), 6.44 (1H, dd), 6.32 (1H, d), 3.87 (2H, t), 3.86 (3H, s), 3.70 (3H, s), 2.26 (3H, s), 1.78-1.69 (2H, m), 1.46-1.31 (4H, m), 0.92 (3H, t).
Present compound 12: 1H-NMR (CDCl3) δ: 7.30 (1H, s), 7.03 (1H, d), 6.43 (1H, dd), 6.37 (1H, d), 3.86 (3H, s), 3.72 (2H, d), 3.70 (3H, s), 2.27 (3H, s), 1.29-1.19 (1H, m), 0.63 (2H, q), 0.32 (2H, q).
Present compound 13: 1H-NMR (CDCl3) δ: 7.31 (1H, s), 7.02 (1H, d), 6.44 (1H, dd), 6.32 (1H, d), 3.86 (3H, s), 3.74 (2H, d), 3.70 (3H, s), 2.36-2.26 (1H, m), 2.26 (3H, s), 1.87-1.75 (2H, m), 1.66-1.53 (4H, m), 1.38-1.27 (2H, m).
Present compound 14: 1H-NMR (CDCl3) δ: 7.31 (1H, s), 7.02 (1H, d), 6.43 (1H, dd), 6.31 (1H, d), 3.86 (3H, s), 3.70 (3H, s), 3.66 (2H, d), 2.26 (3H, s), 1.89-1.64 (6H, m), 1.34-1.15 (3H, m), 1.07-0.94 (2H, m).
Present compound 15: 1H-NMR (CDCl3) δ: 7.31 (1H, s), 7.03 (1H, d), 6.46 (1H, dd), 6.33 (1H, d), 3.95 (2H, t), 3.86 (3H, s), 3.70 (3H, s), 2.27 (3H, s), 1.63 (2H, q), 0.87-0.76 (1H, m), 0.50-0.43 (2H, m), 0.12-0.06 (2H, m).
Present compound 16: 1H-NMR (CDCl3) δ: 7.32 (1H, s), 7.04 (1H, d), 6.46 (1H, dd), 6.33 (1H, d), 4.69 (1H, t), 4.57 (1H, t), 4.02 (2H, t), 3.87 (3H, s), 3.71 (3H, s), 2.28 (3H, s), 2.20-2.06 (2H, m).
Present compound 17: 1H-NMR (CDCl3) δ: 7.32 (1H, s), 7.05 (1H, d), 6.44 (1H, dd), 6.32 (1H, d), 4.12 (2H, t), 3.87 (3H, s), 3.71 (3H, s), 2.63-2.51 (2H, m), 2.27 (3H, s).
Present compound 18: 1H-NMR (CDCl3) δ: 7.32 (1H, s), 7.04 (1H, d), 6.43 (1H, dd), 6.31 (1H, d), 3.93 (2H, t), 3.87 (3H, s), 3.71 (3H, s), 2.33-2.22 (2H, m), 2.27 (3H, s), 2.04-1.96 (2H, m).
Present compound 19: 1H-NMR (CDCl3) δ: 7.31 (1H, s), 7.05 (1H, d), 6.45 (1H, dd), 6.36 (1H, d), 4.16 (2H, t), 3.87 (3H, s), 3.77 (2H, t), 3.71 (3H, s), 2.28 (3H, s).
Present compound 20: 1H-NMR (CDCl3) δ: 7.31 (1H, s), 7.04 (1H, d), 6.46 (1H, dd), 6.32 (1H, d), 4.03 (2H, t), 3.87 (3H, s), 3.72 (2H, t), 3.71 (3H, s), 2.27 (3H, s), 2.23-2.15 (2H, m).
Present compound 21: 1H-NMR (CDCl3) δ: 7.29 (1H, s), 7.03 (1H, d), 6.46 (1H, dd), 6.40 (1H, d), 4.04 (2H, t), 3.86 (3H, s), 3.71 (2H, t), 3.69 (3H, s), 3.44 (3H, s), 2.27 (3H, s).
Present compound 22: 1H-NMR (CDCl3) δ: 7.31 (1H, s), 7.04 (1H, d), 6.45 (1H, dd), 6.38 (1H, d), 4.14 (1H, dd), 3.91-3.85 (1H, m), 3.87 (3H, s), 3.71 (3H, s), 3.34-3.29 (1H, m), 2.91-2.87 (1H, m), 2.74 (1H, dd), 2.27 (3H, s).
Present compound 23: 1H-NMR (CDCl3) δ: 7.30 (1H, s), 7.02 (1H, d), 6.45 (1H, dd), 6.38 (1H, d), 4.27-4.19 (1H, m), 3.96-3.78 (4H, m), 3.86 (3H, s), 3.70 (3H, s), 2.26 (3H, s), 2.10-1.88 (3H, m), 1.77-1.67 (1H, m).
Present compound 24: 1H-NMR (CDCl3) δ: 7.30 (1H, s), 7.03 (1H, d), 6.45 (1H, dd), 6.35 (1H, d), 4.02 (2H, t), 3.86 (3H, s), 3.70 (3H, s), 2.72 (2H, t), 2.53-2.43 (4H, m), 2.26 (3H, s), 1.64-1.56 (4H, m), 1.48-1.40 (2H, m).
Present compound 25: 1H-NMR (CDCl3) δ: 7.30 (1H, s), 7.03 (1H, d), 6.43 (1H, dd), 6.31 (1H, d), 3.99 (2H, t), 3.86 (3H, s), 3.70 (3H, s), 2.27 (3H, s), 1.09 (2H, t), 0.06 (9H, s).
Present compound 26: 1H-NMR (CDCl3) δ: 7.30 (1H, s), 7.03 (1H, d), 6.44 (1H, dd), 6.33 (1H, d), 3.86 (3H, s), 3.83 (2H, t), 3.70 (3H, s), 2.27 (3H, s), 1.79-1.69 (2H, m), 0.60-0.54 (2H, m), 0.01 (9H, s).
Present compound 27: 1H-NMR (CDCl3) δ: 7.31 (1H, s), 7.05 (1H, d), 6.44-6.38 (2H, m), 4.56 (2H, s), 3.87 (3H, s), 3.80 (3H, s), 3.71 (3H, s), 2.28 (3H, s).
Present compound 28: 1H-NMR (CDCl3) δ: 7.46 (1H, s), 7.44-7.28 (5H, m), 7.02 (1H, d), 6.75 (1H, d), 6.69 (1H, dd), 4.99 (2H, s), 3.81 (3H, s), 3.66 (3H, s), 3.51 (2H, s), 2.28 (3H, s).
Present compound 29: 1H-NMR (CDCl3) δ: 7.35-7.21 (6H, m), 7.03 (1H, d), 6.45 (1H, dd), 6.32 (1H, d), 4.09 (2H, t), 3.85 (3H, s), 3.70 (3H, s), 3.06 (2H, t), 2.27 (3H, s).
Present compound 30: 1H-NMR (CDCl3) δ: 7.40-7.34 (2H, m), 7.29 (1H, s), 7.09-7.01 (3H, m), 6.51 (1H, dd), 6.38 (1H, d), 4.93 (2H, s), 3.84 (3H, s), 3.69 (3H, s), 2.27 (3H, s).
Present compound 31: 1H-NMR (CDCl3) δ: 7.39-7.30 (4H, m), 7.29 (1H, s), 7.14-6.98 (6H, m), 6.54 (1H, dd), 6.41 (1H, d), 4.94 (2H, s), 3.85 (3H, s), 3.69 (3H, s), 2.28 (3H, s).
Present compound 32: 1H-NMR (CDCl3) δ: 7.66 (1H, t), 7.45 (1H, d), 7.31 (1H, s), 7.25 (1H, d), 7.04 (1H, d), 6.50 (1H, dd), 6.40 (1H, d), 5.09 (2H, s), 3.86 (3H, s), 3.70 (3H, s), 2.27 (3H, s).
Present compound 33: 1H-NMR (CDCl3) δ: 8.76 (1H, s), 7.94 (1H, d), 7.70 (1H, d), 7.31 (1H, s), 7.07 (1H, d), 6.51 (1H, dd), 6.38 (1H, d), 5.08 (2H, s), 3.86 (3H, s), 3.70 (3H, s), 2.28 (3H, s).
Present compound 34: 1H-NMR (CDCl3) δ: 7.33-7.29 (2H, m), 7.10-6.98 (3H, m), 6.54 (1H, dd), 6.41 (1H, d), 5.13 (2H, s), 3.85 (3H, s), 3.69 (3H, s), 2.28 (3H, s).
Present compound 35: 1H-NMR (CDCl3) δ: 7.78 (1H, d), 7.35 (1H, d), 7.31 (1H, s), 7.06 (1H, d), 6.55 (1H, dd), 6.44 (1H, d), 5.30 (2H, s), 3.86 (3H, s), 3.70 (3H, s), 2.28 (3H, s).
Present compound 36: 1H-NMR (CDCl3) δ: 7.32 (1H, s), 7.07 (1H, d), 6.72 (1H, s), 6.49 (1H, dd), 6.38 (1H, d), 5.12 (2H, s), 4.44 (2H, q), 3.87 (3H, s), 3.71 (3H, s), 2.28 (3H, s), 1.41 (3H, t).
Present compound 37: 1H-NMR (CDCl3) δ: 7.32 (1H, s), 7.05 (1H, d), 6.46 (1H, dd), 6.37 (1H, d), 5.54-5.52 (1H, m), 5.42-5.40 (1H, m), 4.50 (2H, t), 3.87 (3H, s), 3.71 (3H, s), 2.27 (3H, s).
Present compound 38: 1H-NMR (CDCl3) δ: 7.32 (1H, s), 7.05 (1H, d), 6.43 (1H, dd), 6.32 (1H, d), 6.11 (1H, t), 4.59 (2H, d), 3.87 (3H, s), 3.71 (3H, s), 2.28 (3H, s).
Present compound 39: 1H-NMR (CDCl3) δ: 7.38-7.28 (6H, m), 7.01 (1H, d), 6.46 (1H, dd), 6.36 (1H, d), 5.12 (2H, s), 4.45 (2H, s), 3.85 (3H, s), 3.70 (3H, s), 2.27 (3H, s), 1.97 (3H, s).
Present compound 71: 1H-NMR (CDCl3) δ: 7.47 (1H, s), 7.00 (1H, d), 6.67 (1H, d), 6.61 (1H, dd), 3.85 (2H, t), 3.83 (3H, s), 3.66 (3H, s), 3.51 (2H, s), 2.27 (3H, s), 1.82-1.71 (2H, m), 1.01 (3H, t).
Present compound 72: 1H-NMR (CDCl3) δ: 7.33 (1H, s), 7.24 (1H, d), 6.48 (1H, dd), 6.39 (1H, d), 3.90-3.85 (5H, m), 3.72 (3H, s), 1.77-1.68 (2H, m), 1.52-1.41 (2H, m), 0.96 (3H, t).
Present compound 73: 1H-NMR (CDCl3) δ: 7.48 (1H, s), 7.00 (1H, d), 6.67 (1H, d), 6.61 (1H, dd), 3.83 (3H, s), 3.67 (3H, s), 3.65 (2H, d), 3.51 (2H, s), 2.27 (3H, s), 2.09-1.98 (1H, m), 0.99 (6H, d).
Present compound 74: 1H-NMR (CDCl3) δ: 7.47 (1H, s), 7.00 (1H, d), 6.69-6.58 (2H, m), 3.88 (2H, t), 3.83 (3H, s), 3.67 (3H, s), 3.51 (2H, s), 2.27 (3H, s), 1.78-1.71 (2H, m), 1.47-1.30 (4H, m), 0.92 (3H, t).
Present compound 75: 1H-NMR (CDCl3) δ: 7.30 (1H, s), 7.02 (1H, d), 6.44 (1H, dd), 6.32 (1H, d), 3.87 (2H, t), 3.86 (3H, s), 3.70 (3H, s), 2.26 (3H, s), 1.77-1.69 (2H, m), 1.46-1.24 (12H, m), 0.88 (3H, t).
Present compound 76: 1H-NMR (CDCl3) δ: 7.47 (1H, s), 7.00 (1H, d), 6.68 (1H, d), 6.60 (1H, dd), 3.83 (3H, s), 3.72 (2H, d), 3.66 (3H, s), 3.50 (2H, s), 2.26 (3H, s), 1.28-1.19 (1H, m), 0.64-0.58 (2H, m), 0.34-0.29 (2H, m).
Present compound 77: 1H-NMR (CDCl3) δ: 7.42-7.24 (7H, m), 6.57 (1H, dd), 6.48 (1H, d), 4.98 (2H, s), 3.84 (3H, s), 3.70 (3H, s).
Present compound 78: 1H-NMR (CDCl3) δ: 7.47 (1H, s), 7.34-7.19 (5H, m), 7.00 (1H, d), 6.69 (1H, d), 6.62 (1H, dd), 4.11 (2H, t), 3.81 (3H, s), 3.66 (3H, s), 3.51 (2H, s), 3.06 (2H, t), 2.27 (3H, s).
Present compound 79: 1H-NMR (CDCl3) δ: 7.36-7.21 (7H, m), 6.48 (1H, dd), 6.39 (1H, d), 4.09 (2H, t), 3.86 (3H, s), 3.71 (3H, s), 3.06 (2H, t).
Present compound 80: 1H-NMR (CDCl3) δ: 7.30 (1H, s), 7.29-7.25 (2H, m), 7.21-7.15 (3H, m), 7.02 (1H, d), 6.43 (1H, dd), 6.31 (1H, d), 3.91-3.87 (2H, m), 3.85 (3H, s), 3.69 (3H, s), 2.70-2.63 (2H, m), 2.26 (3H, s), 1.80-1.75 (4H, m)).
Present compound 81: 1H-NMR (CDCl3) δ: 7.48 (1H, s), 7.01 (1H, d), 6.70 (1H, d), 6.63 (1H, dd), 6.10-5.98 (1H, m), 5.42-5.34 (1H, m), 5.28-5.23 (1H, m), 4.49-4.45 (2H, m), 3.83 (3H, s), 3.67 (3H, s), 3.51 (2H, s), 2.28 (3H, s).
Present compound 82: 1H-NMR (CDCl3) δ: 7.48 (1H, s), 7.03 (1H, d), 6.75 (1H, d), 6.69 (1H, dd), 4.62 (2H, d), 3.83 (3H, s), 3.67 (3H, s), 3.51 (2H, s), 2.49 (1H, t), 2.29 (3H, s).
Present compound 83: 1H-NMR (CDCl3) δ: 7.46 (1H, s), 7.34 (2H, d), 7.02 (1H, d), 6.90 (2H, d), 6.74 (1H, d), 6.69 (1H, dd), 4.91 (2H, s), 3.82 (3H, s), 3.81 (3H, s), 3.66 (3H, s), 3.51 (2H, s), 2.28 (3H, s).
Present compound 84: 1H-NMR (CDCl3) δ: 7.46 (1H, s), 7.36-7.28 (1H, m), 7.20-7.12 (2H, m), 7.04-6.95 (2H, m), 6.73 (1H, d), 6.67 (1H, dd), 4.99 (2H, s), 3.82 (3H, s), 3.66 (3H, s), 3.51 (2H, s), 2.28 (3H, s).
Present compound 85: 1H-NMR (CDCl3) δ: 7.47 (1H, s), 7.31-7.27 (1H, m), 7.10-6.96 (3H, m), 6.75 (1H, d), 6.70 (1H, dd), 5.14 (2H, s), 3.81 (3H, s), 3.66 (3H, s), 3.51 (2H, s), 2.28 (3H, s).
Present compound 86: 1H-NMR (CDCl3) δ: 7.49-7.46 (1H, m), 7.42-7.40 (1H, m), 7.29 (1H, s), 7.05 (1H, d), 6.52 (1H, dd), 6.47-6.45 (1H, m), 6.39 (1H, d), 4.85 (2H, s), 3.85 (3H, s), 3.69 (3H, s), 2.28 (3H, s).
Present compound 87: 1H-NMR (CDCl3) δ: 8.58-8.55 (2H, m), 7.32 (1H, s), 7.07 (1H, d), 6.52 (1H, dd), 6.42 (1H, d), 5.14 (2H, s), 3.87 (3H, s), 3.71 (3H, s), 2.28 (3H, s).
Present compound 88: 1H-NMR (CDCl3) δ: 7.31 (1H, s), 7.02 (1H, d), 6.52-6.46 (1H, m), 6.36-6.27 (1H, m), 4.17-3.98 (2H, m), 3.87 (3H, s), 3.85-3.65 (1H, m), 3.71 (3H, s), 3.43-3.27 (2H, m), 2.26 (3H, s), 2.06-1.77 (4H, m), 1.47 (9H, s).
To a mixture of the intermediate compound A1 0.29 g, potassium carbonate 0.25 g, and DMF 10 mL was added benzyl bromide 0.16 mL at room temperature, and the mixture was stirred for 3 hours. Water was added to the resulting mixture, and the mixture was extracted with ethyl acetate. The resulting organic layer was washed with water and saturated brie, dried over anhydrous magnesium sulfate, and concentrated under reduced pressure. The resulting residue was subjected to a silica gel column chromatography (ethyl acetate:hexane=1:4) to obtain the present compound 40 represented by the following formula 0.31 g.
Present compound 40: 1H-NMR (CDCl3) δ: 7.44-7.29 (5H, m), 7.29 (1H, s), 7.05 (1H, d), 6.53 (1H, dd), 6.41 (1H, d), 4.98 (2H, s), 3.84 (3H, s), 3.69 (3H, s), 2.27 (3H, s).
The compound which was prepared according to the Preparation Example 2 and its physical property value are shown below.
A compound represented by formula (1a1) wherein a combination of E, R1 and L represents any combinations indicated in [Table 2-1].
Present compound 41: 1H-NMR (CDCl3) δ: 7.70-7.64 (2H, m), 7.61 (1H, t), 7.41 (1H, t), 7.32 (1H, s), 7.06 (1H, d), 6.55 (1H, dd), 6.42 (1H, d), 5.19 (2H, s), 3.87 (3H, s), 3.69 (3H, s), 2.28 (3H, s).
Present compound 42: 1H-NMR (CDCl3) δ: 7.74 (1H, s), 7.66-7.58 (2H, m), 7.48 (1H, t), 7.32 (1H, s), 7.06 (1H, d), 6.49 (1H, dd), 6.39 (1H, d), 5.00 (2H, s), 3.87 (3H, s), 3.70 (3H, s), 2.28 (3H, s).
Present compound 43: 1H-NMR (CDCl3) δ: 7.67 (2H, d), 7.52 (2H, d), 7.30 (1H, s), 7.06 (1H, d), 6.48 (1H, dd), 6.38 (1H, d), 5.04 (2H, s), 3.86 (3H, s), 3.70 (3H, s), 2.28 (3H, s).
Present compound 44: 1H-NMR (CDCl3) δ: 7.31 (1H, s), 7.06 (1H, d), 6.52 (1H, dd), 6.41 (1H, d), 4.61 (2H, d), 3.86 (3H, s), 3.70 (3H, s), 2.50 (1H, t), 2.28 (3H, s).
Present compound 45: 1H-NMR (CDCl3) δ: 7.33 (1H, s), 7.05 (1H, d), 6.44 (1H, dd), 6.32 (1H, d), 4.00 (2H, t), 3.88 (3H, s), 3.72 (3H, s), 2.57 (2H, t), 2.28 (3H, s), 2.14-2.05 (2H, m).
To a mixture of the intermediate compound A1 0.20 g, potassium carbonate 0.15 g, and DMF 5 mL was added dimethyl carbamoyl chloride 0.09 mL at room temperature, and the mixture was stirred for 19 hours. To the resulting mixture was added saturated ammonium chloride aqueous solution, and the mixture was extracted with ethyl acetate. The resulting organic layer was washed with water and saturated brine, dried over anhydrous magnesium sulfate, and concentrated under reduced pressure. The resulting residue was subjected to a silica gel column chromatography (ethyl acetate:hexane=1:3) to obtain the present compound 46 represented by the following formula 0.08 g.
Present compound 46: 1H-NMR (CDCl3) δ: 7.30 (1H, s), 7.10 (1H, d), 6.68 (1H, dd), 6.50 (1H, d), 3.86 (3H, s), 3.70 (3H, s), 3.06 (3H, s), 2.98 (3H, s), 2.31 (3H, s).
The compound which was prepared according to the Preparation Example 3 and its physical property value are shown below.
A compound represented by formula (1a1) wherein a combination of E, R1 and L represents any combinations indicated in [Table 3-1].
Present compound 47: 1H-NMR (CDCl3) δ: 7.30 (1H, s), 7.10 (1H, d), 6.71-6.65 (1H, m), 6.52-6.49 (1H, m), 3.86 (3H, s), 3.70 (3H, s), 3.47-3.34 (2H, in), 3.03 (1.5H, s), 2.96 (1.5H, s), 2.31 (3H, s), 1.24-1.13 (3H, m).
Present compound 48: 1H-NMR (CDCl3) δ: 7.30 (1H, s), 7.10 (1H, d), 6.68 (1H, dd), 6.51 (1H, d), 3.86 (3H, s), 3.71 (3H, s), 3.44-3.32 (4H, m), 2.31 (3H, s), 1.25-1.14 (6H, m)).
Present compound 49: 1H-NMR (CDCl3) δ: 7.42-7.30 (4H, m), 7.29 (1H, s), 7.27-7.22 (1H, m), 7.09 (1H, d), 6.75-6.61 (1H, br m), 6.51 (1H, br s), 3.85 (3H, s), 3.69 (3H, s), 3.40 (3H, s), 2.30 (3H, s).
Present compound 50: 1H-NMR (CDCl3) δ: 7.45 (1H, s), 7.41-7.32 (4H, m), 7.25-7.21 (1H, m), 7.06 (1H, d), 6.86-6.77 (2H, m), 3.83 (3H, s), 3.65 (3H, s), 3.51 (2H, s), 3.41 (3H, s), 2.30 (3H, s).
Present compound 51: 1H-NMR (CDCl3) δ: 7.30 (1H, s), 7.10 (1H, d), 6.71 (1H, dd), 6.54 (1H, d), 3.86 (3H, s), 3.70 (3H, s), 3.52 (2H, t), 3.45 (2H, t), 2.31 (3H, s), 1.98-1.85 (4H, m).
Present compound 52: 1H-NMR (CDCl3) δ: 7.30 (1H, s), 7.10 (1H, d), 6.67 (1H, dd), 6.50 (1H, d), 3.86 (3H, s), 3.70 (3H, s), 3.62-3.43 (4H, br m), 2.30 (3H, s), 1.69-1.52 (6H, m).
Present compound 89: 1H-NMR (CDCl3) δ: 7.46 (1H, s), 7.07 (1H, d), 6.85-6.80 (2H, m), 3.83 (3H, s), 3.66 (3H, s), 3.52 (2H, s), 3.07 (3H, s), 2.99 (3H, s), 2.31 (3H, s).
Present compound 90: 1H-NMR (CDCl3) δ: 7.46 (1H, s), 7.07 (1H, d), 6.87-6.80 (2H, m), 3.83 (3H, s), 3.67 (3H, s), 3.53 (2H, s), 3.46-3.32 (4H, m), 2.31 (3H, s), 1.27-1.15 (6H, m).
To a mixture of the intermediate compound A1 0.25 g, triphosgene 0.10 g, and chloroform 5 mL was added N,N-diisopropylethylamine 0.18 mL at room temperature, and the mixture was stirred for 2 hours. To the resulting mixture were added propyl amine 0.11 mL and N,N-diisopropylethylamine 0.27 mL successively, and the mixture was stirred for 16 hours. Water was added to the resulting mixture, and the mixture was extracted with ethyl acetate. The resulting organic layer was washed with water and saturated brine successively, dried over anhydrous magnesium sulfate, and concentrated under reduced pressure. The resulting residue was subjected to a silica gel column chromatography (ethyl acetate:hexane=1:4) to obtain the present compound 53 represented by the following formula 0.18 g.
Present compound 53: 1H-NMR (CDCl3) δ: 7.29 (1H, s), 7.10 (1H, d), 6.69 (1H, dd), 6.52 (1H, d), 4.97-4.88 (1H, br m), 3.85 (3H, s), 3.70 (3H, s), 3.20 (2H, q), 2.30 (3H, s), 1.63-1.52 (2H, m), 0.95 (3H, t).
The compound which was prepared according to the Preparation Example 4 and its physical property value are shown below.
A compound represented by formula (1a1) wherein a combination of E, R1 and L represents any combinations indicated in [Table 4-1].
Present compound 54: 1H-NMR (CDCl3) δ: 7.29 (1H, s), 7.10 (1H, d), 6.69 (1H, dd), 6.52 (1H, d), 4.94-4.83 (1H, br m), 3.85 (3H, s), 3.70 (3H, s), 3.24 (2H, q), 2.30 (3H, s), 1.58-1.48 (2H, m), 1.43-1.32 (2H, m), 0.94 (3H, t).
Present compound 55: 1H-NMR (CDCl3) δ: 7.29 (1H, s), 7.10 (1H, d), 6.69 (1H, dd), 6.52 (1H, d), 4.93-4.85 (1H, br m), 3.85 (3H, s), 3.70 (3H, s), 3.23 (2H, q), 2.30 (3H, s), 1.59-1.50 (2H, m), 1.38-1.28 (4H, m), 0.91 (3H, t).
Present compound 56: 1H-NMR (CDCl3) δ: 7.29 (1H, s), 7.09 (1H, d), 6.69 (1H, dd), 6.52 (1H, d), 4.83-4.76 (1H, br m), 3.85 (3H, s), 3.70 (3H, s), 3.58-3.47 (1H, m), 2.30 (3H, s), 2.02-1.94 (2H, m), 1.77-1.66 (2H, m), 1.65-1.57 (1H, m), 1.42-1.29 (2H, m), 1.26-1.12 (3H, m).
Present compound 57: 1H-NMR (CDCl3) δ: 7.30 (1H, s), 7.10 (1H, d), 6.71-6.63 (1H, m), 6.52-6.47 (1H, m), 3.86 (3H, s), 3.70 (3H, s), 3.38-3.25 (2H, m), 3.03 (1.4H, s), 2.97 (1.6H, s), 2.31 (3H, s), 1.68-1.58 (2H, m), 0.98-0.90 (3H, m).
Present compound 58: 1H-NMR (CDCl3) δ: 7.30 (1H, s), 7.10 (1H, d), 6.71-6.64 (1H, m), 6.51-6.49 (1H, m), 3.86 (3H, s), 3.70 (3H, s), 3.41-3.28 (2H, m), 3.03 (1.4H, s), 2.96 (1.6H, s), 2.30 (3H, s), 1.64-1.52 (2H, m), 1.41-1.30 (2H, m), 0.98-0.92 (3H, m).
Present compound 59: 1H-NMR (CDCl3) δ: 7.30 (1H, s), 7.13 (1H, d), 6.71 (1H, dd), 6.55 (1H, d), 3.86 (3H, s), 3.78 (3H, s), 3.70 (3H, s), 3.26 (3H, s), 2.32 (3H, s).
To a mixture of the intermediate compound A1 0.20 g, propionyl chloride 0.09 mL, and chloroform 5 mL was added triethylamine 0.17 mL, and the mixture was stirred for 16 hours. To the resulting mixture was added water, and the mixture was extracted with ethyl acetate. The resulting organic layer was washed with water and saturated brine successively, dried over anhydrous magnesium sulfate, and concentrated under reduced pressure. The resulting residue was subjected to a silica gel column chromatography (ethyl acetate:hexane=1:4) to obtain the present compound 60 represented by the following formula 0.18 g.
Present compound 60: 1H-NMR (CDCl3) δ: 7.31 (1H, s), 7.13 (1H, d), 6.66 (1H, dd), 6.48 (1H, d), 3.86 (3H, s), 3.71 (3H, s), 2.54 (2H, q), 2.32 (3H, s), 1.24 (3H, t).
The compound which was prepared according to the Preparation Example 5 and its physical property value are shown below.
A compound represented by formula (1a1) wherein a combination of E, R1 and L represents any combinations indicated in [Table 5-1].
Present compound 61: 1H-NMR (CDCl3) δ: 7.30 (1H, s), 7.11 (1H, d), 6.63 (1H, dd), 6.44 (1H, d), 3.85 (3H, s), 3.70 (3H, s), 2.49 (1H, tt), 2.31 (3H, s), 2.07-1.98 (2H, m), 1.85-1.75 (2H, m), 1.71-1.63 (1H, m), 1.61-1.47 (2H, m), 1.39-1.20 (3H, m).
Present compound 62: 1H-NMR (CDCl3) δ: 8.17 (2H, d), 7.62 (1H, t), 7.49 (2H, t), 7.31 (1H, s), 7.18 (1H, d), 6.79 (1H, dd), 6.60 (1H, d), 3.87 (3H, s), 3.71 (3H, s), 2.35 (3H, s).
Present compound 63: 1H-NMR (CDCl3) δ: 7.31 (1H, s), 7.14 (1H, d), 6.76 (1H, dd), 6.57 (1H, d), 4.29 (2H, q), 3.87 (3H, s), 3.71 (3H, s), 2.32 (3H, s), 1.37 (3H, t).
Present compound 64: 1H-NMR (CDCl3) δ: 7.31 (1H, s), 7.12 (1H, d), 6.77 (1H, dd), 6.55 (1H, d), 3.86 (3H, s), 3.70 (3H, s), 2.31 (3H, s), 1.54 (9H, s).
Present compound 65: 1H-NMR (CDCl3) δ: 7.33 (1H, s), 7.17 (1H, d), 6.83 (1H, dd), 6.68 (1H, d), 3.88 (3H, s), 3.72 (3H, s), 3.07 (3H, s), 2.34 (3H, s).
Present compound 66: 1H-NMR (CDCl3) δ: 7.33 (1H, s), 7.16 (1H, d), 6.81 (1H, dd), 6.66 (1H, d), 3.88 (3H, s), 3.72 (3H, s), 3.18-3.12 (2H, m), 2.33 (3H, s), 2.03-1.91 (2H, m), 1.09 (3H, t).
Present compound 67: 1H-NMR (CDCl3) δ: 7.80 (2H, t), 7.64 (1H, t), 7.50 (2H, t), 7.25 (1H, s), 7.01 (1H, d), 6.46 (1H, dd), 6.42 (1H, d), 3.85 (3H, s), 3.70 (3H, s), 2.28 (3H, s).
To a mixture of the intermediate compound A1 0.18 g, dimethyl carbamoyl chloride 0.11 g and DMF 5 mL was added sodium hydride (60%, oily) 0.05 g at room temperature, and the mixture was stirred for 4 hours. To the resulting mixture was added saturated ammonium chloride aqueous solution, and the mixture was extracted with ethyl acetate. The resulting organic layer was washed with water and saturated brine successively, dried over anhydrous magnesium sulfate, and concentrated under reduced pressure. The resulting residue was subjected to a silica gel column chromatography (ethyl acetate:hexane=1:3) to obtain the present compound 68 represented by the following formula 0.12 g.
Present compound 68: 1H-NMR (CDCl3) δ: 7.30 (1H, s), 7.15 (1H, d), 6.63 (1H, dd), 6.48 (1H, d), 3.86 (3H, s), 3.71 (3H, s), 3.44 (3H, s), 3.31 (3H, s), 2.33 (3H, s).
The compound which was prepared according to the Reference Preparation Example 6 and its physical property value are shown below.
A compound represented by formula (1a1) wherein a combination of E, R1 and L represents any combinations indicated in [Table 6-1].
Present compound 69: 1H-NMR (CDCl3) δ: 7.33 (1H, s), 7.14 (1H, d), 6.83 (1H, dd), 6.69 (1H, d), 3.88 (3H, s), 3.71 (3H, s), 2.90 (6H, s), 2.32 (3H, s).
Present compound 70: 1H-NMR (CDCl3) δ: 7.33 (1H, s), 7.13 (1H, d), 6.81 (1H, dd), 6.67 (1H, d), 3.87 (3H, s), 3.71 (3H, s), 3.30 (4H, q), 2.32 (3H, s), 1.16 (6H, t).
To a mixture of the intermediate compound B1 0.19 g, potassium carbonate 0.10 g and DMF 5 mL was added iodomethane 0.10 mL at 0° C., and the mixture was stirred for 1 hour. To the resulting mixture was added water, and the mixture was extracted with MTBE. The resulting organic layer was washed with water and saturated brine successively, dried over anhydrous magnesium sulfate, and concentrated under reduced pressure. The resulting residue was subjected to a silica gel column chromatography (ethyl acetate:hexane=1:4) to obtain the present compound 40 represented by the following formula 0.09 g.
A mixture of the intermediate compound D2 0.03 g, benzyl alcohol 0.02 g, palladium(II) acetate 0.001 g, 2-(di-t-butylphosphino)-1,1′-binapthyl 0.002 g, cesium carbonate 0.08 g and toluene 2 mL was stirred at 40° C. for 15 hours. Water was added to the resulting mixture, and the mixture was extracted with ethyl acetate. The resulting organic layer was dried over anhydrous sodium sulfate, and concentrated under reduced pressure to obtain a crude product 0.03 g containing the present compound 40. Present compound 40: LCMS: 329 [M+H]+, RT=2.08 min.
A mixture of the intermediate compound D1 0.05 g, benzyl alcohol 0.04 g and tBuBrettPhos Pd G3 0.01 g, sodium tert-butoxide 0.03 g, and dioxane 2 mL was stirred at 80° C. for 4 hours. Water was added to the reaction mixture, and the mixture was extracted with ethyl acetate. The resulting organic layer was dried over anhydrous sodium sulfate, and concentrated under reduced pressure to obtain a crude product 0.05 g containing the present compound 28. Present compound 28: LCMS: 327 [M+H]+, RT=2.22 min.
Next, the present compounds which were prepared according to the Preparation Examples described in the Examples, and the processes described in the Detailed Description, and their intermediate compounds are shown below.
A compound represented by formula (1A):
wherein R1 represents a methyl group, L represents an oxygen atom, and RX1 represents any substituents selected from Group X
(hereinafter, referred to as Compound Class SX1).
Group X: a group consisting of Et, Pr, i-Pr, (CH2)3CH3, CH2CH(CH3)2, CH(CH3)CH2CH3, C(CH3)3, CH2c-Pr, (CH2)4CH3, (CH2)2CH(CH3)2, CH(CH3) (CH2)2CH3, CH(CH2CH3)CH2C H3, CH2CH(CH3)CH2CH3, C(CH3) 2CH2CH3, CH2C(CH3)3, CH2c-Bu, CH2c-Pen, CH2c-Hex, (CH2)2c-Pr, (1-methylcyclopropyl)methyl, (2-methylcyclopropyl)methyl, 1-cyclopropylethyl, (CH2)3c-Pr, (CH2)5CH3, (CH2)3CH(CH3)2, (CH2)2CH(CH3)CH2CH3, CH2CH(CH3) (CH2)2CH3, CH(CH3) (CH2)3CH3, CH2CH(CH2CH3)2, heptyl, octyl, nonyl, decyl, CH2CH═CH2, CH2CH═CHCH3, CH2CH═C(CH3), CH2CH═CF2, CH2CH═CCl2, CH2CH═CHCH2CH3, CH2CH═CH(CH2)2CH3, CH2C(CH3)═CH2, CH2C(CH3)═CHCH3, CH2C(CH3)═C(CH3)2, CH2C(CH3)═CHCH2CH3, CH2C(CH3)═CH(CH2)2CH3, CH2CF═CH2, CH2CF═CHCH3, CH2CF═C(CH3), CH2CF═CF2, CH2CF═CHCH2CH3, CH2CF═CH(CH2)2CH3, CH2CCl═CH2, CH2CCl═CHCH3, CH2CCl═C(CH3)2, CH2CCl═CCl2, CH2CCl═CHCH2CH3, CH2CCl═CH(CH2)2CH3, (CH2)2CH═CH2, (CH2)2CH═CHCH3, (CH2)2CH═CHCH2CH3, (CH2)2CH═C(CH3)2, (CH2)2C(CH3)═CH2, (CH2)2C(CH3)═CHCH3, (CH2)2C(CH3)═CHCH2CH3, (CH2)2C(CH3)═C(CH3)2, (CH2)3CH═CH2, (CH2)3C(CH3)═CH2, (CH2)4CH═CH2, (CH2)4C(CH3)═CH2, CH2C≡CH, CH2C═CCH3, CH2C═CCH2CH3, CH2C≡Cc-Pr, CH2C≡CPh, (CH2)2C═CH, (CH2)2C═CCH3, (CH2)2C═CCH2CH3, (CH2)2C≡Cc-Pr, (CH2)2C≡CPh, (CH2)3C═CH, (CH2)3C═CCH3, (CH2)3C═CCH2CH3, (CH2)3C═Cc-Pr, (CH2)3C≡CPh, CH2Cl, CH2Br, CH2CN, CH2OCH3, CH2OCH2CH3, CH2O(CH2)2CH3, CH2OPh, CH2SCH3, CH2S(O)CH3, CH2S(O)2CH3, CH2SCH2CH3, CH2S(O)CH2CH3, CH2S(O)2CH2CH3, CH2S(CH2)2CH3, CH2S(O)(CH2)2CH3, CH2S(O)2(CH2)2CH3, CH2SPh, CH2S(O) Ph, CH2S(O)2Ph, CH2C(O)CH3, CH2C(O)CH2CH3, CH2C(O)Ph, CH2C(O)NH2, CH2C(O)NHCH3, CH2C(O)N(CH3)2, CH2C(O)NHPh, CH2C(O)N(CH3)Ph, CH2C(O)OCH3, CH2C(O)OCH2CH3, CH2OC(O)Ph, CH2OC(O)OCH3, CH2OC(O)OCH2CH3, CH2OC(O) OPh, CH2OC(O)NHCH3, CH2OC(O)NHCH2CH3, CH2C(O)NHPh, CH2OC(O)N(CH3)2, CH2OC(O)N(CH3)CH2CH3, CH2OC(O)N(CH3)Ph, CH2OC(O)N(CH2CH3)2, CH2 (2-oxiranyl), CH2(2-tetrahydrofuranyl), CH2(2-tetrahydropyranyl), CH2CH═NOCH3, CH2CH═NOCH2CH3, CH2CH═NOCH2Ph, CH2C(CH3)═NOCH3, CH2C(CH3)═NOCH2CH3, CH2C(CH3)═NOCH2Ph, (CH2)2F, CH2CF3, (CH2)2Cl, CH2CCl3, (CH2)2Br, (CH2)2I, CH2Si(CH3)3, (CH2)2CF3, (CH2)2CN, (CH2)2NO2, (CH2)2Si(CH3)3, (CH2)2OCH3, (CH2)2OCH2CH3, (CH2)2SCH3, (CH2)2SCH2CH3, (CH2)2SPh, (CH2)2S(O)CH3, (CH2)2S(O)CH2CH3, (CH2)2S(O)Ph, (CH2)2S(O)2CH3, (CH2)2S(O)2CH2CH3, (CH2)2S(O)2Ph, (CH2)2NHCH3, (CH2)2N(CH3)2, (CH2)2NHPh, (CH2)2NHCH2Ph, (CH2)2N(CH3)CH2Ph, (CH2)2C(O)CH3, (CH2)2C(O)CH2CH3, (CH2)2C(O)Ph, (CH2)2S(O)2NHCH3, (CH2)2S(O)2N(CH3)2, (CH2)2S(O)2NHPh, (CH2)2S(O)2N(CH3)Ph, (CH2)2C(O)NH2, (CH2)2C(O)NHCH3, (CH2)2C(O)N(CH3)2, (CH2)2C(O)NHPh, (CH2)2C(O)N(CH3)Ph, (CH2)2C(O)OCH3, (CH2)2C(O)OCH2CH3, (CH2)2NHC(O)CH3, (CH2)2NHC(O)CH2CH3, (CH2)2NHC(O) Ph, (CH2)2NCH3C(O)CH3, (CH2)2NCH3C(O)CH2CH3, (CH2)2NCH3C(O) Ph, (CH2)2NHC(O)OCH3, (CH2)2NHC(O)OCH2CH3, (CH2)2NHC(O)OPh, (CH2)2NCH3C(O)OCH3, (CH2)2NCH3C(O)OCH2CH3, (CH2)2NCH3C(O)OPh, (CH2)2NHC(O)NHCH3, (CH2)2NHC(O)NHCH2CH3, (CH2)2NHC(O)NHPh, (CH2)2NHC(O)N(CH3)2, (CH2)2NHC(O)N(CH3)CH2CH3, (CH2)2NHC(O)N(CH3)Ph, (CH2)2NHC(O)N(CH2CH3)2, (CH2)2NCH3C(O)NHCH3, (CH2)2NCH3C(O)NHCH2CH3, (CH2)2NCH3C(O)NHPh, (CH2)2NCH3C(O)N(CH3)2, (CH2)2NCH3C(O)N(CH3)CH2CH3, (CH2)2NCH3C(O)N(CH3)Ph, (CH2)2NCH3C(O)N(CH2CH3)2, (CH2)2OC(O)CH3, (CH2)2OC(O)CH2CH3, (CH2)2OC(O)Ph, (CH2)2OC(O)OCH3, (CH2)2OC(O)OCH2CH3, (CH2)2OC(O)OPh, (CH2)2OC(O)NHCH3, (CH2)2OC(O)NHCH2CH3, (CH2)2OC(O) NHPh, (CH2)2OC(O)N(CH3)2, (CH2)2OC(O)N(CH3)CH2CH3, (CH2)2OC(O)N(CH3) Ph, (CH2)2OC(O)N(CH2CH3)2, (CH2)2S(O)2NHCH3, (CH2)2S(O)2NHCH2CH3, (CH2)2S(O)2NHPh, (CH2)2S(O)2N(CH3)2, (CH2)2S(O)2N(CH3)CH2CH3, (CH2)2S(O)2N(CH3)Ph, (CH2)2S(O)2N(CH2CH3)2, (CH2)3F, (CH2)3Cl, (CH2)3Br, (CH2)3I, (CH2)3CF3, (CH2)3CN, (CH2)3NO2, (CH2)3Si(CH3)3, (CH2)3OCH3, (CH2)3OCH2CH3, (CH2)3SCH3, (CH2)3SCH2CH3, (CH2)3NHCH3, (CH2)3N(CH3)2, (CH2)4F, (CH2)4Cl, (CH2)4CF3, (CH2)4CN, (CH2)4NO2, (CH2)4Ph, (CH2)4OCH3, (CH2)4SCH3, (CH2)4NHCH3, (CH2)4N(CH3)2, (CH2)5F, (CH2)5Cl, (CH2)5CF3, (CH2)5CN, (CH2)5NO2, (CH2)5Ph, (CH2)50CH3, (CH2)5SCH3, (CH2)5NHCH3, (CH2)5N(CH3)2, (CH2)6F, (CH2)6Cl, (CH2)6CF3, (CH2)6CN, (CH2)6NO2, (CH2)6Ph, (CH2)6OCH3, (CH2)6SCH3, (CH2)6NHCH3, (CH2)6N(CH3)2, CH2CF2CF3, (CH2)2CF2CF3, CH2 (CF2)2CF3, (CH2)2CF(CF3)2, (CH2)2(CF2)5CF3, CF3, CF2CHF(CF3), and CF2CHF(OCF3), CH2CF2CF2H.
The compound represented by formula (A1) wherein R1 represents a chlorine atom, L represents an oxygen atom, and RX1 represents any substituents selected from Group X (hereinafter, referred to as Compound Class SX2).
The compound represented by formula (1A) wherein R1 represents a methyl group, L represents CH2, and RX1 represents any substituents selected from Group X (hereinafter, referred to Compound Class SX3).
The compound represented by formula (1A) wherein R1 represents a chlorine atom, L represents CH2, and RX1 represents any substituents selected from Group X (hereinafter, referred to Compound Class SX4).
A compound represented by formula (1B):
wherein, R1 represents a methyl group, L represents an oxygen atom, m is 1, and a combination of RX2, RX3, RX4, RX5, and RX6 represents any combinations described in a combination A below (hereinafter, referred to as Compound Class SX5).
The combination A consists of Substituent Nos. ZA1 to ZA311. The Substituents Nos. ZA1 to ZA311 represent any combinations of RX2, RX3, RX4, RX5, and RX6 respectively in the compound represented by formula (1B), the compound represented by formula (2B), and the compound represented by formula (3B), which are described below as [Substituent No. RX2, RX3, RX4, RX5, RX6]. For example, Substituent No. ZA2 represents a combination wherein RX2 represents a methyl group, and a combination of RX3, RX4, RX5, and RX6 represents a hydrogen atom.
Combination A
[ZA1;H,H,H,H,H], [ZA2;Me,H,H,H,H], [ZA3;F,H,H,H,H], [ZA4;Cl,H,H,H,H], [ZA5;OMe,H,H,H,H], [ZA6; CF3,H,H,H,H], [ZA7;H,Me,H,H,H], [ZA8;H,Et,H,H,H], [ZA9;H,Pr,H,H,H], [ZA10;H,i-Pr,H,H,H], [ZA11;H,t-Bu,H,H,H], [ZA12;H,OMe,H,H,H], [ZA13;H,OEt,H,H,H], [ZA14;H,OPr,H,H,H], [ZA15;H,Oi-Pr,H,H,H], [ZA16;H,CF3,H,H,H], [ZA17;H,CF2H,H,H,H], [ZA18;H,CFH2,H,H,H], [ZA19;H,F,H,H,H], [ZA20;H,Cl,H,H,H], [ZA21;H,Br,H,H,H], [ZA22;H,CN,H,H,H], [ZA23;H,Ph,H,H,H], [ZA24;H,OPh,H,H,H], [ZA25;H,c-Pr,H,H,H], [ZA26;H,c-Pen,H,H,H], [ZA27;H,c-Hex,H,H,H], [ZA28;H,H,Me,H,H], [ZA29;H,H,Et,H,H], [ZA30;H,H,Pr,H,H], [ZA31;H,H,i-Pr,H,H], [ZA32;H,H,t-Bu,H,H], [ZA33;H,H,OMe,H,H], [ZA34;H,H,OEt,H,H], [ZA35;H,H,OPr,H,H], [ZA36;H,H,Oi-Pr,H,H], [ZA37;H,H,CF3,H,H], [ZA38;H,H,CF2H,H,H], [ZA39;H,H,CFH2,H,H], [ZA40;H,H,F,H,H], [ZA41;H,H,Cl,H,H], [ZA42;H,H,Br,H,H], [ZA43;H,H,CN,H,H], [ZA44;H,H,Ph,H,H], [ZA45;H,H,OPh,H,H], [ZA46;H,H,c-Pr,H,H], [ZA47;H,H,c-Pen,H,H], [ZA48;H,H,c-Hex,H,H], [ZA49;H,H,H,H,F], [ZA50;Me,H,H,H,F], [ZA51;F,H,H,H,F], [ZA52;Cl,H,H,H,F], [ZA53;H,Me,H,H,F], [ZA54;H,Et,H,H,F], [ZA55;H,Pr,H,H,F], [ZA56;H,i-Pr,H,H,F], [ZA57;H,t-Bu,H,H,F], [ZA58;H,OMe,H,H,F], [ZA59;H,OEt,H,H,F], [ZA60;H,OPr,H,H,F], [ZA61;H,Oi-Pr,H,H,F], [ZA62;H,CF3,H,H,F], [ZA63;H,CF2H,H,H,F], [ZA64;H,CFH2,H,H,F], [ZA65;H,F,H,H,F], [ZA66;H,Cl,H,H,F], [ZA67;H,Br,H,H,F], [ZA68;H,CN,H,H,F], [ZA69;H,Ph,H,H,F], [ZA70;H,OPh,H,H,F], [ZA71;H,c-Pr,H,H,F], [ZA72;H,c-Pen,H,H,F], [ZA73;H,c-Hex,H,H,F], [ZA74;H,H,Me,H,F], [ZA75;H,H,Et,H,F], [ZA76;H,H,Pr,H,F], [ZA77;H,H,i-Pr,H,F], [ZA78;H,H,t-Bu,H,F], [ZA79;H,H,OMe,H,F], [ZA80;H,H,OEt,H,F], [ZA81;H,H,OPr,H,F], [ZA82;H,H,Oi-Pr,H,F], [ZA83;H,H,CF3,H,F], [ZA84;H,H,CF2H,H,F], [ZA85;H,H,CFH2,H,F], [ZA86;H,H,F,H,F], [ZA87;H,H,Cl,H,F], [ZA88;H,H,Br,H,F], [ZA89;H,H,CN,H,F], [ZA90;H,H,Ph,H,F], [ZA91;H,H,OPh,H,F], [ZA92;H,H,c-Pr,H,F], [ZA93;H,H,c-Pen,H,F], [ZA94;H,H,c-Hex,H,F], [ZA95;H,H,H,H,Cl], [ZA96;Me,H,H,H,Cl], [ZA97;F,H,H,H,Cl], [ZA98;Cl,H,H,H,Cl], [ZA99;H,Me,H,H,Cl], [ZA100;H,Et,H,H,Cl]
[ZA101;H,Pr,H,H,Cl], [ZA102;H,i-Pr,H,H,Cl], [ZA103;H,t-Bu,H,H,Cl], [ZA104;H,OMe,H,H,Cl], [ZA105;H,OEt,H,H,Cl], [ZA106;H,OPr,H,H,Cl], [ZA107;H,Oi-Pr,H,H,Cl], [ZA108;H,CF3,H,H,Cl], [ZA109;H,CF2H,H,H,Cl], [ZA110;H,CFH,H,H,Cl], [ZA111;H,F,H,H,Cl], [ZA112;H,Cl,H,H,Cl], [ZA113;H,Br,H,H,Cl], [ZA114;H,CN,H,H,Cl], [ZA115;H,Ph,H,H,Cl], [ZA116;H,OPh,H,H,Cl], [ZA117;H,c-Pr,H,H,Cl], [ZA118;H,c-Pen,H,H,Cl], [ZA119;H,c-Hex,H,H,Cl], [ZA120;H,H,Me,H,Cl], [ZA121;H,H,Et,H,Cl], [ZA122;H,H,Pr,H,Cl], [ZA123;H,H,i-Pr,H,Cl], [ZA124;H,H,t-Bu,H,Cl], [ZA125;H,H,OMe,H,Cl], [ZA126;H,H,OEt,H,Cl], [ZA127;H,H,OPr,H,Cl], [ZA128;H,H,Oi-Pr,H,Cl], [ZA129;H,H,CF3,H,Cl], [ZA130;H,H,CF1H,H,Cl], [ZA131;H,H,CFH2,H,Cl], [ZA132;H,H,F,H,Cl], [ZA133;H,H,Cl,H,Cl], [ZA134;H,H,Br,H,Cl], [ZA135;H,H,CN,H,Cl], [ZA136;H,H,Ph,H,Cl], [ZA137;H,H,OPh,H,Cl], [ZA138;H,H,c-Pr,H,Cl], [ZA139;H,H,c-Pen,H,Cl], [ZA140;H,H,c-Hex,H,Cl], [ZA141;H,H,H,H,Me], [ZA142;Me,H,H,H,Me], [ZA143;F,H,H,H,Me], [ZA144;Cl,H,H,H,Me], [ZA145;H,Me,H,H,Me], [ZA146;H,Et,H,H,Me], [ZA147;H,Pr,H,H,Me], [ZA148;H,i-Pr,H,H,Me], [ZA149;H,t-Bu,H,H,Me], [ZA150;H,OMe,H,H,Me], [ZA151;H,OEt,H,H,Me], [ZA152;H,OPr,H,H,Me], [ZA153;H,Oi-Pr,H,H,Me], [ZA154;H,CF3,H,H,Me], [ZA155;H,CF:H,H,H,Me], [ZA156;H,CFH2,H,H,Me], [ZA157;H,F,H,H,Me], [ZA158;H,Cl,H,H,Me], [ZA159;H,Br,H,H,Me], [ZA160;H,CN,H,H,Me], [ZA161;H,Ph,H,H,Me], [Z A162;H,OPh,H,H,Me], [ZA163;H,c-Pr,H,H,Me], [ZA164;H,c-Pen,H,H,Me], [ZA165;H,c-Hex,H,H,Me], [ZA166;H,H,Me,H,Me], [ZA167;H,H,Et,H,Me], [ZA168; H,H,Pr,H,Me], [ZA169;H,H,i-Pr,H,Me], [ZA170;H,H,t-Bu,H,Me], [ZA171;H,H,OMe,H,Me], [ZA172;H,H,OEt,H,Me], [ZA173;H,H,OPr,H,Me], [ZA174;H,H,Oi-Pr,H,Me], [ZA175;H,H,CF3,H,Me], [ZA176;H,H,CF2H,H,Me], [ZA177;H,H,CFH2,H,Me], [ZA178;H,H,F,H,Me], [ZA179;H,H,Cl,H,Me], [ZA180;H,H,Br,H,Me], [ZA181;H,H,CN,H,Me], [ZA182;H,H,Ph,H,Me], [ZA183;H,H,OPh,H,Me], [ZA184;H,H,c-Pr,H,Me], [ZA185;H,H,c-Pen,H,Me], [ZA186;H,H,c-Hex,H,Me], [ZA187;H,H,H,H,OMe], [ZA188;Me,H,H,H,OMe], [ZA189;F,H,H,H,OMe], [ZA190;Cl,H,H,H,OMe], [ZA191;H,Me,H,H,OMe], [ZA192;H,Et,H,H,OMe], [ZA193;H,Pr,H,H,OMe], [ZA194;H,i-Pr,H,H,OMe], [ZA195;H,t-Bu,H,H,OMe], [ZA196;H,OMe,H,H,OMe], [ZA197;H,OEt,H,H,OMe], [ZA198;H,OPr,H,H,OMe], [ZA199;H,Oi-Pr,H,H,OMe], [ZA200;H,CF3,H,H,OMe]
[ZA201;H,CF2H,H,H,OMe], [ZA202;H,CFH2,H,H,OMe], [ZA203;H,F,H,H,OMe], [ZA204;H,Cl,H,H,OMe], [ZA205;H,Br,H,H,OMe], [ZA206;H,CN,H,H,OMe], [ZA207;H,Ph,H,H,OMe], [ZA208;H,OPh,H,H,OMe], [ZA209;H,c-Pr,H,H,OMe], [ZA210;H,c-Pen,H,H,OMe], [ZA211;H,c-Hex,H,H,OMe], [ZA212;H,H,Me,H,OMe], [ZA213;H,H,Et,H,OMe], [ZA214;H,H,Pr,H,OMe], [ZA215;H,H,i-Pr,H,OMe], [ZA216;H,H,t-Bu,H,OMe], [ZA217;H,H,OMe,H,OMe], [ZA218;H,H,OEt,H,OMe], [ZA219;H,H,OPr,H,OMe], [ZA220;H,H,Oi-Pr,H,OMe], [ZA221;H,H,CF3,H,OMe], [ZA222;H,H,CF2H,H,OMe], [ZA223;H,H,CFH2,H,OMe], [ZA224;H,H,F,H,OMe], [ZA225;H,H,Cl,H,OMe], [ZA226;H,H,Br,H,OMe], [ZA227;H,H,CN,H,OMe], [ZA228;H,H,Ph,H,OMe], [ZA229;H,H,OPh,H,OMe], [ZA230;H,H,c-Pr,H,OMe], [ZA231;H,H,c-Pen,H,OMe], [ZA232;H,H,c-Hex,H,OMe], [ZA233;H,H,H,H,CF3], [ZA234;Me,H,H,H,CF3], [ZA235;F,H,H,H,CF3], [ZA236;Cl,H,H,H,CF3], [ZA237;H,Me,H,H,CF3], [ZA238;H,Et,H,H,CF3], [ZA239;H,Pr,H,H,CF3], [ZA240;H,i-Pr,H,H,CF3], [ZA241;H,t-Bu,H,H,CF3], [ZA242;H,OMe,H,H,CF3], [ZA243;H,OEt,H,H,CF3], [ZA244;H,OPr,H,H,CF3], [ZA245;H,Oi-Pr,H,H,CF3], [ZA246;H,CF3,H,H,CF3], [ZA247;H,CF2H,H,H,CF3], [ZA248;H,CFH2,H,H,CF3], [ZA249;H,F,H,H,CF3], [ZA250;H,Cl,H,H,CF3], [ZA251;H,Br,H,H,CF3], [ZA252;H,CN,H,H,CF3], [ZA253;H,Ph,H,H,CF3], [ZA254;H,OPh,H,H,CF3], [ZA255;H,c-Pr,H,H,CF3], [ZA256;H,c-Pen,H,H,CF3], [ZA257;H,c-Hex,H,H,CF3], [ZA258;H,H,Me,H,CF3], [ZA259;H,H,Et,H,CF3], [ZA260;H,H,Pr,H,CF3], [ZA261;H,H,i-Pr,H,CF3], [ZA262;H,H,t-Bu,H,CF3], [ZA263;H,H,OMe,H,CF3], [ZA264;H,H,OEt,H,CF3], [ZA265;H,H,OPr,H,CF3], [ZA266;H,H,Oi-Pr,H,CF3], [ZA267;H,H,CF3,H,CF3], [ZA268;H,H,CF2H,H,CF3], [ZA269;H,H,CFH2,H,CF3], [ZA270;H,H,F,H,CF3], [ZA271;H,H,Cl,H,CF3], [ZA272;H,H,Br,H,CF3], [ZA273;H,H,CN,H,CF3], [ZA274;H,H,Ph,H,CF3], [ZA275;H,H,OPh,H,CF3], [ZA276;H,H,c-Pr,H,CF3], [ZA277;H,H,c-Pen,H,CF3], [ZA278;H,H,c-Hex,H,CF3], [ZA279;H,F,F,H,H], [ZA280;H,F,H,F,H], [ZA281;H,F,F,F,H], [ZA282; F. F,F,H,H], [ZA283; F. F,H,F,H], [ZA284; F,H,F,H,F], [ZA285;F,F,F,F,F], [ZA286;H,Cl,H,Cl,H], [ZA287;H,OMe,H,OMe,H], [ZA288;H,F,Cl,H,H], [ZA289;H,F,Me,H,H], [ZA290;H,F,OMe,H,H], [ZA291;H,F,CF3,H,H], [ZA292;H,Cl,F,H,H], [ZA293;H,Cl,Cl,H,H], [ZA294;H,Cl,Me,H,H], [ZA295;H,Cl,OMe,H,H], [ZA296;H,Cl,CF3,H,H], [ZA297;H,Me,F,H,H], [ZA298;H,Me,Cl,H,H], [ZA299;H,Me,Me,H,H], [ZA300;H,Me,OMe,H,H],
[ZA301;H,Me,CF3,H,H], [ZA302;H,OMe,F,H,H], [ZA303;H,OMe,Cl,H,H], [ZA304;H,OMe,Me,H,H], [ZA305;H,OMe,OMe,H,H], [ZA306;H,OMe,CF3,H,H], [ZA307;H,CF3,F,H,H], [ZA308;H,CF3,Cl,H,H], [ZA309;H,CF3,F,H,H], [ZA310;H,CF3,Cl,H,H], [ZA311;H,CF3,F,H,H]
The compound represented by formula (1B) wherein R1 represents a chlorine atom, L represents an oxygen atom, m is 1, and a combination of RX2, RX3, RX4, RX5 and RX6 represents any combinations described in the Combination A (hereinafter, referred to as Compound Class SX6).
The compound represented by formula (1B) wherein R1 represents a methyl group, L represents CH2, m is 1, and a combination of RX2, RX3, RX4, RX5 and RX6 represents any combinations described in the Combination A (hereinafter, referred to as Compound Class SX7).
The compound represented by formula (1B) wherein R1 represents a chlorine atom, L represents CH2, m is 1, and a combination of RX2, RX3, RX4, RX5 and RX6 represents any combinations described in the Combination A (hereinafter, referred to as Compound Class SX8).
The compound represented by formula (1B) wherein R1 represents a methyl group, L represents an oxygen atom, m is 2, and a combination of RX2, RX3, RX4, RX5, and RX6 represents any combinations descried in the Combination A (hereinafter, referred to as Compound Class SX9).
The compound represented by formula (1B) wherein R1 represents a chlorine atom, L represents an oxygen atom, m is 2, and a combination of RX2, RX3, RX4, RX5 and RX6 represents any combinations descried in the Combination A (hereinafter, referred to as Compound Class SX10).
The compound represented by formula (1B) wherein R1 represents a methyl group, L represents CH2, m is 2, and a combination of RX2, RX3, RX4, RX5 and RX6 represents any combinations descried in the Combination A (hereinafter, referred to as Compound Class SX11).
The compound represented by formula (1B) wherein R1 represents a chlorine atom, L represents CH2, m is 2, and a combination of RX2, RX3, RX4, RX5 and RX6 represents any combinations descried in the Combination A (hereinafter, referred to as Compound Class SX12).
The compound represented by formula (1B) wherein R1 represents a methyl group, L represents an oxygen atom, m is 3, and a combination of RX2, RX3, RX4, RX5 and RX6 represents any combinations descried in the Combination A (hereinafter, referred to as Compound Class SX13).
The compound represented by formula (1B) wherein R1 represents a chlorine atom, L represents an oxygen atom, m is 3, and a combination of RX2, RX3, RX4, RX5 and RX6 represents any combinations descried in the Combination A (hereinafter, referred to as Compound Class SX14).
The compound represented by formula (1B) wherein R1 represents a methyl group, L represents CH2, m is 3, and a combination of RX2, RX3, RX4, RX5 and RX6 represents any combinations descried in the Combination A (hereinafter, referred to as Compound Class SX15).
The compound represented by formula (1B) wherein R1 represents a chlorine atom, L represents CH2, m is 3, and a combination of RX2. RX3, RX4, RX5 and RX6 represents any combinations descried in the Combination A (hereinafter, referred to as Compound Class SX16).
A compound represented by formula (1C):
[wherein
The Combination B consists of Substituent Nos. ZB1 to ZB1145. The Substituent Nos. ZB1 to ZB1145 represents a combination of a structure of G and the substituents of RX7, RX8, RX9, and RX10 which depend on the structure of G in the compound represented by formula (1C), the compound represented by formula (2C), and the compound represented by formula (3C), which are described below as [Substituent No.: G, RX7, RX8, RX9, RX10]. For example, Substituent No. ZB2 represents a combination wherein G represents G1, RX7 represents a methyl group, and a combination of RX8, RX9, and RX10 represents a hydrogen atom.
Combination B
[ZB1;G1,H,H,H,H], [ZB2;G1,Me,H,H,H], [ZB3;G1,Et,H,H,H], [ZB4;G1,Pr,H,H,H], [ZB5;G1,i-Pr,H,H,H], [ZB6;G1,c-Pr,H,H,H], [ZB7;G1,Ph,H,H,H], [ZB8;G1,OMe,H,H,H], [ZB9;G1,OEt,H,H,H], [ZB10;G1,OPh,H,H,H], [ZB11;G1,CF3,H,H,H], [ZB12;G1,F,H,H,H], [ZB13;G1,Cl,H,H,H], [ZB14;G1,Br,H,H,H], [ZB15;G1,CN,H,H,H], [ZB16;G1,H,Me,H,H], [ZB17;G1,H,Et,H,H], [ZB18;G1,H,Pr,H,H], [ZB19;G1,H,i-Pr,H,H], [ZB20;G1,H,c-Pr,H,H], [ZB21;G1,H,Ph,H,H], [ZB22;G1,H,OMe,H,H], [ZB23;G1,H,OEt,H,H], [ZB24;G1,H,OPh,H,H], [ZB25;G1,H,CF3,H,H], [ZB26;G1,H,F,H,H], [ZB27;G1,H,Cl,H,H], [ZB28;G1,H,Br,H,H], [ZB29;G1,H,CN,H,H], [ZB30;G1,H,H,Me,H], [ZB31;G1,H,H,Et,H], [ZB32;G1,H,H,Pr,H], [ZB33;G1,H,H,i-Pr,H], [ZB34;G1,H,H,c-Pr,H], [ZB35;G1,H,H,Ph,H], [ZB36;G1,H,H,OMe,H], [ZB37;G1,H,H,OEt,H], [ZB38;G1,H,H,OPh,H], [ZB39;G1,H,H,CF3,H], [ZB40;G1,H,H,F,H], [ZB41;G1,H,H,Cl,H], [ZB42;G1,H,H,Br,H], [ZB43;G1,H,H,CN,H], [ZB44;G1,H,H,H,Me], [ZB45;G1,H,H,H,Et], [ZB46;G1,H,H,H,Pr], [ZB47;G1,H,H,H,i-Pr], [ZB48;G1,H,H,H,c-Pr], [ZB49;G1,H,H,H,Ph], [ZB50;G1,H,H,H,OMe], [ZB51;G1,H,H,H,OEt], [ZB52;G1,H,H,H,OPh], [ZB53;G1,H,H,H,CF3], [ZB54;G1,H,H,H,F], [ZB55;G1,H,H,H,Cl], [ZB56;G1,H,H,H,Br], [ZB57;G1,H,H,H,CN], [ZB58;G2,H,H,H,H], [ZB59;G2,Me,H,H,H], [ZB60;G2,Et,H,H,H], [ZB61;G2,Pr,H,H,H], [ZB62;G2,i-Pr,H,H,H], [ZB63;G2,c-Pr,H,H,H], [ZB64;G2,Ph,H,H,H], [ZB65;G2,OMe,H,H,H], [ZB66;G2,OEt,H,H,H], [ZB67;G2,OPh,H,H,H], [ZB68;G2,CF3,H,H,H], [ZB69;G2,F,H,H,H], [ZB70;G2,Cl,H,H,H], [ZB71;G2,Br,H,H,H], [ZB72;G2,CN,H,H,H], [ZB73;G2,H,Me,H,H], [ZB74;G2,H,Et,H,H], [ZB75;G2,H,Pr,H,H], [ZB76;G2,H,i-Pr,H,H], [ZB77;G2,H,c-Pr,H,H], [ZB78;G2,H,Ph,H,H], [ZB79;G2,H,OMe,H,H], [ZB80;G2,H,OEt,H,H], [ZB81;G2,H,OPh,H,H], [ZB82;G2,H,CF3,H,H], [ZB83;G2,H,F,H,H], [ZB84;G2,H,Cl,H,H], [ZB85;G2,H,Br,H,H], [ZB86;G2,H,CN,H,H], [ZB87;G2,H,H,Me,H], [ZB88;G2,H,H,Et,H], [ZB89;G2,H,H,Pr,H], [ZB90;G2,H,H,i-Pr,H], [ZB91;G2,H,H,c-Pr,H], [ZB92;G2,H,H,Ph,H], [ZB93;G2,H,H,OMe,H], [ZB94;G2,H,H,OEt,H], [ZB95;G2,H,H,OPh,H], [ZB96;G2,H,H,CF3,H], [ZB97;G2,H,H,F,H], [ZB98;G2,H,H,Cl,H], [ZB99;G2,H,H,Br,H], [ZB100;G2,H,H,CN,H]
[ZB101;G2,H,H,H,Me], [ZB102;G2,H,H,H,Et], [ZB103;G2,H,H,H,Pr], [ZB104;G2,H,H,H,i-Pr], [ZB105;G2,H,H,H,c-Pr], [ZB106;G2,H,H,H,Ph], [ZB107;G2,H,H,H,OMe], [ZB108;G2,H,H,H,OEt], [ZB109;G2,H,H,H,OPh], [ZB110;G2,H,H,H,CF3], [ZB111;G2,H,H,H,F], [ZB112;G2,H,H,H,Cl], [ZB113;G2,H,H,H,Br], [ZB114;G2,H,H,H,CN], [ZB115;G3,H,H,H,H], [ZB116;G3,Me,H,H,H], [ZB117;G3,Et,H,H,H], [ZB118;G3,Pr,H,H,H], [ZB119;G3,i-Pr,H,H,H], [ZB120;G3,c-Pr,H,H,H], [ZB121;G3,Ph,H,H,H], [ZB122;G3,OMe,H,H,H], [ZB123;G3,OEt,H,H,H], [ZB124;G3,OPh,H,H,H], [ZB125;G3,CF3,H,H,H], [ZB126;G3,F,H,H,H], [ZB127;G3,Cl,H,H,H], [ZB128;G3,Br,H,H,H], [ZB129;G3,CN,H,H,H], [ZB130;G3,H,Me,H,H], [ZB131;G3,H,Et,H,H], [ZB132;G3,H,Pr,H,H], [ZB133;G3,H,i-Pr,H,H], [ZB134;G3,H,c-Pr,H,H], [ZB135;G3,H,Ph,H,H], [ZB136;G3,H,OMe,H,H], [ZB137;G3,H,OEt,H,H], [ZB138;G3,H,OPh,H,H], [ZB139;G3,H,CF3,H,H], [ZB140;G3,H,F,H,H], [ZB141;G3,H,Cl,H,H], [ZB142;G3,H,Br,H,H], [ZB143; G3,H,CN,H,H], [ZB144;G3,H,H,Me,H], [ZB145;G3,H,H,Et,H], [ZB146;G3,H,H,Pr,H], [ZB147;G3,H,H,i-Pr,H], [ZB148;G3,H,H,c-Pr,H], [ZB149;G3,H,H,Ph,H], [ZB150;G3,H,H,OMe,H], [ZB151;G3,H,H,OEt,H], [ZB152;G3,H,H,OPh,H], [ZB153;G3,H,H,CF3,H], [ZB154;G3,H,H,F,H], [ZB155;G3,H,H,Cl,H], [ZB156;G3,H,H,Br,H], [ZB157;G3,H,H,CN,H], [ZB158;G3,H,H,H,Me], [ZB159;G3,H,H,H,Et], [ZB160;G3,H,H,H,Pr], [ZB161;G3,H,H,H,i-Pr], [ZB162;G3,H,H,H,c-Pr], [ZB163;G3,H,H,H,Ph], [ZB164;G3,H,H,H,OMe], [ZB165;G3,H,H,H,OEt], [ZB166;G3,H,H,H,OPh], [ZB167;G3,H,H,H,CF3], [ZB168;G3,H,H,H,F], [ZB169;G3,H,H,H,Cl], [ZB170;G3,H,H,H,Br], [ZB171;G3,H,H,H,CN], [ZB172;G4,H,H,H,-], [ZB173;G4,Me,H,H,-], [ZB174;G4,Et,H,H,-], [ZB175;G4,Pr,H,H,-], [ZB176;G4,i-Pr,H,H,-], [ZB177;G4,c-Pr,H,H,-], [ZB178;G4,Ph,H,H,-], [ZB179;G4,OMe,H,H,-], [ZB180;G4,OEt,H,H,-], [ZB181;G4,OPh,H,H,-], [ZB182;G4,CF3,H,H,-], [ZB183;G4,F,H,H,-], [ZB184;G4,Cl,H,H,-], [ZB185;G4,Br,H,H,-], [ZB186;G4,CN,H,H,-], [ZB187;G4,H,Me,H,-], [ZB188;G4,H,Et,H,-], [ZB189;G4,H,Pr,H,-], [ZB190;G4,H,i-Pr,H,-], [ZB191;G4,H,c-Pr,H,-], [ZB192;G4,H,Ph,H,-], [ZB193;G4,H,OMe,H,-], [ZB194;G4,H,OEt,H,-], [ZB195;G4,H,OPh,H,-], [ZB196;G4,H,CF3,H,-], [ZB197;G4,H,F,H,-], [ZB198;G4,H,Cl,H,-], [ZB199;G4,H,Br,H,-], [ZB200;G4,H,CN,H,-]
[ZB201;G4,H,H,Me,-], [ZB202;G4,H,H,Et,-], [ZB203;G4,H,H,Pr,-], [ZB204;G4,H,H,i-Pr,-], [ZB205;G4,H,H,c-Pr,-], [ZB206;G4,H,H,Ph,-], [ZB207;G4,H,H,OMe,-], [ZB208;G4,H,H,OEt,-], [ZB209;G4,H,H,OPh,-], [ZB210;G4,H,H,CF3,-], [ZB211;G4,H,H,F,-], [ZB212;G4,H,H,Cl,-], [ZB213;G4,H,H,Br,-], [ZB214;G4,H,H,CN,-], [ZB215;G5,H,H,H,-], [ZB216;G5,Me,H,H,-], [ZB217;G5,Et,H,H,-], [ZB218;G5,Pr,H,H,-], [ZB219;G5,i-Pr,H,H,-], [ZB220;G5,c-Pr,H,H,-], [ZB221;G5,Ph,H,H,-], [ZB222;G5,OMe,H,H,-], [ZB223;G5,OEt,H,H,-], [ZB224;G5,OPh,H,H,-], [ZB225;G5,CF3,H,H,-], [ZB226;G5,F,H,H,-], [ZB227;G5,Cl,H,H,-], [ZB228;G5,Br,H,H,-], [ZB229;G5,CN,H,H,-], [ZB230;G5,H,Me,H,-], [ZB231;G5,H,Et,H,-], [ZB232;G5,H,Pr,H,-], [ZB233;G5,H,i-Pr,H,-], [ZB234;G5,H,c-Pr,H,-], [ZB235;G5,H,Ph,H,-], [ZB236;G5,H,OMe,H,-], [ZB237;G5,H,OEt,H,-], [ZB238;G5,H,OPh,H,-], [ZB239;G5,H,CF3,H,-], [ZB240;G5,H,F,H,-], [ZB241;G5,H,Cl,H,-], [ZB242;G5,H,Br,H,-], [ZB243;G5,H,CN,H,-], [ZB244;G5,H,H,Me,-], [ZB245;G5,H,H,Et,-], [ZB246;G5,H,H,Pr,-], [ZB247;G5,H,H,i-Pr,-], [ZB248;G5,H,H,c-Pr,-], [ZB249;G5,H,H,Ph,-], [ZB250;G5,H,H,OMe,-], [ZB251;G5,H,H,OEt,-], [ZB252;G5,H,H,OPh,-], [ZB253;G5,H,H,CF3,-], [ZB254;G5,H,H,F,-], [ZB255;G5,H,H,Cl,-], [ZB256;G5,H,H,Br,-], [ZB257;G5,H,H,CN,-], [ZB258;G6,H,H,H,-], [ZB259;G6,Me,H,H,-], [ZB260;G6,Et,H,H,-], [ZB261;G6,Pr,H,H,-], [ZB262;G6,i-Pr,H,H,-], [ZB263;G6,c-Pr,H,H,-], [ZB264;G6,Ph,H,H,-], [ZB265;G6,OMe,H,H,-], [ZB266;G6,OEt,H,H,-], [ZB267;G6,OPh,H,H,-], [ZB268;G6,CF3,H,H,-], [ZB269;G6,F,H,H,-], [ZB270;G6,Cl,H,H,-], [ZB271;G6,Br,H,H,-], [ZB272;G6,CN,H,H,-], [ZB273;G6,H,Me,H,-], [ZB274;G6,H,Et,H,-], [ZB275;G6,H,Pr,H,-], [ZB276;G6,H,i-Pr,H,-], [ZB277;G6,H,c-Pr,H,-], [ZB278;G6,H,Ph,H,-], [ZB279;G6,H,OMe,H,-], [ZB280;G6,H,OEt,H,-], [ZB281;G6,H,OPh,H,-], [ZB282;G6,H,CF3,H,-], [ZB283;G6,H,F,H,-], [ZB284;G6,H,Cl,H,-], [ZB285;G6,H,Br,H,-], [ZB286;G6,H,CN,H,-], [ZB287;G6,H,H,Me,-], [ZB288;G6,H,H,Et,-], [ZB289;G6,H,H,Pr,-], [ZB290;G6,H,H,i-Pr,-], [ZB291;G6,H,H,c-Pr,-], [ZB292;G6,H,H,Ph,-], [ZB293;G6,H,H,OMe,-], [ZB294;G6,H,H,OEt,-], [ZB295;G6,H,H,OPh,-], [ZB296;G6,H,H,CF3,-], [ZB297;G6,H,H,F,-], [ZB298;G6,H,H,Cl,-], [ZB299;G6,H,H,Br,-], [ZB300;G6,H,H,CN,-]
[ZB301;G7,H,H,H,-], [ZB302;G7,Me,H,H,-], [ZB303;G7,Et,H,H,-], [ZB304;G7,Pr,H,H,-], [ZB305;G7,i-Pr,H,H,-], [ZB306;G7,c-Pr,H,H,-], [ZB307;G7,Ph,H,H,-], [ZB308;G7,OMe,H,H,-], [ZB309;G7,OEt,H,H,-], [ZB310;G7,OPh,H,H,-], [ZB311;G7,CF3,H,H,-], [ZB312;G7,F,H,H,-], [ZB313;G7,Cl,H,H,-], [ZB314;G7,Br,H,H,-], [ZB315;G7,CN,H,H,-], [ZB316;G7,H,Me,H,-], [ZB317;G7,H,Et,H,-], [ZB318;G7,H,Pr,H,-], [ZB319;G7,H,i-Pr,H,-], [ZB320;G7,H,c-Pr,H,-], [ZB321;G7,H,Ph,H,-], [ZB322;G7,H,OMe,H,-], [ZB323;G7,H,OEt,H,-], [ZB324;G7,H,OPh,H,-], [ZB325;G7,H,CF3,H,-], [ZB326;G7,H,F,H,-], [ZB327;G7,H,Cl,H,-], [ZB328;G7,H,Br,H,-], [ZB329;G7,H,CN,H,-], [ZB330;G7,H,H,Me,-], [ZB331;G7,H,H,Et,-], [ZB332;G7,H,H,Pr,-], [ZB333;G7,H,H,i-Pr,-], [ZB334;G7,H,H,c-Pr,-], [ZB335;G7,H,H,Ph,-], [ZB336;G7,H,H,OMe,-], [ZB337;G7,H,H,OEt,-], [ZB338;G7,H,H,OPh,-], [ZB339;G7,H,H,CF3,-], [ZB340;G7,H,H,F,-], [ZB341;G7,H,H,Cl,-], [ZB342;G7,H,H,Br,-], [ZB343;G7,H,H,CN,-], [ZB344;G8,H,H,H,-], [ZB345;G8,Me,H,H,-], [ZB346;G8,Et,H,H,-], [ZB347;G8,Pr,H,H,-], [ZB348;G8,i-Pr,H,H,-], [ZB349;G8,c-Pr,H,H,-], [ZB350;G8,Ph,H,H,-], [ZB351;G8,OMe,H,H,-], [ZB352;G8,OEt,H,H,-], [ZB353;G8,OPh,H,H,-], [ZB354;G8,CF3,H,H,-], [ZB355;G8,F,H,H,-], [ZB356;G8,Cl,H,H,-], [ZB357;G8,Br,H,H,-], [ZB358;G8,CN,H,H,-], [ZB359;G8,H,Me,H,-], [ZB360;G8,H,Et,H,-], [ZB361;G8,H,Pr,H,-], [ZB362;G8,H,i-Pr,H,-], [ZB363;G8,H,c-Pr,H,-], [ZB364;G8,H,Ph,H,-], [ZB365;G8,H,OMe,H,-], [ZB366;G8,H,OEt,H,-], [ZB367;G8,H,OPh,H,-], [ZB368;G8,H,CF3,H,-], [ZB369;G8,H,F,H,-], [ZB370;G8,H,Cl,H,-], [ZB371;G8,H,Br,H,-], [ZB372;G8,H,CN,H,-], [ZB373;G8,H,H,Me,-], [ZB374;G8,H,H,Et,-], [ZB375;G8,H,H,Pr,-], [ZB376;G8,H,H,i-Pr,-], [ZB377;G8,H,H,c-Pr,-], [ZB378;G8,H,H,Ph,-], [ZB379;G8,H,H,OMe,-], [ZB380;G8,H,H,OEt,-], [ZB381;G8,H,H,OPh,-], [ZB382;G8,H,H,CF3,-], [ZB383;G8,H,H,F,-], [ZB384;G8,H,H,Cl,-], [ZB385;G8,H,H,Br,-], [ZB386;G8,H,H,CN,-], [ZB387;G9,H,H,H,-], [ZB388;G9,Me,H,H,-], [ZB389;G9,Et,H,H,-], [ZB390;G9,Pr,H,H,-], [ZB391;G9,i-Pr,H, H,-], [ZB392;G9, c-Pr,H,H,-], [ZB393;G9,Ph,H,H,-], [ZB394;G9,OMe,H,H,-], [ZB395;G9,OEt,H,H,-], [ZB396;G9,OPh,H,H,-], [ZB397;G9,CF3,H,H,-], [ZB398;G9,F,H,H,-], [ZB399;G9,Cl,H,H,-], [ZB400;G9,Br,H,H,-]
[ZB401;G9,CN,H,H,-], [ZB402;G9,H,Me,H,-], [ZB403;G9,H,Et,H,-], [ZB404;G9,H,Pr,H.-], [ZB405;G9,H,i-Pr,H,-], [ZB406;G9,H,c-Pr,H,-], [ZB407;G9,H,Ph,H,-], [ZB408;G9,H,OMe,H,-], [ZB409;G9,H,OEt,H,-], [ZB410;G9,H,OPh,H,-], [ZB411;G9,H,CF3,H,-], [ZB412;G9,H,F,H,-], [ZB413;G9,H,Cl,H,-], [ZB414;G9,H,Br,H,-], [ZB415;G9,H,CN,H,-], [ZB416;G9,H,H,Me,-], [ZB417;G9,H,H,Et,-], [ZB418;G9,H,H,Pr,-], [ZB419;G9,H,H,i-Pr,-], [ZB420;G9,H,H,c-Pr,-], [ZB421;G9,H,H,Ph,-], [ZB422;G9,H,H,OMe,-], [ZB423;G9,H,H,OEt,-], [ZB424;G9,H,H,OPh,-], [ZB425;G9,H,H,CF3,-], [ZB426;G9,H,H,F,-], [ZB427;G9,H,H,Cl,-], [ZB428;G9,H,H,Br,-], [ZB429;G9,H,H,CN,-], [ZB430;G10,H,H,H,-], [ZB431;G10,Me,H,H,-], [ZB432;G10,Et,H,H,-], [ZB433;G10,Pr,H,H,-], [ZB434;G10,i-Pr,H,H,-], [ZB435;G10,c-Pr,H,H,-], [ZB436;G10,Ph,H,H,-], [ZB437;G10,OMe,H,H,-], [ZB438;G10,OEt,H,H,-], [ZB439;G10,OPh,H,H,-], [ZB440;G10,CF3,H,H,-], [ZB441;G10,F,H,H,-], [ZB442;G10,Cl,H,H,-], [ZB443;G10,Br,H,H,-], [ZB444;G10,CN,H,H,-], [ZB445;G10,H,Me,H,-], [ZB446;G10,H,Et,H,-], [ZB447;G10,H,Pr,H,-], [ZB448;G10,H,i-Pr,H,-], [ZB449;G10,H,c-Pr,H,-], [ZB450;G10,H,Ph,H,-], [ZB451;G10,H,OMe,H,-], [ZB452;G10,H,OEt,H,-], [ZB453;G10,H,OPh,H,-], [ZB454;G10,H,CF3,H,-], [ZB455;G10,H,F,H,-], [ZB456;G10,H,Cl,H,-], [ZB457;G10,H,Br,H,-], [ZB458;G10,H,CN,H,-], [ZB459;G10,H,H,Me,-], [ZB460;G10,H,H,Et,-], [ZB461;G10,H,H,Pr,-], [ZB462;G10,H,H,i-Pr,-], [ZB463;G10,H,H,c-Pr,-], [ZB464;G10,H,H,Ph,-], [ZB465;G10,H,H,OMe,-], [ZB466;G10,H,H,OEt,-], [ZB467;G10,H,H,OPh,-], [ZB468;G10,H,H,CF3,-], [ZB469;G10,H,H,F,-], [ZB470;G10,H,H,Cl,-], [ZB471;G10,H,H,Br,-], [ZB472;G10,H,H,CN,-], [ZB473;G11,H,H,H,-], [ZB474;G11,H,Me,H,-], [ZB475;G11,HEt,H,-], [ZB476;G11,HPr,H,-], [ZB477;G11,Hi-Pr,H,-], [ZB478;G11,Hc-Pr,H,-], [ZB479;G11,HPh,H,-], [ZB480;G11,HOMe,H,-], [ZB481;G11,HOEt,H,-], [ZB482;G11,HOPh,H,-], [ZB483;G11,HCF3,H,-], [ZB484;G11,HF,H,-], [ZB485;G11,HCl,H,-], [ZB486;G11,HBr,H,-], [ZB487;G11,HCN,H,-], [ZB488;G11,H,H,Me,-], [ZB489;G11,H,H,Et,-], [ZB490;G11,H,H,Pr,-], [ZB491;G11,H,H,i-Pr,-], [ZB492;G11,H,H,c-Pr,-], [ZB493;G11,H,H,Ph,-], [ZB494;G11,H,H,OMe,-], [ZB495;G11,H,H,OEt,-], [ZB496;G11,H,H,OPh,-], [ZB497;G11,H,H,CF3,-], [ZB498;G11,H,H,F,-], [ZB499;G11,H,H,Cl,-], [ZB500;G11,H,H,Br,-]
[ZB501;G11,H,H,CN,-], [ZB502;G11,Me,H,H,-], [ZB503;G11,Me,Me,H,-], [ZB504;G11,MeEt,H,-], [ZB505;G11,MePr,H,-], [ZB506;G11,Mei-Pr,H,-], [ZB507;G11,Mec-Pr,H,-], [ZB508;G11,MePh,H,-], [ZB509;G11,MeOMe,H,-], [ZB510;G11,MeOEt,H,-], [ZB511;G11,MeOPh,H,-], [ZB512;G11,MeCF3,H,-], [ZB513;G11,MeF,H,-], [ZB514;G11,MeCl,H,-], [ZB515;G11,MeBr,H,-], [ZB516;G11,MeCN,H,-], [ZB517;G11,Me,H,Me,-], [ZB518;G11,Me,H,Et,-], [ZB519;G11,Me,H,Pr,-], [ZB520;G11,Me,H,i-Pr,-], [ZB521;G11,Me,H,c-Pr,-], [ZB522;G11,Me,H,Ph,-], [ZB523;G11,Me,H,OMe,-], [ZB524;G11,Me,H,OEt,-], [ZB525;G11,Me,H,OPh,-], [ZB526;G11,Me,H,CF3,-], [ZB527;G11,Me,H,F,-], [ZB528;G11,Me,H,Cl,-], [ZB529;G11,Me,H,Br,-], [ZB530;G11,Me,H,CN,-], [ZB531;G12,H,H,H,-], [ZB532;G12,Me,H,H,-], [ZB533;G12,Et,H,H,-], [ZB534;G12,Pr,H,H,-], [ZB535;G12,i-Pr,H,H,-], [ZB536;G12,c-Pr,H,H,-], [ZB537;G12,Ph,H,H,-], [ZB538;G12,OMe,H,H,-], [ZB539;G12,OEt,H,H,-], [ZB540;G12,OPh,H,H,-], [ZB541;G12,CF3,H,H,-], [ZB542;G12,F,H,H,-], [ZB543;G12,Cl,H,H,-], [ZB544;G12,Br,H,H,-], [ZB545;G12,CN,H,H,-], [ZB546;G12,H,Me,H,-], [ZB547;G12,H,Et,H,-], [ZB548;G12,H,Pr,H,-], [ZB549;G12,H,i-Pr,H,-], [ZB550;G12,H,c-Pr,H,-], [ZB551;G12,H,Ph,H,-], [ZB552;G12,H,OMe,H,-], [ZB553;G12,H,OEt,H,-], [ZB554;G12,H,OPh,H,-], [ZB555;G12,H,CF3,H,-], [ZB556;G12,H,F,H,-], [ZB557;G12,H,Cl,H,-], [ZB558;G12,H,Br,H,-], [ZB559;G12,H,CN,H,-], [ZB560;G12,H,H,Me,-], [ZB561;G12,H,H,Et,-], [ZB562;G12,H,H,Pr,-], [ZB563;G12,H,H,i-Pr,-], [ZB564;G12,H,H,c-Pr,-], [ZB565;G12,H,H,Ph,-], [ZB566;G12,H,H,OMe,-], [ZB567;G12,H,H,OEt,-], [ZB568;G12,H,H,OPh,-], [ZB569;G12,H,H,CF3,-], [ZB570;G12,H,H,F,-], [ZB571;G12,H,H,Cl,-], [ZB572;G12,H,H,Br,-], [ZB573;G12,H,H,CN,-], [ZB574;G13,H,H,H,-], [ZB575;G13,Me,H,H,-], [ZB576;G13,Et,H,H,-], [ZB577;G13,Pr,H,H,-], [ZB578;G13,i-Pr,H,H,-], [ZB579;G13,c-Pr,H,H,-], [ZB580;G13,Ph,H,H,-], [ZB581;G13,OMe,H,H,-], [ZB582;G13,OEt,H,H,-], [ZB583;G13,OPh,H,H,-], [ZB584;G13,CF3,H,H,-], [ZB585;G13,F,H,H,-], [ZB586;G13,Cl,H,H,-], [ZB587;G13,Br,H,H,-], [ZB588;G13,CN,H,H,-], [ZB589;G13,H,H,Me,-], [ZB590;G13,H,H,Et,-], [ZB591;G13,H,H,Pr,-], [ZB592;G13,H,H,i-Pr,-], [ZB593;G13,H,H,c-Pr,-], [ZB594;G13,H,H,Ph,-], [ZB595;G13,H,H,OMe,-], [ZB596;G13,H,H,OEt,-], [ZB597;G13,H,H,OPh,-], [ZB598;G13,H,H,CF3,-], [ZB599;G13,H,H,F,-], [ZB600;G13,H,H,Cl,-]
[ZB601;G13,H,H,Br,-], [ZB602;G13,H,H,CN,-], [ZB603;G13,H,Me,H,-], [ZB604;G13,Me,Me,H,-], [ZB605;G13,Et,Me,H,-], [ZB606;G13,Pr,Me,H,-], [ZB607;G13,i-Pr,Me, H,-], [ZB608;G13, c-Pr,Me, H,-], [ZB609;G13, Ph,Me,H,-], [ZB610;G13,OMe,Me,H,-], [ZB611;G13,OEt,Me,H,-], [ZB612;G13,OPh,Me,H,-], [ZB613;G13,CF3,Me,H,-], [ZB614;G13,F,Me,H,-], [ZB615;G13,Cl,Me,H,-], [ZB616;G13,Br,Me,H,-], [ZB617;G13,CN,Me,H,-], [ZB618;G13,H,Me,Me,-], [ZB619;G13,H,Me,Et,-], [ZB620;G13,H,Me,Pr,-], [ZB621;G13,H,Me,i-Pr,-], [ZB622;G13,H,Me,c-Pr,-], [ZB623;G13,H,Me,Ph,-], [ZB624;G13,H,Me,OMe,-], [ZB625;G13,H,Me,OEt,-], [ZB626;G13,H,Me,OPh,-], [ZB627;G13,H,Me,CF3,-], [ZB628;G13,H,Me,F,-], [ZB629;G13,H,Me,Cl,-], [ZB630;G13,H,Me,Br,-], [ZB631;G13,H,Me,CN,-], [ZB632;G14,H,H,H,-], [ZB633;G14,Me,H,H,-], [ZB634;G14,Et,H,H,-], [ZB635;G14,Pr,H,H,-], [ZB636;G14,i-Pr,H,H,-], [ZB637;G14,c-Pr,H,H,-], [ZB638;G14,Ph,H,H,-], [ZB639;G14,OMe,H,H,-], [ZB640;G14,OEt,H,H,-], [ZB641;G14,OPh,H,H,-], [ZB642;G14,CF3,H,H,-], [ZB643;G14, F,H,H,-], [ZB644;G14,Cl,H,H,-], [ZB645;G14,Br,H,H,-], [ZB646;G14,CN,H,H,-], [ZB647;G14,H,Me,H,-], [ZB648;G14,H,Et,H,-], [ZB649;G14,H,Pr,H,-], [ZB650;G14,H,i-Pr,H,-], [ZB651;G14,H,c-Pr,H,-], [ZB652;G14,H,Ph,H,-], [ZB653;G14,H,OMe,H,-], [ZB654;G14,H,OEt,H,-], [ZB655;G14,H,OPh,H,-], [ZB656;G14,H,CF3,H,-], [ZB657;G14,H,F,H,-], [ZB658;G14,H,Cl,H,-], [ZB659;G14,H,Br,H,-], [ZB660;G14,H,CN,H,-], [ZB661;G14,H,H,Me,-], [ZB662;G14,H,H,Et,-], [ZB663;G14,H,H,Pr,-], [ZB664;G14,H,H,i-Pr,-], [ZB665;G14,H,H,c-Pr,-], [ZB666;G14,H,H,Ph,-], [ZB667;G14,H,H,OMe,-], [ZB668;G14,H,H,OEt,-], [ZB669;G14,H,H,OPh,-], [ZB670;G14,H,H,CF3,-], [ZB671;G14,H,H,F,-], [ZB672;G14,H,H,Cl,-], [ZB673;G14,H,H,Br,-], [ZB674;G14,H,H,CN,-], [ZB675;G15,H,H,H,-], [ZB676;G15,Me,H,H,-], [ZB677;G15,Et,H,H,-], [ZB678;G15,Pr,H,H,-], [ZB679;G15,i-Pr,H,H,-], [ZB680;G15, c-Pr, H, H,-], [ZB681;G15, Ph, H, H,-], [ZB682;G15,OMe,H,H,-], [ZB683;G15,OEt,H,H,-], [ZB684;G15,OPh,H,H,-], [ZB685;G15,CF3,H,H,-], [ZB686;G15,F,H,H,-], [ZB687;G15,Cl,H,H,-], [ZB688;G15,Br,H,H,-], [ZB689;G15,CN,H,H,-], [ZB690;G15,H,Me,H,-], [ZB691;G15,H,Et,H,-], [ZB692;G15,H,Pr,H,-], [ZB693;G15,H,i-Pr,H,-], [ZB694;G15,H,c-Pr,H,-], [ZB695;G15,H,Ph,H,-], [ZB696;G15,H,OMe,H,-], [ZB697;G15,H,OEt,H,-], [ZB698;G15,H,OPh,H,-], [ZB699;G15,H,CF3,H,-], [ZB700;G15,H,F,H,-]
[ZB701;G15,H,Cl,H,-], [ZB702;G15,H,Br,H,-], [ZB703;G15,H,CN,H,-], [ZB704;G15,H,H,Me,-], [ZB705;G15,H,H,Et,-], [ZB706;G15,H,H,Pr,-], [ZB707;G15,H,H,i-Pr,-], [ZB708;G15,H,H,c-Pr,-], [ZB709;G15,H,H,Ph,-], [ZB710;G15,H,H,OMe,-], [ZB711;G15,H,H,OEt,-], [ZB712;G15,H,H,OPh,-], [ZB713;G15,H,H,CF3,-], [ZB714;G15,H,H,F,-], [ZB715;G15,H,H,Cl,-], [ZB716;G15,H,H,Br,-], [ZB717;G15,H,H,CN,-], [ZB718;G16,H,H,-,-], [ZB719;G16,Me,H,-,-], [ZB720;G16,Et,H,-,-], [ZB721;G16,Pr,H,-,-], [ZB722;G16,i-Pr,H,-,-], [ZB723;G16,c-Pr,H,-,-], [ZB724;G16,Ph,H,-,-], [ZB725;G16,OMe,H,-,-], [ZB726;G16,OEt,H,-,-], [ZB727;G16,OPh,H,-,-], [ZB728;G16,CF3,H,-,-], [ZB729;G16,F,H,-,-], [ZB730;G16,Cl,H,-,-], [ZB731;G16,Br,H,-,-], [ZB732;G16,CN,H,-,-], [ZB733;G16,H,Me,-,-], [ZB734;G16,H,Et,-,-], [ZB735;G16,H,Pr,-,-], [ZB736;G16,H,i-Pr,-,-], [ZB737;G16,H,c-Pr,-,-], [ZB738;G16,H,Ph,-,-], [ZB739;G16,H,OMe,-,-], [ZB740;G16,H,OEt,-,-], [ZB741;G16,H,OPh,-,-], [ZB742;G16,H,CF3,-,-], [ZB743;G16,H, F,-,-], [ZB744;G16,H,Cl,-,-], [ZB745;G16,H,Br,-,-], [ZB746;G16,H,CN,-,-], [ZB747;G17,H,H,-,-], [ZB748;G17,Me,H,-,-], [ZB749;G17,Et,H,-,-], [ZB750;G17,Pr,H,-,-], [ZB751;G17,i-Pr,H,-,-], [ZB752;G17,c-Pr,H,-,-], [ZB753;G17,Ph,H,-,-], [ZB754;G17,OMe,H,-,-], [ZB755;G17,OEt,H,-,-], [ZB756;G17,OPh,H,-,-], [ZB757;G17,CF3,H,-,-], [ZB758;G17,F,H,-,-], [ZB759;G17,Cl,H,-,-], [ZB760;G17,Br,H,-,-], [ZB761;G17,CN,H,-,-], [ZB762;G17,H,Me,-,-], [ZB763;G17,H,Et,-,-], [ZB764;G17,H,Pr,-,-], [ZB765;G17,H,i-Pr,-,-], [ZB766;G17,H,c-Pr,-,-], [ZB767;G17,H,Ph,-,-], [ZB768;G17,H,OMe,-,-], [ZB769;G17,H,OEt,-,-], [ZB770;G17,H,OPh,-,-], [ZB771;G17,H,CF3,-,-], [ZB772;G17,H,F,-,-], [ZB773;G17,H,Cl,-,-], [ZB774;G17,H,Br,-,-], [ZB775;G17,H,CN,-,-], [ZB776;G18,H,H,-,-], [ZB777;G18,Me,H,-,-], [ZB778;G18,Et,H,-,-], [ZB779;G18,Pr,H,-,-], [ZB780;G18,i-Pr,H,-,-], [ZB781;G18,c-Pr,H,-,-], [ZB782;G18,Ph,H,-,-], [ZB783;G18,OMe,H,-,-], [ZB784;G18,OEt,H,-,-], [ZB785;G18,OPh,H,-,-], [ZB786;G18,CF3,H,-,-], [ZB787;G18,F,H,-,-], [ZB788;G18,Cl,H,-,-], [ZB789;G18,Br,H,-,-], [ZB790;G18,CN,H,-,-], [ZB791;G18,H,Me,-,-], [ZB792;G18,H,Et,-,-], [ZB793;G18,H,Pr,-,-], [ZB794;G18,H,i-Pr,-,-], [ZB795;G18,H,c-Pr,-,-], [ZB796;G18,H,Ph,-,-], [ZB797;G18,H,OMe,-,-], [ZB798;G18,H,OEt,-,-], [ZB799;G18,H,OPh,-,-], [ZB800;G18,H,CF3,-,-]
[ZB801;G18,H,F,-,-], [ZB802;G18,H,Cl,-,-], [ZB803;G18,H,Br,-,-], [ZB804;G18,H,CN,-,-], [ZB805;G19,H,H,-,-], [ZB806;G19,Me,H,-,-], [ZB807;G19,Et,H,-,-], [ZB808;G19,Pr,H,-,-], [ZB809;G19,i-Pr,H,-,-], [ZB810;G19,c-Pr,H,-,-], [ZB811;G19,Ph,H,-,-], [ZB812;G19,OMe,H,-,-], [ZB813;G19,OEt,H,-,-], [ZB814;G19,OPh,H,-,-], [ZB815;G19,CF3,H,-,-], [ZB816;G19,F,H,-,-], [ZB817;G19,Cl,H,-,-], [ZB818;G19,Br,H,-,-], [ZB819;G19,CN,H,-,-], [ZB820;G19,H,Me,-,-], [ZB821;G19,H,Et,-,-], [ZB822;G19,H,Pr,-,-], [ZB823;G19,H,i-Pr,-,-], [ZB824;G19,H,c-Pr,-,-], [ZB825;G19,H,Ph,-,-], [ZB826;G19,H,OMe,-,-], [ZB827;G19,H,OEt,-,-], [ZB828;G19,H,OPh,-,-], [ZB829;G19,H,CF3,-,-], [ZB830;G19,H,F,-,-], [ZB831;G19,H,Cl,-,-], [ZB832;G19,H,Br,-,-], [ZB833;G19,H,CN,-,-], [ZB834;G20,H,H,-,-], [ZB835;G20,Me,H,-,-], [ZB836;G20,Et,H,-,-], [ZB837;G20,Pr,H,-,-], [ZB838;G20,i-Pr,H,-,-], [ZB839;G20,c-Pr,H,-,-], [ZB840;G20,Ph,H,-,-], [ZB841;G20,OMe,H,-,-], [ZB842;G20,OEt,H,-,-], [ZB843;G20,OPh,H,-,-], [ZB844;G20,CF3,H,-,-], [ZB845;G20, F,H,-,-], [ZB846;G20,Cl, H,-,-], [ZB847;G20,Br,H,-,-], [ZB848;G20,CN,H,-,-], [ZB849;G20,H,Me,-,-], [ZB850;G20,H,Et,-,-], [ZB851;G20,H,Pr,-,-], [ZB852;G20,H,i-Pr,-,-], [ZB853;G20,H,c-Pr,-,-], [ZB854;G20,H,Ph,-,-], [ZB855;G20,H,OMe,-,-], [ZB856;G20,H,OEt,-,-], [ZB857;G20,H,OPh,-,-], [ZB858;G20,H,CF3,-,-], [ZB859;G20,H,F,-,-], [ZB860;G20,H,Cl,-,-], [ZB861;G20,H,Br,-,-], [ZB862;G20,H,CN,-,-], [ZB863;G21,H,H,-,-], [ZB864;G21,Me,H,-,-], [ZB865;G21,Et,H,-,-], [ZB866;G21,Pr,H,-,-], [ZB867;G21,i-Pr,H,-,-], [ZB868;G21,c-Pr,H,-,-], [ZB869;G21,Ph,H,-,-], [ZB870;G21,OMe,H,-,-], [ZB871;G21,OEt,H,-,-], [ZB872;G21,OPh,H,-,-], [ZB873;G21,CF3,H,-,-], [ZB874;G21,F,H,-,-], [ZB875;G21,Cl,H,-,-], [ZB876;G21,Br,H,-,-], [ZB877;G21,CN,H,-,-], [ZB878;G21,H,Me,-,-], [ZB879;G21,H,Et,-,-], [ZB880;G21,H,Pr,-,-], [ZB881;G21,H,i-Pr,-,-], [ZB882;G21,H,c-Pr,-,-], [ZB883;G21,H,Ph,-,-], [ZB884;G21,H,OMe,-,-], [ZB885;G21,H,OEt,-,-], [ZB886;G21,H,OPh,-,-], [ZB887;G21,H,CF3,-,-], [ZB888;G21,H,F,-,-], [ZB889;G21,H,Cl,-,-], [ZB890;G21,H,Br,-,-], [ZB891;G21,H,CN,-,-], [ZB892;G22,H,H,-,-], [ZB893;G22,Me,H,-,-], [ZB894;G22,Et,H,-,-], [ZB895;G22,Pr,H,-,-], [ZB896;G22,i-Pr,H,-,-], [ZB897;G22,c-Pr,H,-,-], [ZB898;G22,Ph,H,-,-], [ZB899;G22,OMe,H,-,-], [ZB900;G22,OEt,H,-,-]
[ZB901;G22,OPh,H,-,-], [ZB902;G22,CF3,H,-,-], [ZB903;G22,F,H,-,-], [ZB904;G22,Cl,H,-,-], [ZB905;G22,Br,H,-,-], [ZB906;G22,CN,H,-,-], [ZB907;G22,H,Me,-,-], [ZB908;G22,H,Et,-,-], [ZB909;G22,H,Pr,-,-], [ZB910;G22,H,i-Pr,-,-], [ZB911;G22,H,c-Pr,-,-], [ZB912;G22,H,Ph,-,-], [ZB913;G22,H,OMe,-,-], [ZB914;G22,H,OEt,-,-], [ZB915;G22,H,OPh,-,-], [ZB916;G22,H,CF3-,-], [ZB917;G22,H,F,-,-], [ZB918;G22,H,Cl,-,-], [ZB919;G22,H,Br,-,-], [ZB920;G22,H,CN,-,-], [ZB921;G23,H,H,-,-], [ZB922;G23,Me,H,-,-], [ZB923;G23,Et,H,-,-], [ZB924;G23,Pr,H,-,-], [ZB925;G23,i-Pr,H,-,-], [ZB926;G23,c-Pr,H,-,-], [ZB927;G23,Ph,H,-,-], [ZB928;G23,OMe,H,-,-], [ZB929;G23,OEt,H,-,-], [ZB930;G23,OPh,H,-,-], [ZB931;G23,CF3,H,-,-], [ZB932;G23,F,H,-,-], [ZB933;G23,Cl,H,-,-], [ZB934;G23,Br,H,-,-], [ZB935;G23,CN,H,-,-], [ZB936;G23,H,Me,-,-], [ZB937;G23,H,Et,-,-], [ZB938;G23,H,Pr,-,-], [ZB939;G23,H,i-Pr,-,-], [ZB940;G23,H,c-Pr,-,-], [ZB941;G23,H,Ph,-,-], [ZB942;G23,H,OMe,-,-], [ZB943;G23,H,OEt,-,-], [ZB944;G23,H,OPh,-,-], [ZB945;G23,H,CF3,-,-], [ZB946;G23,H,F,-,-], [ZB947;G23,H,Cl,-,-], [ZB948;G23,H,Br,-,-], [ZB949;G23,H,CN,-,-], [ZB950;G24,H,H,-,-], [ZB951;G24,Me,H,-,-], [ZB952;G24,Et,H,-,-], [ZB953;G24,Pr,H,-,-], [ZB954;G24,i-Pr,H,-,-], [ZB955;G24,c-Pr,H,-,-], [ZB956;G24,Ph,H,-,-], [ZB957;G24,OMe,H,-,-], [ZB958;G24,OEt,H,-,-], [ZB959;G24,OPh,H,-,-], [ZB960;G24,CF3,H,-,-], [ZB961;G24,F,H,-,-], [ZB962;G24,Cl,H,-,-], [ZB963;G24,Br,H,-,-], [ZB964;G24,CN,H,-,-], [ZB965;G24,H,Me,-,-], [ZB966;G24,H,Et,-,-], [ZB967;G24,H,Pr,-,-], [ZB968;G24,H,i-Pr,-,-], [ZB969;G24,H,c-Pr,-,-], [ZB970;G24,H,Ph,-,-], [ZB971;G24,H,OMe,-,-], [ZB972;G24,H,OEt,-,-], [ZB973;G24,H,OPh,-,-], [ZB974;G24,H,CF3,-,-], [ZB975;G24,H,F,-,-], [ZB976;G24,H,Cl,-,-], [ZB977;G24,H,Br,-,-], [ZB978;G24,H,CN,-,-], [ZB979;G25,H,H,H,-], [ZB980;G25,H,Me,H,-], [ZB981;G25,H,Et,H,-], [ZB982;G25,H,Pr,H,-], [ZB983;G25,H,i-Pr,H,-], [ZB984;G25,H,c-Pr,H,-], [ZB985;G25,H,Ph,H,-], [ZB986;G25,H,OMe,H,-], [ZB987;G25,H,OEt,H,-], [ZB988;G25,H,OPh,H,-], [ZB989;G25,H,CF3,H,-], [ZB990;G25,H,F,H,-], [ZB991;G25,H,Cl,H,-], [ZB992;G25,H,Br,H,-], [ZB993;G25,H,CN,H,-], [ZB994;G25,H,H,Me,-], [ZB995;G25,H,H,Et,-], [ZB996;G25,H,H, Pr,-], [ZB997;G25,H,H, i-Pr,-], [ZB998;G25,H,H,c-Pr,-], [ZB999;G25,H,H,Ph,-], [ZB1000;G25,H,H,OMe,-]
[ZB1001;G25,H,H,OEt,-], [ZB1002;G25,H,H,OPh,-], [ZB1003;G25,H,H,CF3,-], [ZB1004;G25,H,H,F,-], [ZB1005;G25,H,H,Cl,-], [ZB1006;G25,H,H,Br,-], [ZB1007;G25,H,H,CN,-], [ZB1008;G25,Me,H,H,-], [ZB1009;G25,Me,Me,H,-], [ZB1010;G25,Me,Et,H,-], [ZB1011;G25,Me,Pr,H,-], [ZB1012;G25,Me,i-Pr,H,-], [ZB1013;G25,Me,c-Pr,H,-], [ZB1014;G25,Me,Ph,H,-], [ZB1015;G25,Me,OMe,H,-], [ZB1016;G25,Me,OEt,H,-], [ZB1017;G25,Me,OPh,H,-], [ZB1018;G25,Me,CF3,H,-], [ZB1019;G25,Me,F,H,-], [ZB1020;G25,Me,Cl,H,-], [ZB1021;G25,Me,Br,H,-], [ZB1022;G25,Me,CN,H,-], [ZB1023;G25,Me,H,Me,-], [ZB1024;G25,Me,H,Et,-], [ZB1025;G25,Me,H,Pr,-], [ZB1026;G25,Me,H,i-Pr,-], [ZB1027;G25,Me,H,c-Pr,-], [ZB1028;G25,Me,H,Ph,-], [ZB1029;G25,Me,H,OMe,-], [ZB1030;G25,Me,H,OEt,-], [ZB1031;G25,Me,H,OPh,-], [ZB1032;G25,Me,H,CF3,-], [ZB1033;G25,Me,H,F,-], [ZB1034;G25,Me,H,Cl,-], [ZB1035;G25,Me,H,Br,-], [ZB1036;G25,Me,H,CN,-], [ZB1037;G26,H,H,H,-], [ZB1038;G26,H,Me,H,-], [ZB1039;G26,H,Et,H,-], [ZB1040;G26,H,Pr,H,-], [ZB1041;G26,H,i-Pr,H,-], [ZB1042;G26,H,c-Pr,H,-], [ZB1043;G26,H,Ph,H,-], [ZB1044;G26,H,OMe,H,-], [ZB1045;G26,H,OEt,H,-], [ZB1046;G26,H,OPh,H,-], [ZB1047;G26,H,CF3,H,-], [ZB1048;G26,H,F,H,-], [ZB1049;G26,H,Cl,H,-], [ZB1050;G26,H,Br,H,-], [ZB1051;G26,H,CN,H,-], [ZB1052;G26,H,H,Me,-], [ZB1053;G26,H,H,Et,-], [ZB1054;G26,H,H,Pr,-], [ZB1055;G26,H,H,i-Pr,-], [ZB1056;G26,H,H,c-Pr,-], [ZB1057;G26,H,H,Ph,-], [ZB1058;G26,H,H,OMe,-], [ZB1059;G26,H,H,OEt,-], [ZB1060;G26,H,H,OPh,-], [ZB1061;G26,H,H,CF3,-], [ZB1062;G26,H,H,F,-], [ZB1063;G26,H,H,Cl,-], [ZB1064;G26,H,H,Br,-], [ZB1065;G26,H,H,CN,-], [ZB1066;G26,Me,H,H,-], [ZB1067;G26,Me,Me,H,-], [ZB1068;G26,Me,Et,H,-], [ZB1069;G26,Me,Pr,H,-], [ZB1070;G26,Me,i-Pr,H,-], [ZB1071;G26,Me,c-Pr,H,-], [ZB1072;G26,Me,Ph,H,-], [ZB1073;G26,Me,OMe,H,-], [ZB1074;G26,Me,OEt,H,-], [ZB1075;G26,Me,OPh,H,-], [ZB1076;G26,Me,CF3,H,-], [ZB1077;G26,Me,F,H,-], [ZB1078;G26,Me,Cl,H,-], [ZB1079;G26,Me,Br,H,-], [ZB1080;G26,Me,CN,H,-], [ZB1081;G26,Me,H,Me,-], [ZB1082;G26,Me,H,Et,-], [ZB1083;G26,Me,H,Pr,-], [ZB1084;G26,Me,H,i-Pr,-], [ZB1085;G26,Me,H,c-Pr,-], [ZB1086;G26,Me,H,Ph,-], [ZB1087;G26,Me,H,OMe,-], [ZB1088;G26,Me,H,OEt,-], [ZB1089;G26,Me,H,OPh,-], [ZB1090;G26,Me,H,CF3,-], [ZB1091;G26,Me,H,F,-], [ZB1092;G26,Me,H,Cl,-], [ZB1093;G26,Me,H,Br,-], [ZB1094;G26,Me,H,CN,-], [ZB1095;G27,H,H,H,-], [ZB1096;G27,Me,H,H,-], [ZB1097;G27,Et,H,H,-], [ZB1098;G27,Pr,H,H,-], [ZB1099;G27,i-Pr,H,H,-], [ZB1100;G27,c-Pr,H,H,-]
[ZB1101;G27, Ph,H, H,-], [ZB1102;G27,OMe,H,H,-], [ZB1103;G27,OEt,H,H,-], [ZB1104;G27,OPh,H,H,-], [ZB1105;G27,CF3,H,H,-], [ZB1106;G27,F,H,H,-], [ZB1107;G27,Cl,H,H,-], [ZB1108;G27,Br,H,H,-], [ZB1109;G27,CN,H,H,-], [ZB1110;G27,H,Me,H,-], [ZB1111;G27,H,Et,H,-], [ZB1112;G27,H,Pr,H,-], [ZB1113;G27,H,i-Pr,H,-], [ZB1114;G27,H,c-Pr,H,-], [ZB1115; G27, H, Ph, H,-], [ZB1116; G27, H, OMe, H,-], [ZB1117;G27,H,OEt,H,-], [ZB1118;G27,H,OPh,H,-], [ZB1119;G27,H,CF3,H,-], [ZB1120;G27,H,F,H,-], [ZB1121;G27,H,Cl,H,-], [ZB1122;G27,H,Br,H,-], [ZB1123;G27,H,CN,H,-], [ZB1124;G27,H,H,Me,-], [ZB1125;G27,H,H,Et,-], [ZB1126;G27,H,H,Pr,-], [ZB1127;G27,H,H,i-Pr,-], [ZB1128;G27,H,H,c-Pr,-], [ZB1129; G27, H, H, Ph,-], [ZB1130; G27, H,H,OMe,-], [ZB1131;G27,H,H,OEt,-], [ZB1132;G27,H,H,OPh,-], [ZB1133;G27,H,H,CF3,-], [ZB1134;G27,H,H,F,-], [ZB1135;G27,H,H,Cl,-], [ZB1136;G27,H,H,Br,-], [ZB1137;G27,H,H,CN,-], [ZB1138;G28,H,H,-,-], [ZB1139;G28,Me,H,-,-], [ZB1140;G28,Cl,H,-,-], [ZB1141;G28,CF3,H,-,-], [ZB1142;G28,H,Me,-,-], [ZB1143;G28,H,Cl,-,-], [ZB1144;G28,H,CF3,-,-], [ZB1145;G28,H,SH,-,-]
The compound represented by formula (1C) wherein R1 represents a chlorine atom, L represents an oxygen atom, m is 1, and a combination of a structure of G and the substituents of RX7, RX8, RX9, and RX10 which depend on a structure of G represents any combinations descried in the Combination B (hereinafter, referred to as Compound Class SX18).
The compound represented by formula (1C) wherein R1 represents a methyl group, L represents CH2, m is 1, and a combination of a structure of G and the substituents of RX7, RX8, RX9, and RX10 which depend on a structure of G represents any combinations descried in the Combination B (hereinafter, referred to as Compound Class SX19).
The compound represented by formula (1C) wherein R1 represents a chlorine atom, L represents CH2, m is 1, and a combination of a structure of G and the substituents of RX7, RX8, RX9, and RX10 which depend on a structure of G represents any combinations descried in the Combination B (hereinafter, referred to as Compound Class SX20).
The compound represented by formula (1C) wherein R1 represents a methyl group, L represents an oxygen atom, m is 2, and a combination of a structure of G and the substituents of RX7, RX8, RX9, and RX10 which depend on a structure of G represents any combinations descried in the Combination B (hereinafter, referred to as Compound Class SX21).
The compound represented by formula (1C) wherein R1 represents a chlorine atom, L represents an oxygen atom, m is 2, and a combination of a structure of G and the substituents of RX7, RX8, RX9, and RX10 which depend on a structure of G represents any combinations descried in the Combination B (hereinafter, referred to as Compound Class SX22).
The compound represented by formula (1C) wherein R1 represents a methyl group, L represents CH2, m is 2, and a combination of a structure of G and the substituents of RX7, RX8, RX9, and RX10 which depend on a structure of G represents any combinations descried in the Combination B (hereinafter, referred to as Compound Class SX23).
The compound represented by formula (1C) wherein R1 represents a chlorine atom, L represents CH2, m is 2, and a combination of a structure of G and the substituents of RX7, RX8, RX9, and RX10 which depend on a structure of G represents any combinations descried in the Combination B (hereinafter, referred to as Compound Class SX24).
The compound represented by formula (1C) wherein R1 represents a methyl group, L represents an oxygen atom, m is 3, and a combination of a structure of G and the substituents of RX7, RX8, RX9, and RX10 which depend on a structure of G represents any combinations descried in the Combination B (hereinafter, referred to as Compound Class SX25).
The compound represented by formula (1C) wherein R1 represents a chlorine atom, L represents an oxygen atom, m is 3, and a combination of a structure of G and the substituents of RX7, RX8, RX9, and RX10 which depend on a structure of G represents any combinations descried in the Combination B (hereinafter, referred to as Compound Class SX26).
The compound represented by formula (1C) wherein R1 represents a methyl group, L represents CH2, m is 3, and a combination of a structure of G and the substituents of RX7, RX8, RX9, and RX10 which depend on a structure of G represents any combinations descried in the Combination B (hereinafter, referred to as Compound Class SX27).
The compound represented by formula (1C) wherein R1 represents a chlorine atom, L represents CH2, m is 3, and a combination of a structure of G and the substituents of RX7, RX8, RX9, and RX10 which depend on a structure of G represents any combinations descried in the Combination B (hereinafter, referred to as Compound Class SX28).
A compound represented by formula (1D):
wherein R1 represents a methyl group, L represents an oxygen atom, and RX11 represents any substituents selected from Group X, Group Y and Group Z (hereinafter, referred to as Compound Class SX29).
Group Y: a group consisting of Me, Ph, CH2Ph, (CH2)2Ph, (CH2)3Ph, 2-pyridyl, 3-pyridyl, 4-pyridyl, 2-thienyl, and 3-thienyl.
Group Z: a group consisting of 1-pyrrolidinyl, 1-piperidinyl, and 4-morpholinyl.
The compound represented by formula (1D) wherein R1 represents a chlorine atom, L represents an oxygen atom, and RX11 represents any substituents selected from Group X, Group Y and Group Z (hereinafter, referred to as Compound Class SX30).
The compound represented by formula (1D) wherein R1 represents a methyl group, L represents CH2, and RX11 represents any substituents selected from Group X, Group Y and Group Z (hereinafter, referred to as Compound Class SX31).
The compound represented by formula (1D) wherein R1 represents a chlorine atom, L represents CH2, and RX11 represents any substituents selected from Group X, Group Y and Group Z (hereinafter, referred to as Compound Class SX32).
A compound represented by formula (1E):
wherein R1 represents a methyl group, L represents an oxygen atom, and RX12 represents any substituents selected from Group X and Group Y (hereinafter, referred to as Compound Class SX33).
The compound represented by formula (1E) wherein R1 represents a chlorine atom, L represents an oxygen atom, and RX12 represents any substituents selected from Group X and Group Y (hereinafter, referred to as Compound Class SX34).
The compound represented by formula (1E) wherein R1 represents a methyl group, L represents CH2, and RX12 represents any substituents selected from Group X and Group Y (hereinafter, referred to as Compound Class SX35).
The compound represented by formula (1E) wherein R1 represents a chlorine atom, L represents CH2, and RX12 represents any substituents selected from Group X and Group Y (hereinafter, referred to as Compound Class SX36).
A compound represented by formula (1F):
wherein R1 represents a methyl group, L represents an oxygen atom, and RX13 represents a hydrogen atom, and RX14 represents any substituents selected from Group X and Group Y (hereinafter, referred to as Compound Class SX37).
The compound represented by formula (1F) wherein R1 represents a chlorine atom, L represents an oxygen atom, and RX13 represents a hydrogen atom, and RX14 represents any substituents selected from Group X and Group Y (hereinafter, referred to as Compound Class SX38).
The compound represented by formula (1F) wherein R1 represents a methyl group, L represents CH2, and RX13 represents a hydrogen atom, and RX14 represents any substituents selected from Group X and Group Y (hereinafter, referred to as Compound Class SX39).
The compound represented by formula (1F) wherein R1 represents a chlorine atom, L represents CH2, and RX13 represents a hydrogen atom, and RX14 represents any substituents selected from Group X and Group Y (hereinafter, referred to as Compound Class SX40).
The compound represented by formula (1F) wherein R1 represents a methyl group, L represents an oxygen atom, and RX13 represents a methyl group, and RX14 represents any substituents selected from Group X and Group Y (hereinafter, referred to as Compound Class SX41).
The compound represented by formula (1F) wherein R1 represents a chlorine atom, L represents an oxygen atom, and RX13 represents a methyl group, and RX14 represents any substituents selected from Group X and Group Y (hereinafter, referred to as Compound Class SX42).
The compound represented by formula (1F) wherein R1 represents a methyl group, L represents CH2, and RX13 represents a methyl group, and RX14 represents any substituents selected from Group X and Group Y (hereinafter, referred to as Compound Class SX43).
The compound represented by formula (1F) wherein R1 represents a chlorine atom, L represents CH2, and RX13 represents a methyl group, and RX14 represents any substituents selected from Group X and Group Y (hereinafter, referred to as Compound Class SX44).
The compound represented by formula (1F) wherein R1 represents a methyl group, L represents an oxygen atom, and RX13 represents an ethyl group, and RX14 represents any substituents selected from Group X and Group Y (hereinafter, referred to as Compound Class SX45).
The compound represented by formula (1F) wherein R1 represents a chlorine atom, L represents an oxygen atom, and RX13 represents an ethyl group, and RX14 represents any substituents selected from Group X and Group Y (hereinafter, referred to as Compound Class SX46).
The compound represented by formula (1F) wherein R1 represents a methyl group, L represents CH2, and RX13 represents an ethyl group, and RX14 represents any substituents selected from Group X and Group Y (hereinafter, referred to as Compound Class SX47).
The compound represented by formula (1F) wherein R1 represents a chlorine atom, L represents CH2, and R13 represents an ethyl group, and RX14 represents any substituents selected from Group X and Group Y (hereinafter, referred to as Compound Class SX48).
A compound represented by formula (1G):
wherein R1 represents a methyl group, L represents an oxygen atom, RX13 represents a hydrogen atom, and a combination of RX2, RX3, RX4, RX5, and RX6 represents any combinations described in the Combination A (hereinafter, referred to as Compound Class SX49).
The compound represented by formula (1G) wherein R1 represents a chlorine atom, L represents an oxygen atom, and RX13 represents a hydrogen atom, and a combination of RX2, RX3, RX4, RX5, and RX6 represents any combinations described in the Combination A (hereinafter, referred to as Compound Class SX50).
The compound represented by formula (1G) wherein R1 represents a methyl group, L represents CH2, and RX13 represents a hydrogen atom, and a combination of RX2, RX3, RX4, RX5, and RX6 represents any combinations described in the Combination A (hereinafter, referred to as Compound Class SX51).
The compound represented by formula (1G) wherein R1 represents a chlorine atom, L represents CH2, and RX13 represents a hydrogen atom, and a combination of RX2, RX3, RX4, RX5, and RX6 represents any combinations described in the Combination A (hereinafter, referred to as Compound Class SX52).
The compound represented by formula (1G) wherein R1 represents a methyl group, L represents an oxygen atom, and RX13 represents a methyl group, and a combination of RX2, RX3, RX4, RX5, and RX6 represents any combinations described in the Combination A (hereinafter, referred to as Compound Class SX53).
The compound represented by formula (1G) wherein R1 represents a chlorine atom, L represents an oxygen atom, and RX13 represents a methyl group, and a combination of RX2, RX3, RX4, RX5, and RX6 represents any combinations described in the Combination A (hereinafter, referred to as Compound Class SX54).
The compound represented by formula (1G) wherein R1 represents a methyl group, L represents CH2, and RX13 represents a methyl group, and a combination of RX2, RX3, RX4, RX5, and RX6 represents any combinations described in the Combination A (hereinafter, referred to as Compound Class SX55).
The compound represented by formula (1G) wherein R1 represents a chlorine atom, L represents CH2, and RX13 represents a methyl group, and a combination of RX2, RX3, RX4, RX5, and RX6 represents any combinations described in the Combination A (hereinafter, referred to as Compound Class SX56).
The compound represented by formula (1G) wherein R1 represents a methyl group, L represents an oxygen atom, and RX13 represents an ethyl group, and a combination of RX2, RX3, RX4, RX5, and RX6 represents any combinations described in the Combination A (hereinafter, referred to as Compound Class SX57).
The compound represented by formula (1G) wherein R1 represents a chlorine atom, L represents an oxygen atom, and RX13 represents an ethyl group, and a combination of RX2, RX3, RX4, RX5, and RX6 represents any combinations described in the Combination A (hereinafter, referred to as Compound Class SX58).
The compound represented by formula (1G) wherein R1 represents a methyl group, L represents CH2, and RX13 represents an ethyl group, and a combination of RX2, RX3, RX4, RX5, and RX6 represents any combinations described in the Combination A (hereinafter, referred to as Compound Class SX59).
The compound represented by formula (1G) wherein R1 represents a chlorine atom, L represents CH2, and RX13 represents an ethyl group, and a combination of RX2, RX3, RX4, RX5, and RX6 represents any combinations described in the Combination A (hereinafter, referred to as Compound Class SX60).
A compound represented by formula (1H):
wherein R1 represents a methyl group, L represents an oxygen atom, RX15 represents a hydrogen atom, and RX16 represents any substituents selected from Group X and Group Y (hereinafter, referred to as Compound Class SX61).
The compound represented by formula (1H) wherein R1 represents a chlorine atom, L represents an oxygen atom, and RX15 represents a hydrogen atom, and RX16 represents any substituents selected from Group X and Group Y (hereinafter, referred to as Compound Class SX62).
The compound represented by formula (1H) wherein R1 represents a methyl group, L represents CH2, and RX15 represents a hydrogen atom, and RX16 represents any substituents selected from Group X and Group Y (hereinafter, referred to as Compound Class SX63).
The compound represented by formula (1H) wherein R1 represents a chlorine atom, L represents CH2, and RX15 represents a hydrogen atom, and RX16 represents any substituents selected from Group X and Group Y (hereinafter, referred to as Compound Class SX64).
The compound represented by formula (1H) wherein R1 represents a methyl group, L represents an oxygen atom, and RX15 represents a methyl group, and RX16 represents any substituents selected from Group X and Group Y (hereinafter, referred to as Compound Class SX65).
The compound represented by formula (1H) wherein R1 represents a chlorine atom, L represents an oxygen atom, and RX15 represents a methyl group, and RX16 represents any substituents selected from Group X and Group Y (hereinafter, referred to as Compound Class SX66).
The compound represented by formula (1H) wherein R1 represents a methyl group, L represents CH2, and RX15 represents a methyl group, and RX16 represents any substituents selected from Group X and Group Y (hereinafter, referred to as Compound Class SX67).
The compound represented by formula (1H) wherein R1 represents a chlorine atom, L represents CH2, and RX15 represents a methyl group, and RX16 represents any substituents selected from Group X and Group Y (hereinafter, referred to as Compound Class SX68).
A compound represented by formula (1K):
wherein R1 represents a methyl group, L represents an oxygen atom, and RX17 represents any substituents selected from Group X and Group Y (hereinafter, referred to as Compound Class SX69).
The compound represented by formula (1K) wherein R1 represents a chlorine atom, L represents an oxygen atom, and RX17 represents any substituents selected from Group X and Group Y (hereinafter, referred to as Compound Class SX70).
The compound represented by formula (1K) wherein R1 represents a methyl group, L represents CH2, and RX17 represents any substituents selected from Group X and Group Y (hereinafter, referred to as Compound Class SX71).
The compound represented by formula (1K) wherein R1 represents a chlorine atom, L represents CH2, and RX17 represents any substituents selected from Group X and Group Y (hereinafter, referred to as Compound Class SX72).
A compound represented by formula (1J):
wherein R1 represents a methyl group, L represents an oxygen atom, RX10 represents a hydrogen atom, and RX19 represents any substituents selected from Group X and Group Y (hereinafter, referred to as Compound Class SX73).
The compound represented by formula (1J) wherein R1 represents a chlorine atom, L represents an oxygen atom, RX18 represents a hydrogen atom, and RX19 represents any substituents selected from Group X and Group Y (hereinafter, referred to as Compound Class SX74).
The compound represented by formula (1J) wherein R1 represents a methyl group, L represents CH2, RX18 represents a hydrogen atom, and RX19 represents any substituents selected from Group X and Group Y (hereinafter, referred to as Compound Class SX75).
The compound represented by formula (1J) wherein R1 represents a chlorine atom, L represents CH2, RX18 represents a hydrogen atom, and RX19 represents any substituents selected from Group X and Group Y (hereinafter, referred to as Compound Class SX76).
The compound represented by formula (1J) wherein R1 represents a methyl group, L represents an oxygen atom, RX18 represents a methyl group, and RX19 represents any substituents selected from Group X and Group Y (hereinafter, referred to as Compound Class SX77).
The compound represented by formula (1J) wherein R1 represents a chlorine atom, L represents an oxygen atom, RX18 represents a methyl group, and RX19 represents any substituents selected from Group X and Group Y (hereinafter, referred to as Compound Class SX78).
The compound represented by formula (1J) wherein R1 represents a methyl group, L represents CH2, RX18 represents a methyl group, and RX19 represents any substituents selected from Group X and Group Y (hereinafter, referred to as Compound Class SX79).
The compound represented by formula (1J) wherein R1 represents a chlorine atom, L represents CH2, RX18 represents a methyl group, and RX19 represents any substituents selected from Group X and Group Y (hereinafter, referred to as Compound Class SX80).
A compound represented by formula (2A):
wherein R1 represents a methyl group, L represents an oxygen atom, and RX1 represents any substituents selected from Group X.
The compound represented by formula (2A) wherein R1 represents a chlorine atom, L represents an oxygen atom, and RX1 represents any substituents selected from Group X.
The compound represented by formula (2A) wherein R1 represents a methyl group, L represents CH2, and RX1 represents any substituents selected from Group X.
The compound represented by formula (2A) wherein R1 represents a chlorine atom, L represents CH2, and RX1 represents any substituents selected from Group X.
A compound represented by formula (2B):
wherein R1 represents a methyl group, L represents an oxygen atom, m is 1, and a combination of RX2, RX3, RX4, RX5, and RX6 represents any combinations described in Combination A.
The compound represented by formula (2B) wherein R1 represents a chlorine atom, L represents an oxygen atom, m is 1, and a combination of RX2, RX3, RX4, RX5, and RX6 represents any combinations described in Combination A.
The compound represented by formula (2B) wherein R1 represents a methyl group, L represents CH2, m is 1, and a combination of RX2, RX3, RX4, RX5, and RX6 represents any combinations described in Combination A.
The compound represented by formula (2B) wherein R1 represents a chlorine atom, L represents CH2, m is 1, and a combination of RX2, RX3, RX4, RX5, and RX6 represents any combinations described in Combination A.
The compound represented by formula (2B) wherein R1 represents a methyl group, L represents an oxygen atom, m is 2, and a combination of RX2, RX3, RX4, RX5, and RX6 represents any combinations described in Combination A.
The compound represented by formula (2B) wherein R1 represents a chlorine atom, L represents an oxygen atom, m is 2, and a combination of RX2, RX3, RX4, RX5, and RX6 represents any combinations described in Combination A.
The compound represented by formula (2B) wherein R1 represents a methyl group, L represents CH2, m is 2, and a combination of RX2, RX3, RX4, RX5, and RX6 represents any combinations described in Combination A.
The compound represented by formula (2B) wherein R1 represents a chlorine atom, L represents CH2, m is 2, and a combination of RX2, RX3, RX4, RX5, and RX6 represents any combinations described in Combination A.
The compound represented by formula (2B) wherein R1 represents a methyl group, L represents an oxygen atom, m is 3, and a combination of RX2, RX3, RX4, RX5, and RX6 represents any combinations described in Combination A.
The compound represented by formula (2B) wherein R1 represents a chlorine atom, L represents an oxygen atom, m is 3, and a combination of RX2, RX3, RX4, RX5, and RX6 represents any combinations described in Combination A.
The compound represented by formula (2B) wherein R1 represents a methyl group, L represents CH2, m is 3, and a combination of RX2, RX3, RX4, RX5, and RX6 represents any combinations described in Combination A.
The compound represented by formula (2B) wherein R1 represents a chlorine atom, L represents CH2, m is 3, and a combination of RX2, RX3, RX4, RX5, and RX6 represents any combinations described in Combination A.
A compound represented by formula (2C):
wherein R1 represents a methyl group, L represents an oxygen atom, m is 1, and a combination of a structure of G and the substituents of RX7, RX8, RX9, and RX10 which depend on a structure of G represents any combinations descried in the Combination B.
A compound represented by formula (2C) wherein R1 represents a chlorine atom, L represents an oxygen atom, m is 1, and a combination of a structure of G and the substituents of RX7, RX8, RX9, and RX10 which depend on a structure of G represents any combinations descried in the Combination B.
A compound represented by formula (2C) wherein R1 represents a methyl group, L represents CH2, m is 1, and a combination of a structure of G and the substituents of RX7, RX8, RX9, and RX10 which depend on a structure of G represents any combinations descried in the Combination B.
A compound represented by formula (2C) wherein R1 represents a chlorine atom, L represents CH2, m is 1, and a combination of a structure of G and RX7, RX8, RX9, and RX10 which depend on a structure of G represents any combinations descried in the Combination B.
A compound represented by formula (2C) wherein R1 represents a methyl group, L represents an oxygen atom, m is 2, and a combination of a structure of G and RX7, RX8, RX9, and RX10 which depend on a structure of G represents any combinations descried in the Combination B.
A compound represented by formula (2C) wherein R1 represents a chlorine atom, L represents an oxygen atom, m is 2, and a combination of a structure of G and RX7, RX8, RX9, and RX10 which depend on a structure of G represents any combinations descried in the Combination B.
A compound represented by formula (2C) wherein R1 represents a methyl group, L represents CH2, m is 2, and a combination of a structure of G and the substituents of RX7, RX8, RX9, and RX10 which depend on a structure of G represents any combinations descried in the Combination B.
A compound represented by formula (2C) wherein R1 represents a chlorine atom, L represents CH2, m is 2, and a combination of a structure of G and the substituents of RX7, RX8, RX9, and RX10 which depend on a structure of G represents any combinations descried in the Combination B.
A compound represented by formula (2C) wherein R1 represents a methyl group, L represents an oxygen atom, m is 3, and a combination of a structure of G and the substituents of RX7, RX8, RX9, and RX10 which depend on a structure of G represents any combinations descried in the Combination B.
A compound represented by formula (2C) wherein R1 represents a chlorine atom, L represents an oxygen atom, m is 3, and a combination of a structure of G and the substituents of RX7, RX8, RX9, and RX10 which depend on a structure of G represents any combinations descried in the Combination B.
A compound represented by formula (2C) wherein R1 represents a methyl group, L represents CH2, m is 3, and a combination of a structure of G and the substituents of RX7, RX8, RX9, and RX10 which depend on a structure of G represents any combinations descried in the Combination B.
A compound represented by formula (2C) wherein R1 represents a chlorine atom, L represents CH2, m is 3, and a combination of a structure of G and the substituents of RX7, RX8, RX9, and RX10 which depend on a structure of G represents any combinations descried in the Combination B.
A compound represented by formula (2D):
wherein R1 represents a methyl group, L represents an oxygen atom, and RX11 represents any substituents selected from Group X, Group Y and Group Z.
The compound represented by formula (2D) wherein R1 represents a chlorine atom, L represents an oxygen atom, and RX11 represents any substituents selected from Group X, Group Y and Group Z.
The compound represented by formula (2D) wherein R1 represents a methyl group, L represents CH2, and RX11 represents any substituents selected from Group X, Group Y and Group Z.
The compound represented by formula (2D) wherein R1 represents a chlorine atom, L represents CH2, and RX11 represents any substituents selected from Group X, Group Y and Group Z.
A compound represented by formula (2F):
wherein R1 represents a methyl group, L represents an oxygen atom, RX13 represents a hydrogen atom, and RX14 represents any substituents selected from Group X and Group Y.
A compound represented by formula (2F) wherein R1 represents a chlorine atom, L represents an oxygen atom, RX13 represents a hydrogen atom, and RX14 represents any substituents selected from Group X and Group Y.
A compound represented by formula (2F) wherein R1 represents a methyl group, L represents CH2, RX13 represents a hydrogen atom, and RX14 represents any substituents selected from Group X and Group Y.
A compound represented by formula (2F) wherein R1 represents a chlorine atom, L represents CH2, RX13 represents a hydrogen atom, and RX14 represents any substituents selected from Group X and Group Y.
A compound represented by formula (2F) wherein R1 represents a methyl group, L represents an oxygen atom, RX13 represents a methyl group, and RX14 represents any substituents selected from Group X and Group Y.
A compound represented by formula (2F) wherein R1 represents a chlorine atom, L represents an oxygen atom, RX13 represents a methyl group, and RX14 represents any substituents selected from Group X and Group Y.
A compound represented by formula (2F) wherein R1 represents a methyl group, L represents CH2, RX13 represents a methyl group, and RX14 represents any substituents selected from Group X and Group Y.
A compound represented by formula (2F) wherein R1 represents a chlorine atom, L represents CH2, RX13 represents a methyl group, and RX14 represents any substituents selected from Group X and Group Y.
A compound represented by formula (2F) wherein R1 represents a methyl group, L represents an oxygen atom, RX13 represents an ethyl group, and RX14 represents any substituents selected from Group X and Group Y.
A compound represented by formula (2F) wherein R1 represents a chlorine atom, L represents an oxygen atom, RX13 represents an ethyl group, and RX14 represents any substituents selected from Group X and Group Y.
A compound represented by formula (2F) wherein R1 represents a methyl group, L represents CH2, RX13 represents an ethyl group, and RX14 represents any substituents selected from Group X and Group Y.
A compound represented by formula (2F) wherein R1 represents a chlorine atom, L represents CH2, RX13 represents an ethyl group, and RX14 represents any substituents selected from Group X and Group Y.
A compound represented by formula (3A):
wherein RX1 represents any substituents selected from Group X.
A compound represented by formula (3B):
wherein m is 1, and a combination of RX2, RX3, RX4, RX5 and RX6 represents any combinations described in the Combination A.
The compound represented by formula (3B) wherein m is 2, and a combination of RX2, RX3, RX4, RX5 and RX6 represents any combinations described in the Combination A.
The compound represented by formula (3B) wherein m is 3, and a combination of RX2, RX3, RX4, RX5 and RX6 represents any combinations described in the Combination A.
A compound represented by formula (3C):
wherein m is 1, and a combination of a structure of G and the substituents of RX7, RX8, RX9, and RX10 which depend on a structure of G represents any combinations descried in the Combination B.
The compound represented by formula (3C) wherein m is 2, and a combination of a structure of G and the substituents of RX7, RX8, RX9, and RX10 which depend on a structure of G represents any combinations descried in the Combination B.
The compound represented by formula (3C) wherein m is 3, and a combination of a structure of G and the substituents of RX7, RX8, RX9, and RX10 which depend on a structure of G represents any combinations descried in the Combination B.
A compound represented by formula (3D):
wherein RX11 represents any substituents selected from Group X, Group Y and Group Z.
A compound represented by formula (3F):
wherein RX13 represents a hydrogen atom, and RX14 represents any substituents selected from Group X and Group Y.
The compound represented by formula (3F) wherein RX13 represents a methyl group, and RX14 represents any substituents selected from Group X and Group Y.
The compound represented by formula (3F) wherein RX13 represents an ethyl group, and RX14 represents any substituents selected from Group X and Group Y.
A compound represented by formula (4A):
wherein L represents an oxygen atom, and R1 represents any substituents selected from Group W.
Group W: a group consisting of Me, Et, Pr, c-Pr, CF3, F, C1, Br, and I.
The compound represented by formula (4A) wherein L represents CH2, and R1 represents any substituents selected from Group W.
A compound represented by formula (5A):
wherein RX1 represents any substituents selected from Group X.
A compound represented by formula (5B):
wherein m is 1, and a combination of RX2, RX3, RX4, RX5, and RX6 represents any combinations described in Combination A.
The compound represented by formula (5B) wherein m is 2, and a combination of RX2, RX3, RX4, RX5, and RX6 represents any combinations described in Combination A.
The compound represented by formula (5B) wherein m is 3, and a combination of RX2, RX3, RX4, RX5, and RX6 represents any combinations described in Combination A.
A compound represented by formula (5C):
wherein m is 1, and a combination of a structure of G and the substituents of RX7, RX8, RX9, and RX10 which depend on a structure of G represents any combinations descried in the Combination B.
The compound represented by formula (5C) wherein m is 2, and a combination of a structure of G and the substituents of RX7, RX8, RX9, and RX10 which depend on a structure of G represents any combinations descried in the Combination B.
The compound represented by formula (5C) wherein m is 3, and a combination of a structure of G and the substituents of RX7, RX8, RX9, and RX10 which depend on a structure of G represents any combinations descried in the Combination B.
A compound represented by formula (5D):
wherein RX11 represents any substituents selected from Group X, Group Y and Group Z.
A compound represented by formula (5F):
wherein RX13 represents a hydrogen atom, and RX14 represents any substituents selected from Group X and Group Y.
The compound represented by formula (5F) wherein RX13 represents a methyl group, and RX14 represents any substituents selected from Group X and Group Y.
The compound represented by formula (5F) wherein RX13 represents an ethyl group, and RX14 represents any substituents selected from Group X and Group Y.
Next, the formulation Examples of the Present compound is described. The “parts” represents “part by weight” unless otherwise specified. Also the present compound S represents any compounds described as Compound Class SX1 to SX80.
Fifty (50) parts of any one of the present compound S, 3 parts of calcium lignin sulfonate, 2 parts of magnesium lauryl sulfate, and 45 parts of synthetic hydrated silicon dioxide are well mixed-grinding to obtain a formulation.
Twenty (20) parts of any one of the present compound S, and 1.5 parts of sorbitan trioleate are mixed with 28.5 parts of an aqueous solution containing 2 parts of polyvinyl alcohol, and the mixture is then finely-ground by a wet grinding method. To the mixture is then added 40 parts of an aqueous solution containing 0.05 parts of xanthan gum and 0.1 parts of magnesium aluminum silicate, and 10 parts of propylene glycol is further added thereto, and the mixture is mixed with starring to obtain a formulation.
Two (2) parts of any one of the present compound S, 88 parts of kaolin clay and 10 parts of talc are mixed-grinding thoroughly to obtain a formulation.
Five (5) parts of any one of the present compound S, 14 parts of polyoxyethylene styryl phenyl ether, 6 parts of calcium dodecylbenzene sulfonate and 75 parts of xylene are mixed-grinding thoroughly to obtain a formulation.
Two (2) parts of any one of the present compound S, 1 part of synthetic hydrated silicon dioxide, 2 parts of calcium lignosulfonate, 30 parts of bentonite and 65 parts of kaolin clay are mixed-grinding, and thereto is added water, and the mixture is well kneaded and is then granulated and dried to obtain a formulation.
Twenty (20) parts of the present compound S, 35 parts of a mixture of white carbon and ammonium polyoxyethylene alkyl ether sulfate (weight ratio is 1:1) and appropriate amount of water is mixed to make the total amount thereof 100 parts, and the mixture is then finely-ground with a grinder to obtain a formulation.
Next, Test Examples are described.
The untreated groups in Test Example 1 to Test Example 9 represent tested groups in which the same conditions as those of each of the Test Examples were conducted except that DMSO was dispensed in the place of a DMSO diluted solution comprising the present compound. Also the untreated groups in Test Example 10 to Test Example 22 represent tested groups in which an aqueous diluted solution of a formulation comprising the present compound is not applied.
The present compound 1 to 16, 18 to 23, 25, 26, 28 to 30, 33 to 35, 37, 38 to 40, 42 to 52, 54 to 87, 89, or 90 was diluted with DMSO so as to contain 150 ppm, and 1 μL of the dilution solutions were dispensed into titer plate (96 well), and thereafter, thereto was then dispensed 150 μL of a potato dextrose broth (PDB broth) to which conidia of Septoria tritici were inoculated in advance. This plate was cultured at 18° C. for 5 days, thereby allowing Septoria tritici to undergo proliferation, and the absorbance at 550 nm of each well of the titer plate was then measured to determine a degree of growth of Septoria tritici. As a result, every of the growth in the well in treated groups treated with each of the present compounds showed 50% or less compared to the growth in an untreated well.
The present compound 2 to 16, 18 to 20, 25, 26, 29, 38, 40, 42 to 44, 46 to 49, 51, 52, 55, 57 to 64, 71, or 76 was diluted with DMSO so as to contain 150 ppm, and 1 μL of the dilution solutions were dispensed into titer plate (96 well), and thereafter, thereto was then dispensed 150 μL of a potato dextrose broth (PDB broth) to which conidia of Colletotrichum truncatum were inoculated in advance. This plate was cultured at 18° C. for 4 days, thereby allowing Colletotrichum truncatum to undergo proliferation, and the absorbance at 550 nm of each well of the titer plate was then measured to determine a degree of growth of the Colletotrichum truncatum. As a result, every of the growth in the well in treated groups treated with each of the present compounds showed 50% or less compared to the growth in an untreated well.
The present compound 1 to 20, 23, 25, 26, 29, 34, 37, 38, 40 to 49, 51, 52, 54 to 64, 68, 71, 73 to 76, 80, 89, or 90 was diluted with DMSO so as to contain 150 ppm, and 1 μL of the dilution solutions were dispensed into titer plate (96 well), and thereafter, thereto was then dispensed 150 μL of a potato dextrose broth (PDB broth) to which spores of Phytophthora capsici were inoculated in advance. This plate was cultured at 27° C. for 3 days, thereby allowing Phytophthora capsici to undergo proliferation, and the absorbance at 550 nm of each well of the titer plate was then measured to determine a degree of growth of the Phytophthora capsici. As a result, every of the growth in the well in treated groups treated with each of the present compounds showed 50% or less compared to the growth in an untreated well.
The present compound 1 to 20, 23, 25, 26, 29, 34, 37, 38, 40 to 49, 51, 52, 54 to 64, 66, 68, 71 to 76, 79 to 81, 84 to 86, 89, or 90 was diluted with DMSO so as to contain 150 ppm, and 1 μL of the dilution solutions were dispensed into titer plate (96 well), and thereafter, thereto was then dispensed 150 μL of a potato dextrose broth (PDB broth) to which spores of Pythium ultimum were inoculated in advance. This plate was cultured at 23° C. for 5 days, thereby allowing Pythium ultimum to undergo proliferation, and the absorbance at 550 nm of each well of the titer plate was then measured to determine a degree of growth of the Pythium ultimum. As a result, every of the growth in the well in treated groups treated with each of the present compounds showed 50% or less compared to the growth in an untreated well.
The present compound 1 to 20, 23, 25, 26, 29, 30, 34, 37 to 49, 51, 52, 54 to 64, 68, 71 to 76, 78 to 87, 89, or 90 was diluted with DMSO so as to contain 150 ppm, and 1 μL of the dilution solutions were dispensed into titer plate (96 well), and thereafter, thereto was then dispensed 150 μL of a potato dextrose broth (PDB broth) to which conidia of Ustilago maydis were inoculated in advance. This plate was cultured at 18° C. for 4 days, thereby allowing Ustilago maydis to undergo proliferation, and the absorbance at 550 nm of each well of the titer plate was then measured to determine a degree of growth of the Ustilago maydis. As a result, every of the growth in the well in treated groups treated with each of the present compounds showed 50% or less compared to the growth in an untreated well.
The present compound 1 to 20, 23, 25, 26, 29 to 49, 51, 52, 54 to 64, 66 to 68, 71 to 87, 89, or 90 was diluted with DMSO so as to contain 150 ppm, and 1 μL of the dilution solutions were dispensed into titer plate (96 well), and thereafter, thereto was then dispensed 150 μL of a potato dextrose broth (PDB broth) to which conidia of Rhynchosporium secalis were inoculated in advance. This plate was cultured at 18° C. for 7 days, thereby allowing Rhynchosporium secalis to undergo proliferation, and the absorbance at 550 nm of each well of the titer plate was then measured to determine a degree of growth of the Rhynchosporium secalis. As a result, every of the growth in the well in treated groups treated with each of the present compounds showed 50% or less compared to the growth in an untreated well.
The present compound 1 to 20, 23, 25, 26, 29 to 34, 36 to 49, 51, 52, 54 to 64, 66, 68, 71 to 85, 87, 89, or 90 was diluted with DMSO so as to contain 150 ppm, and 1 μL of the dilution solutions were dispensed into titer plate (96 well), and thereafter, thereto was then dispensed 150 μL of a potato dextrose broth (PDB broth) to which conidia of Botrytis cinerea were inoculated in advance. This plate was cultured at 18° C. for 4 days, thereby allowing Botrytis cinerea to undergo proliferation, and the absorbance at 550 nm of each well of the titer plate was then measured to determine a degree of growth of the Botrytis cinerea. As a result, every of the growth in the well in treated groups treated with each of the present compounds showed 50% or less compared to the growth in an untreated well.
The present compound 1 to 20, 23, 25, 26, 29 to 49, 51, 52, 54 to 64, 66 to 68, 71 to 87, 89, or 90 was diluted with DMSO so as to contain 150 ppm, and 1 μL of the dilution solutions were dispensed into titer plate (96 well), and thereafter, thereto was then dispensed 150 μL of a potato dextrose broth (PDB broth) to which conidia of Cladosporium carpophilum were inoculated in advance. This plate was cultured at 18° C. for 5 days, thereby allowing Cladosporium carpophilum to undergo proliferation, and the absorbance at 550 nm of each well of the titer plate was then measured to determine a degree of growth of the Cladosporium carpophilum. As a result, every of the growth in the well in treated groups treated with each of the present compounds showed 50% or less compared to the growth in an untreated well.
The present compound 28, 30 to 33, 35, 37, 39, 50, 66, 67, 69, 70, 72 to 75, 77 to 89, or 90 was diluted with DMSO so as to contain 150 ppm, and 1 μL of the dilution solutions were dispensed into titer plate (96 well), and thereafter, thereto was then dispensed 150 μL of a potato dextrose broth (PDB broth) to which conidia of Cochliobolus miyabeanus were inoculated in advance. This plate was cultured at 23° C. for 3 days, thereby allowing Cochliobolus miyabeanus to undergo proliferation, and the absorbance at 550 nm of each well of the titer plate was then measured to determine a degree of growth of the Cochliobolus miyabeanus. As a result, every of the growth in the well in treated groups treated with each of the present compounds showed 50% or less compared to the growth in an untreated well.
Soybean leaf (cv; Kurosengoku) was punched out to 1 cm diameter to prepare a leaf disk. Each 1 mL of an agar medium (agar concentration 1.2%) was dispensed in each well of 24 well microplate. A piece of the leaf disk was placed on agar medium on each well. To a mixture of 0.5 μL of Sorpol (registered trademark) 1200KX, 4.5 μL of DMSO, and 5 μL of xylene was added 20 μL of a solution containing 10000 ppm of the test compound in DMSO. The resulting mixture was diluted with ion exchange water to prepare a mixture containing a predetermined concentration of the test compound. The resulting mixture was sprayed in 10 μL per one leaf disk. After 1 day, an aqueous suspension of conidia of Phakopsora pachyrhizi having an amino acid substitution of F129L on mitochondrial cytochrome b protein (1.0×105/mL) was inoculated onto the leaf disks. After the inoculation, the microplate was placed in a growth chamber (light on for 6 hours, light off for 18 hours, 23° C. temperature, 60% humidity). After 1 day, the leaf disks were air-dried to disappear water droplets on the surface of the leaf disk, and the microplate was placed again in the growth chamber for 12 days. Thereafter, a lesion area of soybean rust disease was assessed. As a result, lesion areas in the leaf disk treated with any one of the present compounds 1 to 10, 15 to 20, 23, 28 to 31, 33 to 35, 37, 39, 40, 50, 55, 56, 66 to 68, 70, 71 to 87, 89, or 90 as a tested compound at a prescribed concentration of 50 ppm showed 30% or more compared to the lesion areas in an untreated leaf disk.
Each of plastic pots was filled with soil and thereto rice (cv; HINOHIKARI) seeds were sown and the plants were grown in a greenhouse for 20 days. Thereafter, the present compound 19, 44, or 80, each of which was made to a formulation according to the similar method to that of Formulation Example 6, was mixed with water so as to be 200 ppm. The mixtures were sprayed to foliar parts so as to adhere adequately on the leaves of the above-mentioned rice. After spraying the mixtures, the rices were air-dried and were placed at 24° C. during daytime and 20° C. during nighttime under a high humidity for 6 to 7 days while the above-mentioned spraying-treated rice were contacted rice seedlings (cv; Hinohikari) infected by Pyricularia oryzae, and a lesion area was observed. As a result, every of the lesion areas in rice treated with each of the present compounds showed 30% or less compared to the lesion are in an untreated rice.
Each of plastic pots was filled with soil and thereto barley (cv; NISHINOHOSHI) seeds were sown and the barleys were grown in a greenhouse for 7 days. Thereafter, the present compound 2, 4 to 6, 13, 14, 16, 18 to 20, 26, 34, 39, 46 to 49, 51, 52, 54, 55, 57, 58, 64, 67, 68, 75 to 77, 80 to 83, 85 to 88, or 89, each of which was made to a formulation according to the similar method to that of Formulation Example 6, was mixed with water so as to be a prescribed concentration (200 ppm). The resulting mixtures were sprayed to foliar parts so as to adhere adequately on the leaves of the above-mentioned barley. After spraying the mixtures, the barleys were air-dried and after 1 day, an aqueous suspension of the conidia of Pyrenophora teres was spraying-inoculated. After the inoculation, the barleys were placed at 23° C. during daytime and 20° C. during nighttime under a high humidity for 3 day and then cultivated in a greenhouse for 7 days, and a lesion area was observed. As a result, every of the lesion areas in barleys treated with each of the present compounds showed 30% or less compared to the lesion area in an untreated barley.
Each of plastic pots was filled with soil and thereto cucumber (cv; SAGAMIHANJIRO) seeds were sown and the cucumbers were grown in a greenhouse for 12 days. Thereafter, the present compound 2, 47, or 61, each of which was made to a formulation according to the similar method to that of Formulation Example 6, was mixed with water so as to be 200 ppm. The mixtures were sprayed to foliar parts so as to adhere adequately on the leaves of the above-mentioned cucumber. After spraying the mixtures, the cucumbers were air-dried and after 1 day, an aqueous suspension of a spore of Pseudoperonospora cubensis was spraying-inoculated. After the inoculation, the cucumbers were placed firstly at 23° C. under a high humidity for 1 day and were then cultivated in a greenhouse for 10 days, and a lesion area was observed. As a result, every of the lesion areas in cucumbers treated with each of the present compounds showed 30% or less compared to the lesion area in an untreated cucumber.
Each of plastic pots was filled with soil and thereto wheat (cv; SHIROGANE) seeds were sown and the wheats were grown in a greenhouse for 9 days. The present compound 2 to 6, 10 to 16, 18, 19, 20, 25, 26, 29, 31, 32, 34, 35, 39 to 42, 46, 47, 49, 52 to 64, 66 to 68, 73, 75 to 78, 80, 81, 83 to 89, or 90, each of which was made to a formulation according to the similar method to that of Formulation Example 6, was mixed with water so as to be 200 ppm, and the mixtures were sprayed to foliar parts so as to adhere adequately on the leaves of the above-mentioned wheat. After spraying the mixtures, the wheats were air-dried and were then cultivated at 20° C. under lighting for 5 to 7 days. The conidia of Puccinia recondita were sprinkling-inoculated. After the inoculation, the wheats were placed under a dark and humid condition at 23° C. for 1 day and were then cultivated at 20° C. under lighting for 8 days, and a lesion area was observed. As a result, every of the lesion areas in wheats treated with each of the present compounds showed 30% or less compared to the lesion area in an untreated wheat.
Each of plastic pots was filled with soil and thereto wheat (cv; Apogee) seeds were sown and the wheats were grown in a greenhouse for 10 days. Thereafter, the present compound 1, 3 to 6, 10, 11, 13 to 16, 18 to 21, 25, 26, 29 to 37, 39, 40, 46 to 49, 51, 53 to 55, 57, 58, 64, 72, 73, 75, 77 to 80, 82, 83, 85 to 88, or 89, each of which was made to a formulation according to the similar method to that of Formulation Example 6, was mixed with water so as to be 200 ppm. The mixtures were sprayed to foliar parts so as to adhere adequately on the leaves of the above-mentioned wheat. After spraying the mixtures, the wheats were air-dried and after 4 days, an aqueous suspension of the conidia of Septoria tritici was spraying-inoculated. After the inoculation, the wheats were placed at 18° C. under a high humidity for 3 days and then under lighting for 14 to 18 days, and a lesion area was observed. As a result, every of the lesion areas in wheats treated with each of the present compounds showed 30% or less compared to the lesion area in an untreated wheat.
Each of plastic pots was filled with soil and thereto wheat (cv; Apogee) seeds were sown and the wheats were grown in a greenhouse for 10 days. Thereafter, the present compound 3 to 5, 7 to 11, 15, 16, 21, 25, 26, 29, 31, 34, 37, 39, 44, 46, 47, 49, 57, 58, 71 to 75, 77 to 82, 84, 88, 89, or 90, each of which was made to a formulation according to the similar method to that of Formulation Example 6, was mixed with water so as to be 200 ppm. The mixtures were sprayed to foliar parts so as to adhere adequately on the leaves of the above-mentioned wheat. After spraying the mixtures, the wheats were air-dried and were placed under lighting for 14 to 18 days, and a lesion area was observed. As a result, every of the lesion areas in wheats treated with each of the present compounds showed 30% or less compared to the lesion area in an untreated wheat.
Each of plastic pots was filled with soils and thereto tomato (cv; PATIO) seeds were sown and the tomatoes were grown in a greenhouse for 20 days. Thereafter, the present compound 2, 11 to 14, 16, 18 to 21, 29, 35, 39, 49, 51, 52, 55, 56, 60 to 64, 66, 76, 80, 85, or 86, each of which was made to a formulation according to the similar method to that of Formulation Example 6, was mixed with water so as to be 200 ppm. The mixtures were sprayed to foliar parts so as to adhere adequately on the leaves of the above-mentioned tomato. After spraying the mixtures, the tomatoes were air-dried and after 1 day, an aqueous suspension of the spores of Phytophthora infestans were spraying-inoculated. After the inoculation, the tomatoes were placed in a greenhouse of 23° C. during daytime and 20° C. during nighttime under a high humidity for 1 day, and a lesion area was observed. As a result, every of the lesion areas in tomatoes treated with each of the present compounds showed 30% or less compared to the lesion area in an untreated tomato.
Each of plastic pots was filled with soil and thereto soybean (cv: Kurosengoku) seeds were sown and the soybeans were grown in a greenhouse for 10 to 14 days. Thereafter, the present compound 1 to 16, 18 to 23, 25, 26, 29 to 32, 34, 35, 37 to 40, 44 to 46, 48, 49, 51 to 59, 61 to 64, 68, 71 to 73, 75 to 77, 79 to 83, 85 to 89, or 90, each of which was made to a formulation according to the similar method to that of Formulation Example 6, was mixed with water so as to be 200 ppm. The resulting mixtures were sprayed to foliar parts so as to adhere adequately on the leaves of the above-mentioned soybean. After spraying the mixtures, the soybeans were air-dried and after 2 to 5 days, an aqueous suspension of the conidia of Phakopsora pachyrhizi was spraying-inoculated. After the inoculation, the soybeans were placed in a greenhouse of 23° C. during daytime and 20° C. during nighttime under a high humidity for 1 to 2 days, and were then cultivated in the greenhouse for 12 days, and a lesion area was observed. As a result, every of the lesion areas in soybean treated with each of the present compounds showed 30% or less compared to the lesion area in an untreated soybean.
Each of plastic pots was filled with soil and thereto soybean (cv: Kurosengoku) seeds were sown and the soybeans were grown in a greenhouse for 10 days, and an aqueous suspension containing the conidia of Phakopsora pachyrhizi was spraying-inoculated. After the inoculation, the soybeans were placed in a greenhouse of 23° C. during daytime and 20° C. during nighttime under a high humidity for 1 day, and were then cultivated in the greenhouse for 1 to 2 days, and thereafter, the present compound 1 to 16, 18, 19, 21 to 23, 25, 26, 37, 40, 44, 46, 47 to 49, 57, 58, 68, 71 to 77, 80 to 82, 89, or 90, each of which was made to a formulation according to the similar method to that of Formulation Example 6, was mixed with water so as to be 200 ppm, and the resulting mixtures were sprayed to foliar parts so as to adhere adequately on the leaves of the above-mentioned soybean. After spraying the mixtures, the soybeans were air-dried and cultivated in a greenhouse for 8 days, and a lesion area was then observed. As a result, every of the lesion areas in soybean treated with each of the present compounds showed 30% or less compared to the lesion area in an untreated soybean.
Each of plastic pots was filled with soil and thereto soybean (cv: Tachinagawa) seeds were sown and the soybeans were grown in a greenhouse for 13 days. Thereafter, the present compound 1 to 16, 18 to 21, 25, 26, 29 to 35, 37, 39, 40, 44, 46 to 49, 54 to 58, 64, 71 to 89, or 90, each of which was made to a formulation according to the similar method to that of Formulation Example 6, was mixed with water so as to be 200 ppm. The resulting mixtures were sprayed to foliar parts so as to adhere adequately on the leaves of the above-mentioned soybean. After spraying the mixtures, the soybeans were air-dried and after 1 day, an aqueous suspension of the conidia of Cercospora sojina was spraying-inoculated. After the inoculation, the soybeans were placed in a greenhouse of 23° C. during daytime and 20° C. during nighttime under a high humidity for 3 days, and were then cultivated in the greenhouse for 16 days, and a lesion area was observed. As a result, every of the lesion areas in soybean treated with each of the present compounds showed 30% or less compared to the lesion area in an untreated soybean.
Each of plastic pots was filled with soils and thereto tomato (cv; PATIO) seeds were sown and the tomatoes were grown in a greenhouse for 20 days. Thereafter, the present compound 3 to 6, 9, 11 to 16, 18 to 20, 29, 32, 35, 36, 44, 51, 57 to 59, 68, 71, 75, 76, 80, 86, or 87, each of which was made to a formulation according to the similar method to that of Formulation Example 6, was mixed with water so as to be 200 ppm. The resulting mixtures were sprayed to foliar parts so as to adhere adequately on the leaves of the above-mentioned tomato. After spraying the mixtures, the tomatoes were air-dried and after 1 day, an aqueous suspension of the conidia of Alternaria solani were spraying-inoculated. After the inoculation, the tomatoes were placed at 18° C. under a high humidity for 6 days, and a lesion area was observed. As a result, every of the lesion areas in tomatoes treated with each of the present compounds showed 30% or less compared to the lesion area in an untreated tomato.
Each of plastic pots was filled with soil and thereto Kidney bean (cv; NAGAUZURA SAITO) seeds were sown and the kidney beans were grown in a greenhouse for 8 days. Thereafter, the present compound 2 to 16, 18 to 20, 25, 26, 29, 48, 53, 55, 57, 58, 64, 71, 76, 77, or 89, each of which was made to a formulation according to the similar method to that of Formulation Example 6, was mixed with water so as to be 200 ppm. The resulting mixtures were sprayed to the foliar parts so as to adhere adequately on the leaves of the above-mentioned kidney bean. After spraying the mixtures, the kidney beans were air-dried and a PDA medium containing hyphae of Sclerotinia sclerotiorum was placed on the leaves of the kidney bean. After the inoculation, all kidney beans were placed under a high humidity during only night and after 4 days, a lesion area was observed. As a result, every of the lesion areas in kidney beans treated with each of the present compounds showed 30% or less compared to the lesion area in an untreated kidney beans.
Next, it is shown that the present compound is useful for control on harmful arthropod.
Test Method 23
The present compound is made to a formulation according to a similar method to that described in the Formulation Example 6, and thereto is added water containing 0.03 v/v % of a spreader to prepare a diluted solution containing a prescribed concentration of the test compound.
Cabbage (Brassicae oleracea) seedling (on the developmental stage of the second to third true leaf) is planted in a cup, and the diluted solutions are sprayed into the seedling at a ratio of 20 mL/seedling. Thereafter, the stem and leaf of the seedling is cut out and is then installed into the container that is covered with the filter paper. Five (5) cabbage moth (Plutella xylostella) at the second instar larval stages are released into the cup. After 5 days, the surviving insects are counted, and the mortality of insects is calculated by the following equation.
Mortality (%)={1−the number of the surviving insects/5}×100
The test was conducted at the prescribed concentration of 500 ppm by using the present compound 28 according to the Test method 23, and as a result, the present compound 28 showed 100% as a mortality.
The compound of the present invention has efficacies on controlling pests, and can be used to control pests.
| Number | Date | Country | Kind |
|---|---|---|---|
| 2019-120901 | Jun 2019 | JP | national |
| 2020-015184 | Jan 2020 | JP | national |
| Filing Document | Filing Date | Country | Kind |
|---|---|---|---|
| PCT/JP2020/025341 | 6/26/2020 | WO |
| Publishing Document | Publishing Date | Country | Kind |
|---|---|---|---|
| WO2020/262648 | 12/30/2020 | WO | A |
| Number | Name | Date | Kind |
|---|---|---|---|
| 4802913 | Clough et al. | Feb 1989 | A |
| 20010029239 | Cramp et al. | Oct 2001 | A1 |
| 20030225158 | Auerbach et al. | Dec 2003 | A1 |
| Number | Date | Country |
|---|---|---|
| 0 212 859 | Mar 1987 | EP |
| 62-48649 | Mar 1987 | JP |
| 2001-64237 | Mar 2001 | JP |
| 2002-520384 | Jul 2002 | JP |
| 2005-521741 | Jul 2005 | JP |
| WO 0003975 | Jan 2000 | WO |
| WO 0041999 | Jul 2000 | WO |
| WO 0100562 | Jan 2001 | WO |
| Entry |
|---|
| RN2369626-33-3, registry database compound, 2019. |
| RN2239284-23-0, registry database compound, 2018. |
| Indian Office Action issued Nov. 24, 2023 in Indian Patent Application No. 202247003497, 7 pages. |
| International Search Report issued Aug. 18, 2020 in PCT/JP2020/025341 filed Jun. 26, 2020, 4 pages. |
| English translation of International Preliminary Report on Patentability and Written Opinion issued Dec. 28, 2021 in PCT/JP2020/025341, 6 pages. |
| Hideo Ishii, “Current Status of Qol-Resistant Bacteria,” Plant Protection, vol. 69, No. 8, 2015, 10 pages (with partial English language translation). |
| Extended European Search Report issued on Aug. 31, 2023 in European Patent Application No. 20833402.9, 10 pages. |
| Bolivian Office Action issued on Aug. 17, 2023 in Bolivian Patent Application No. SP-000093-2020 (with English translation), 27 pages. |
| First Office Action with Search Report issued Jun. 7, 2024 in corresponding Chinese Patent Application No. 202080046220.1 (with English-language Translation), 16 pages. |
| Office Action issued Jul. 9, 2024 in corresponding Japanese Patent Application No. 2021-527794 (with machine English translation), 10 pages. |
| Number | Date | Country | |
|---|---|---|---|
| 20220256844 A1 | Aug 2022 | US |
